data_1y29_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y29 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 19' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.205 0.526 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 16' ' ' ILE . 88.6 mt -70.76 140.43 86.54 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.456 -0.777 . . . . 0.0 110.399 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 43.7 Cg_endo -70.12 164.16 35.92 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.893 1.47 . . . . 0.0 110.596 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.0 130.63 19.38 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.753 1.396 . . . . 0.0 110.32 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.87 7.46 33.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.5 mmmt -86.09 125.83 67.1 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.996 -1.297 . . . . 0.0 109.845 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.4 Cg_endo -72.62 107.06 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.68 1.358 . . . . 0.0 110.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.553 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p -86.44 148.67 25.45 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -0.759 . . . . 0.0 110.14 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 78.22 2.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 110.305 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.87 -126.49 41.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.43 6.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.528 -0.984 . . . . 0.0 110.563 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.8 m -106.44 71.01 0.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.29 -0.881 . . . . 0.0 109.742 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -169.3 140.9 2.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.464 -0.772 . . . . 0.0 110.314 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 25.7 2.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.338 -0.851 . . . . 0.0 110.418 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.526 HD12 ' HD2' ' A' ' 17' ' ' PRO . 8.1 tp -116.85 116.5 38.2 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.586 -0.696 . . . . 0.0 109.866 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -76.0 126.88 9.62 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.806 1.424 . . . . 0.0 110.626 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -81.86 147.19 29.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 19.5 m -56.93 -35.67 69.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.397 -0.815 . . . . 0.0 110.305 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.59 -126.09 4.0 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.0 176.15 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.996 . . . . 0.0 109.896 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 m -82.07 113.26 19.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.467 -0.771 . . . . 0.0 109.996 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 44.1 t -119.43 102.6 8.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.919 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 54.06 53.79 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.517 -0.739 . . . . 0.0 109.976 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 64.27 43.88 4.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.727 -0.608 . . . . 0.0 110.608 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 27.2 mtmt -147.67 178.52 8.4 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.602 -0.686 . . . . 0.0 109.916 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.8 m -138.65 120.99 15.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.374 -0.829 . . . . 0.0 110.065 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.832 -1.08 . . . . 0.0 110.402 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.9 p . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 1.8 mt -78.64 137.91 58.64 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.539 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 41.5 Cg_endo -66.47 165.1 26.12 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.652 1.343 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.3 Cg_endo -68.43 124.07 11.22 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.084 1.57 . . . . 0.0 110.76 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.3 -19.14 13.36 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 36.0 mmtt -68.08 158.99 82.26 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.257 -1.143 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.6 155.79 40.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.896 1.472 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' HB3' ' N ' ' A' ' 26' ' ' LYS . 9.2 t -133.29 143.36 49.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.709 . . . . 0.0 109.456 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -122.54 148.14 45.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.432 -0.792 . . . . 0.0 110.768 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.46 144.6 16.53 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 57.29 27.77 14.21 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.791 -0.829 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 15.4 t -177.49 59.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.746 0.784 . . . . 0.0 109.964 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.418 ' HG2' HG21 ' A' ' 16' ' ' ILE . 11.4 tt0 -151.51 104.89 3.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.703 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -90.62 21.47 3.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.334 -0.854 . . . . 0.0 110.498 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 HG23 ' CD1' ' A' ' 3' ' ' LEU . 1.3 tp -138.45 114.19 8.83 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.72 146.81 24.14 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.721 1.379 . . . . 0.0 110.909 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 35.3 m -77.36 153.87 33.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 58.5 m -54.09 -35.13 61.78 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.231 -0.918 . . . . 0.0 109.745 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.82 -97.69 2.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.87 177.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.474 -1.015 . . . . 0.0 109.844 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 1.2 m -100.49 122.58 43.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -139.45 132.87 30.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.415 -0.803 . . . . 0.0 110.128 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.406 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 52.8 m-70 52.17 39.06 26.04 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.688 -0.633 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.82 40.61 7.45 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.458 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 31.0 mtmt -141.0 175.26 9.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.417 -0.802 . . . . 0.0 110.248 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 21.5 m -112.78 105.4 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.623 -0.673 . . . . 0.0 109.268 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.541 -179.615 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.503 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.3 p . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.249 0.547 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.563 ' CD1' HG13 ' A' ' 16' ' ' ILE . 1.2 mp -77.59 154.71 81.34 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 164.66 34.91 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.815 1.429 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.76 137.92 30.77 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.9 1.473 . . . . 0.0 110.699 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.63 5.01 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -61.95 123.52 77.95 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.365 -1.08 . . . . 0.0 110.602 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.719 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.09 134.36 23.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.059 1.557 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -94.36 160.14 14.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -112.68 108.01 16.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.25 -0.907 . . . . 0.0 110.439 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.87 -147.49 43.72 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.21 35.9 4.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.94 . . . . 0.0 110.558 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -143.65 96.42 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -153.04 158.8 42.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.564 -0.71 . . . . 0.0 110.614 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.92 22.69 3.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.434 -0.791 . . . . 0.0 110.537 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.563 HG13 ' CD1' ' A' ' 3' ' ' LEU . 5.4 tp -138.7 97.61 9.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.6 138.82 22.08 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.585 1.308 . . . . 0.0 110.968 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' SG ' HD13 ' A' ' 3' ' ' LEU . 67.5 m -80.48 160.41 25.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.561 -0.712 . . . . 0.0 110.03 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.503 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.0 m -61.43 -48.16 82.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.096 -1.002 . . . . 0.0 109.628 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.74 -118.98 4.53 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -133.34 171.74 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.52 -0.988 . . . . 0.0 109.448 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.24 107.51 20.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.431 -0.793 . . . . 0.0 110.47 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.7 p -126.93 145.19 50.77 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 34.43 24.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.28 -0.887 . . . . 0.0 110.275 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.56 35.44 9.25 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.612 -0.68 . . . . 0.0 111.674 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -161.75 139.89 9.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.065 -1.022 . . . . 0.0 110.118 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 52.6 m -78.84 127.32 31.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.445 -0.784 . . . . 0.0 110.386 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.783 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.511 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 2.4 p . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.543 HD12 HG23 ' A' ' 16' ' ' ILE . 1.8 mp -78.72 157.59 76.67 Favored Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 121.681 -0.637 . . . . 0.0 110.504 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 42.8 Cg_endo -68.09 167.42 21.87 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.848 1.446 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.39 135.91 30.09 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.882 1.464 . . . . 0.0 110.526 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.58 -18.56 44.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtm -61.36 121.64 64.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.281 -1.129 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.4 Cg_endo -71.44 113.0 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.814 1.429 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 17.6 p -101.71 161.23 13.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.43 -0.794 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.605 ' HB3' HG22 ' A' ' 13' ' ' THR . 73.9 m-85 -100.54 172.9 6.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.234 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.02 -45.53 1.17 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.41 26.52 9.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.376 -1.073 . . . . 0.0 111.352 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -170.88 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 110.446 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.98 96.57 2.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.71 24.99 2.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.543 HG23 HD12 ' A' ' 3' ' ' LEU . 4.0 tp -120.12 130.59 24.77 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.38 127.84 10.02 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.8 1.421 . . . . 0.0 110.995 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' SG ' HD13 ' A' ' 3' ' ' LEU . 1.3 m -90.65 163.35 14.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.612 -0.68 . . . . 0.0 109.974 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 86.8 m -68.99 -51.44 39.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.144 -0.972 . . . . 0.0 109.537 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.0 -116.54 2.7 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -137.11 174.0 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.542 -0.975 . . . . 0.0 109.676 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -91.8 97.46 11.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.375 -0.828 . . . . 0.0 110.074 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -128.41 139.45 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.54 -0.725 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.24 40.81 31.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.552 -0.717 . . . . 0.0 110.693 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.17 36.45 25.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.587 -0.695 . . . . 0.0 111.393 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.8 ptmt -159.71 169.51 23.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.145 -0.972 . . . . 0.0 110.39 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 65.3 m -111.68 131.35 55.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.338 -0.851 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.431 HG22 ' HE2' ' A' ' 26' ' ' LYS . 20.9 p . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.595 -0.691 . . . . 0.0 110.045 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.2 p . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.56 HD12 ' SG ' ' A' ' 18' ' ' CYS . 1.1 mt -78.54 153.32 78.69 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.444 -0.785 . . . . 0.0 109.983 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.36 159.38 46.85 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.81 1.426 . . . . 0.0 110.406 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.64 127.48 10.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.915 1.481 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.66 -28.91 7.51 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.68 140.42 98.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.383 -1.069 . . . . 0.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 43.8 Cg_endo -71.83 131.84 19.07 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.817 1.43 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -112.25 166.92 10.84 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.774 . . . . 0.0 110.5 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.11 149.52 38.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.457 -0.777 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.31 54.81 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 49.48 1.63 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -1.001 . . . . 0.0 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.7 m 56.09 91.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -111.41 160.53 17.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.384 -0.822 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -90.48 21.98 3.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.419 -0.801 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.556 HG13 ' CD1' ' A' ' 3' ' ' LEU . 7.9 tp -136.44 113.1 10.18 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.31 135.19 9.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.845 1.445 . . . . 0.0 111.119 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.56 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.9 m -81.3 152.39 27.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.314 -0.867 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -48.04 80.51 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.471 -0.768 . . . . 0.0 110.048 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.07 -119.13 4.56 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -130.66 175.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.484 -1.009 . . . . 0.0 109.427 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.4 t -108.4 131.58 54.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.449 -0.782 . . . . 0.0 110.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.65 125.28 23.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 57.49 43.92 22.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.055 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.498 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 2.0 t-20 59.79 34.91 22.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.798 -0.564 . . . . 0.0 110.785 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 5.4 mmpt? -140.14 125.15 18.51 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.443 -0.786 . . . . 0.0 109.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -86.15 134.53 33.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.254 -0.904 . . . . 0.0 110.804 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.538 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.162 0.506 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.543 HD13 HG23 ' A' ' 16' ' ' ILE . 2.7 mp -65.36 133.4 95.41 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.571 -0.705 . . . . 0.0 110.358 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.13 167.36 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.806 1.424 . . . . 0.0 110.616 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 128.69 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.869 1.458 . . . . 0.0 110.801 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.23 37.57 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -87.66 142.68 32.89 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.234 -1.156 . . . . 0.0 109.569 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.01 134.33 27.2 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.531 1.28 . . . . 0.0 110.743 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.32 144.05 30.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.602 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.449 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 93.2 m-85 -104.18 84.18 2.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.499 -0.751 . . . . 0.0 110.748 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 -147.51 50.1 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.52 40.61 3.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.911 . . . . 0.0 109.801 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -154.86 70.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.315 -0.865 . . . . 0.0 110.336 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -113.2 161.1 17.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.325 -0.859 . . . . 0.0 110.291 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.4 19.18 5.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.305 -0.872 . . . . 0.0 110.461 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.543 HG23 HD13 ' A' ' 3' ' ' LEU . 3.2 tp -142.47 122.76 8.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.533 -0.73 . . . . 0.0 110.084 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.46 138.94 17.94 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.706 1.372 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.3 m -90.01 155.28 19.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.601 -0.687 . . . . 0.0 110.092 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -63.53 -45.3 91.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.228 -0.92 . . . . 0.0 109.821 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.59 -115.68 3.21 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -136.36 174.82 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.549 -0.971 . . . . 0.0 109.825 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -97.12 104.98 17.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -144.59 146.7 32.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m170 54.76 40.24 31.82 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.6 -0.687 . . . . 0.0 110.925 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.93 35.52 26.48 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.566 -0.709 . . . . 0.0 111.194 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -162.88 177.57 9.14 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.293 -0.88 . . . . 0.0 110.652 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 55.3 m -118.86 134.1 55.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.695 . . . . 0.0 110.604 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.824 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.2 p . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 121.176 0.513 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.495 ' CD1' HG23 ' A' ' 16' ' ' ILE . 1.2 mp -86.34 150.12 51.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.361 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 40.1 Cg_endo -66.06 166.76 19.82 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.788 1.415 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.03 131.57 22.55 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.849 1.447 . . . . 0.0 111.357 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.2 55.53 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mmmt -78.23 149.18 75.69 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.975 -1.309 . . . . 0.0 110.185 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 45.6 Cg_endo -73.23 94.88 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.895 1.471 . . . . 0.0 110.51 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 18.5 p -87.66 144.83 26.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.429 -0.794 . . . . 0.0 110.378 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 7.0 m-85 -101.35 164.5 11.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.889 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.2 -79.6 0.69 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.45 28.9 7.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.979 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 m -141.27 68.89 1.33 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.228 -0.92 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 10' ' ' TYR . 24.2 tt0 -162.06 120.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.464 -0.772 . . . . 0.0 110.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -90.86 18.96 5.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.0 110.826 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.495 HG23 ' CD1' ' A' ' 3' ' ' LEU . 4.0 tp -142.87 114.36 5.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 110.129 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.27 147.84 29.84 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.523 1.275 . . . . 0.0 111.162 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.484 ' HA ' HD13 ' A' ' 3' ' ' LEU . 86.4 m -70.34 160.52 32.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.514 -0.741 . . . . 0.0 109.598 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 93.4 m -60.09 -33.11 71.65 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -89.51 1.86 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.13 177.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.465 -1.02 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -118.7 110.06 16.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -132.79 135.64 45.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.751 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.9 m170 53.18 38.04 26.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.652 -0.655 . . . . 0.0 109.938 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 1.2 t30 61.74 36.09 16.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.742 -0.599 . . . . 0.0 110.674 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 1.3 mmpt? -135.24 138.12 43.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 31.2 m -83.12 104.45 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.363 -0.835 . . . . 0.0 109.619 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.302 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.0 143.81 66.7 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 43.6 Cg_endo -71.4 167.07 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.862 1.454 . . . . 0.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.44 120.42 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.878 1.462 . . . . 0.0 110.88 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.87 -25.39 6.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -72.22 130.39 86.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.228 -1.16 . . . . 0.0 110.68 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 42.5 Cg_endo -70.36 128.23 15.2 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.79 1.416 . . . . 0.0 110.639 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.74 165.7 22.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.512 -0.743 . . . . 0.0 110.398 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.88 141.47 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 110.431 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.55 -152.93 29.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 54.19 41.03 32.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 58.2 m 60.35 107.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.742 -0.598 . . . . 0.0 111.265 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -117.09 147.64 42.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -91.12 24.8 2.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.344 -0.847 . . . . 0.0 110.716 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.36 112.56 11.02 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.94 138.88 9.39 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.866 1.456 . . . . 0.0 110.759 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.35 140.26 29.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.288 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -45.16 73.52 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.04 -131.77 7.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -127.06 172.63 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -1.045 . . . . 0.0 109.463 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.28 107.44 19.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.394 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -132.54 124.18 27.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 0.0 109.434 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 64.5 39.39 6.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.502 -0.748 . . . . 0.0 110.376 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 60.78 47.68 7.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.658 -0.651 . . . . 0.0 111.469 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -167.19 151.87 7.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 88.2 m -103.53 137.26 41.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 110.07 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.427 HG22 ' HE2' ' A' ' 26' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.197 0.522 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.04 152.65 62.47 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.58 -0.7 . . . . 0.0 110.547 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.984 1.518 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.6 Cg_endo -69.41 123.91 10.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.966 1.509 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.6 -24.27 5.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 136.72 96.84 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.188 -1.184 . . . . 0.0 110.13 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.12 135.07 18.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.693 1.365 . . . . 0.0 111.072 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.7 p -110.2 124.96 52.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -82.39 88.28 6.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.559 -0.713 . . . . 0.0 110.457 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 -156.78 53.07 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.93 30.9 6.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.427 -1.043 . . . . 0.0 110.384 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.6 m -143.9 90.22 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.326 -0.859 . . . . 0.0 109.858 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.11 168.75 23.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.446 -0.784 . . . . 0.0 110.562 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 23.69 2.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.564 -0.71 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.54 HG23 ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.5 107.79 12.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.77 129.88 4.18 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.705 1.371 . . . . 0.0 110.492 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.513 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.7 m -55.32 -43.96 75.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.54 -121.48 3.49 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.35 173.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.491 -1.005 . . . . 0.0 110.001 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.82 114.73 25.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.0 110.074 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.63 120.65 20.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.305 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.18 45.01 28.27 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.625 -0.672 . . . . 0.0 109.506 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.45 34.72 20.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.772 -0.58 . . . . 0.0 110.741 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.17 164.34 29.43 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.4 -0.813 . . . . 0.0 110.071 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 45.2 m -116.5 112.5 21.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.395 -0.816 . . . . 0.0 110.454 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.077 0.465 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.567 HD11 HG12 ' A' ' 16' ' ' ILE . 8.5 mp -83.26 149.96 59.64 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.478 -0.764 . . . . 0.0 110.801 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 Cg_endo -72.17 162.66 41.03 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.99 1.521 . . . . 0.0 110.65 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 44.7 Cg_endo -72.1 112.33 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.849 1.447 . . . . 0.0 110.705 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.83 -23.29 3.56 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -68.22 144.13 96.48 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.155 -1.203 . . . . 0.0 110.401 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 146.22 41.06 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.792 1.417 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 7.7 p -136.43 153.8 50.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.559 -0.713 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' HB3' HG22 ' A' ' 13' ' ' THR . 25.0 m-85 -114.3 175.15 5.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.671 -0.643 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.24 -45.68 1.06 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.98 25.75 4.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -1.152 . . . . 0.0 111.281 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 10' ' ' TYR . 9.2 t -173.31 66.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.253 -0.905 . . . . 0.0 110.245 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.19 93.63 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.921 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 23.65 3.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.491 -0.756 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 3' ' ' LEU . 8.2 tp -135.27 129.63 18.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 16' ' ' ILE . 51.3 Cg_endo -80.47 100.81 1.27 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.731 1.385 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.44 152.57 43.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.344 -0.848 . . . . 0.0 109.787 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -44.37 96.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.37 -0.831 . . . . 0.0 109.781 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.64 -123.88 4.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.09 174.7 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -1.069 . . . . 0.0 109.753 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 14.0 t -94.14 108.82 20.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.465 -0.772 . . . . 0.0 110.289 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 p -127.33 127.86 44.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.8 t-160 57.56 34.43 24.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.484 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 68.13 25.8 7.3 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.851 -0.531 . . . . 0.0 110.738 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' A' ' 25' ' ' ASN . 6.5 mmmm -130.23 156.72 44.15 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.369 -0.832 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -104.56 120.64 41.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.98 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.329 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' CYS . 77.8 mt -89.77 149.6 42.37 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.9 Cg_endo -69.98 160.17 50.6 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.65 1.342 . . . . 0.0 110.452 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.22 122.28 8.57 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.976 1.514 . . . . 0.0 110.503 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.82 -34.97 2.87 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 1.7 mmtm -60.44 158.44 29.52 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.562 -0.963 . . . . 0.0 110.555 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.35 161.58 42.34 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.782 1.412 . . . . 0.0 110.816 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -154.72 159.52 40.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.45 -0.781 . . . . 0.0 110.653 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.469 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 37.9 m-85 -126.6 144.31 50.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.655 -0.653 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 133.71 11.94 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.26 16.56 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 0.0 111.865 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 10' ' ' TYR . 12.8 t -173.81 69.84 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 110.595 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -150.33 141.79 23.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.997 -1.065 . . . . 0.0 111.045 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.01 11.82 21.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.217 -0.927 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.42 HG23 ' CD1' ' A' ' 3' ' ' LEU . 8.6 tp -150.15 127.55 5.56 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HD2' HD13 ' A' ' 16' ' ' ILE . 48.0 Cg_endo -78.83 148.5 22.43 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.727 1.383 . . . . 0.0 111.275 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 92.5 m -88.64 137.04 32.68 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -58.24 -39.05 78.11 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.01 -105.78 2.61 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.93 174.51 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.347 -1.09 . . . . 0.0 109.939 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 99.78 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' ASN . 20.9 m -88.89 -132.71 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.633 -0.667 . . . . 0.0 109.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.11 74.42 0.12 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.492 -0.755 . . . . 0.0 109.753 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' SER . 0.6 OUTLIER 57.47 48.64 14.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.434 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -167.44 146.71 5.05 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.319 -0.863 . . . . 0.0 111.37 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m -79.7 123.27 27.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.663 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 49.8 mt -77.67 148.77 76.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.0 Cg_endo -71.7 157.88 54.59 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.713 1.375 . . . . 0.0 109.957 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -74.43 114.46 4.04 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.885 1.466 . . . . 0.0 110.714 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.81 -27.74 5.86 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -57.4 151.85 36.13 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.341 -1.093 . . . . 0.0 110.427 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.28 108.19 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.906 1.477 . . . . 0.0 110.721 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -89.0 145.73 25.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.538 -0.726 . . . . 0.0 110.142 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . 8.3 m-85 -100.29 156.15 17.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.482 -0.761 . . . . 0.0 110.606 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.59 130.94 9.83 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.4 31.67 15.01 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.86 -0.788 . . . . 0.0 111.342 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -174.82 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.39 -0.819 . . . . 0.0 109.807 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -149.26 122.5 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.316 -0.865 . . . . 0.0 110.916 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -90.96 21.31 4.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.267 -0.895 . . . . 0.0 110.597 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 3' ' ' LEU . 6.9 tp -137.84 119.66 10.8 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.78 138.41 16.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.702 1.37 . . . . 0.0 111.169 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.4 t -78.6 146.22 34.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.562 -0.711 . . . . 0.0 109.283 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -50.5 60.73 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 109.532 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.19 1.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.76 177.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.493 -1.004 . . . . 0.0 110.111 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.34 112.45 24.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 110.379 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 28' ' ' THR . 5.9 t -95.41 -138.69 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.35 76.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.896 . . . . 0.0 108.962 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.515 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 60.69 35.05 19.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.658 -0.651 . . . . 0.0 110.079 -178.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.515 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 2.8 mmpt? -137.87 165.12 27.28 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.46 -0.775 . . . . 0.0 110.615 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.6 t -111.83 109.57 19.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 109.268 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 23' ' ' SER . 24.5 p . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.482 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.32 150.18 42.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.28 161.54 44.16 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.765 1.403 . . . . 0.0 110.943 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 114.51 4.05 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.836 1.44 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.97 -34.3 2.41 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -58.92 141.16 86.15 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.478 -1.013 . . . . 0.0 110.396 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.3 Cg_endo -72.49 137.77 28.53 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.987 1.519 . . . . 0.0 110.744 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 3.3 p -133.54 163.43 29.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.496 -0.752 . . . . 0.0 110.401 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.7 166.64 11.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.5 -62.31 4.94 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.63 37.46 2.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.558 -0.966 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m -136.55 73.26 1.45 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -164.13 128.18 2.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.511 -0.743 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -91.32 24.54 2.9 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.368 -0.833 . . . . 0.0 111.118 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.503 HD13 ' HD2' ' A' ' 17' ' ' PRO . 7.4 tp -124.49 126.71 25.4 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.379 -0.826 . . . . 0.0 110.246 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HD2' HD13 ' A' ' 16' ' ' ILE . 52.8 Cg_endo -76.05 124.79 8.19 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.804 1.423 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m -90.51 138.65 31.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.489 -0.757 . . . . 0.0 109.88 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -40.69 83.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.478 -0.764 . . . . 0.0 110.236 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -130.37 6.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -132.74 173.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.236 -1.155 . . . . 0.0 109.685 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.98 103.59 15.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.446 -0.784 . . . . 0.0 110.455 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 p -133.9 138.25 45.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 56.8 36.13 27.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.569 -0.707 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.06 30.2 17.83 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.577 -0.702 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 10.5 ptmt -156.01 149.41 24.69 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 53.0 m -87.0 128.55 35.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.416 -0.802 . . . . 0.0 110.383 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.612 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.361 0.6 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 13.4 mt -79.21 142.23 58.84 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 109.782 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.6 160.91 46.95 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.758 1.399 . . . . 0.0 110.108 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.93 110.7 2.98 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.745 1.392 . . . . 0.0 110.333 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.64 -37.36 2.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -56.76 140.01 76.14 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.42 -1.047 . . . . 0.0 110.092 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -69.47 128.07 15.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.64 1.337 . . . . 0.0 111.071 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -102.27 136.97 41.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.0 110.296 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.87 154.69 33.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.57 -0.706 . . . . 0.0 110.541 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 101.7 2.7 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.6 31.64 15.49 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.754 -0.85 . . . . 0.0 111.053 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.4 m -143.35 66.95 1.3 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.0 137.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.55 24.62 2.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.503 HD12 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -140.93 113.8 7.01 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.724 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.69 152.54 47.93 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.681 1.358 . . . . 0.0 111.568 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -82.21 143.11 31.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.638 -0.663 . . . . 0.0 109.463 179.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -52.98 57.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.492 -0.755 . . . . 0.0 109.439 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.18 -98.97 1.13 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.57 174.02 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.39 -1.065 . . . . 0.0 110.273 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -102.84 97.64 7.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.738 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -136.33 156.45 48.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.0 109.688 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 52.46 33.7 13.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 58.23 42.92 21.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 0.0 110.678 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 ptmt -167.74 163.65 14.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.349 -0.844 . . . . 0.0 111.078 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 35.6 t -88.5 121.19 30.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.683 -0.636 . . . . 0.0 109.626 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.596 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.5 p . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 121.415 0.626 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.548 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mt -74.33 136.55 75.29 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 0.0 110.45 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 40.9 Cg_endo -67.65 163.66 34.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.794 1.418 . . . . 0.0 110.644 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.53 131.88 22.49 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.851 1.448 . . . . 0.0 110.352 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.87 -34.01 4.81 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -59.93 156.69 34.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.515 -0.991 . . . . 0.0 110.136 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.24 169.35 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.82 1.432 . . . . 0.0 111.085 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 15.3 t -143.74 144.97 32.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.644 -0.66 . . . . 0.0 109.406 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -97.89 72.84 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 110.771 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.09 -143.44 37.28 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.65 32.45 5.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.934 . . . . 0.0 110.475 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 m -135.8 89.15 2.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -159.35 147.41 17.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.499 -0.75 . . . . 0.0 110.131 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 23.03 3.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.335 -0.853 . . . . 0.0 111.171 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.548 ' CG1' HD11 ' A' ' 3' ' ' LEU . 9.0 tp -119.66 120.73 30.4 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 109.935 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' HD13 ' A' ' 16' ' ' ILE . 55.2 Cg_endo -76.48 124.63 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.869 1.457 . . . . 0.0 111.649 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.3 m -90.29 148.27 22.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.441 -0.787 . . . . 0.0 108.92 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.6 m -60.41 -36.94 79.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.13 -121.92 4.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.28 175.55 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.487 -1.008 . . . . 0.0 109.768 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 34.6 t -97.72 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.845 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 p -132.17 129.48 39.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.643 -0.661 . . . . 0.0 109.957 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.477 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 91.6 m-70 55.95 36.87 28.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.618 -0.676 . . . . 0.0 110.42 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 2.1 t30 67.56 24.51 8.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.787 -0.57 . . . . 0.0 111.091 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 24' ' ' HIS . 1.1 mmmt -127.8 172.15 11.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 0.0 109.779 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 1.4 m -126.11 124.66 41.07 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.378 -0.826 . . . . 0.0 109.968 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.448 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.423 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.2 p . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.137 0.494 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.567 ' HG ' HD13 ' A' ' 16' ' ' ILE . 92.8 mt -90.49 161.12 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.418 -0.801 . . . . 0.0 110.581 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.36 162.79 41.23 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.914 1.481 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.33 112.42 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.861 1.453 . . . . 0.0 110.314 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.56 2.43 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -55.75 129.28 71.02 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.366 -1.079 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.56 130.43 16.0 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.686 1.361 . . . . 0.0 110.847 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 13.3 p -117.15 166.55 12.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.605 -0.684 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.85 172.01 7.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.348 -0.845 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.33 -74.43 1.07 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.18 30.26 6.07 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.931 . . . . 0.0 110.699 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.9 m -145.37 69.28 1.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.38 101.21 5.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -91.55 25.31 2.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.709 . . . . 0.0 110.389 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.603 HD11 ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -134.71 131.91 20.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HD2' HD11 ' A' ' 16' ' ' ILE . 51.0 Cg_endo -73.33 117.32 5.04 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.83 1.437 . . . . 0.0 110.768 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.5 141.97 28.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.306 -0.871 . . . . 0.0 109.85 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -61.4 -45.44 94.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.61 -123.56 4.2 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.5 t -137.91 174.78 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.609 -0.936 . . . . 0.0 109.599 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.9 98.96 11.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -133.54 144.07 49.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.537 -0.727 . . . . 0.0 109.863 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 53.11 40.19 30.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.594 -0.691 . . . . 0.0 110.663 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.84 32.52 22.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.089 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 7.0 ptmt -159.25 169.6 23.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 21.4 m -103.86 129.72 51.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.77 . . . . 0.0 110.21 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.687 179.784 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.224 0.535 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 16' ' ' ILE . 3.7 mp -87.48 149.44 46.61 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.488 -0.757 . . . . 0.0 110.097 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.27 164.6 35.14 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.986 1.519 . . . . 0.0 110.459 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.56 123.79 9.76 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.978 1.515 . . . . 0.0 110.021 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.63 -39.81 1.72 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -56.34 128.92 74.22 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.682 -0.893 . . . . 0.0 109.909 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.16 127.45 11.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.7 1.368 . . . . 0.0 110.626 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 142.66 35.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.474 -0.766 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -86.51 77.94 9.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.227 -0.921 . . . . 0.0 110.959 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.78 -136.22 33.26 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.77 30.04 6.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.462 -1.022 . . . . 0.0 110.602 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -130.98 88.59 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.66 132.88 29.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 18.44 6.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.57 HG23 HD11 ' A' ' 3' ' ' LEU . 8.8 tp -139.97 122.99 10.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.89 130.37 11.36 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.689 1.363 . . . . 0.0 110.921 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' HD12 ' A' ' 3' ' ' LEU . 12.6 m -83.1 148.0 27.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.75 . . . . 0.0 109.386 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.33 83.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.243 -0.911 . . . . 0.0 109.841 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 -130.47 6.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -132.07 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.397 -1.061 . . . . 0.0 109.57 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 25' ' ' ASN . 43.5 t -91.67 97.7 11.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.418 -0.801 . . . . 0.0 110.296 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -98.63 113.84 26.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 55.63 46.32 22.98 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 109.089 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.485 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 3.0 t30 63.58 36.63 10.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.809 -0.557 . . . . 0.0 110.595 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 3.1 mmpt? -138.49 114.33 9.95 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 18.5 m -71.21 117.18 12.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 109.701 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.515 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 16' ' ' ILE . 1.1 mp -90.11 158.0 44.7 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -72.34 158.69 51.07 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.821 1.432 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 122.11 7.2 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.874 1.46 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.66 -34.74 3.81 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 26.3 mmtm -59.65 148.46 74.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.544 -0.974 . . . . 0.0 110.1 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.1 Cg_endo -70.77 136.27 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.728 1.383 . . . . 0.0 110.799 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -111.24 145.98 37.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.798 -0.564 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -92.87 71.67 4.78 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.363 -0.836 . . . . 0.0 110.562 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.16 -143.94 33.13 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.47 48.48 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.466 -1.02 . . . . 0.0 109.968 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.1 t -150.27 64.67 0.96 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.277 -0.889 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -138.89 168.15 20.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.355 -0.841 . . . . 0.0 110.275 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 15.8 5.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 0.0 111.246 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 3' ' ' LEU . 7.4 tp -147.48 101.48 3.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 110.082 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.56 138.18 23.84 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.523 1.275 . . . . 0.0 111.389 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 t -63.99 145.74 55.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.759 -0.588 . . . . 0.0 109.763 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -50.32 70.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.768 . . . . 0.0 109.353 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.36 -96.7 0.89 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.84 175.57 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.56 -0.965 . . . . 0.0 109.986 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.3 t -105.89 113.61 27.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.512 -0.743 . . . . 0.0 110.031 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.494 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 4.3 t -100.12 -139.57 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -70.22 80.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.784 . . . . 0.0 110.25 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.65 49.58 8.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.768 -0.582 . . . . 0.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 6.3 ptmt -161.8 161.2 29.0 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.292 -0.88 . . . . 0.0 110.74 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -107.07 112.37 25.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.453 -0.78 . . . . 0.0 110.005 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 179.822 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 24.9 p . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 16' ' ' ILE . 1.2 mt -86.51 135.08 36.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.483 -0.761 . . . . 0.0 110.266 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.4 172.37 10.31 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.823 1.433 . . . . 0.0 111.011 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.42 124.89 11.68 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.852 1.448 . . . . 0.0 111.004 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.571 ' HA2' ' HD3' ' A' ' 26' ' ' LYS . . . 107.81 6.03 32.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -88.2 152.84 50.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.101 -1.235 . . . . 0.0 109.787 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD2' ' HE2' ' A' ' 7' ' ' LYS . 45.8 Cg_endo -70.99 135.43 27.5 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.73 1.384 . . . . 0.0 111.032 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 147.05 49.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.01 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -102.45 173.61 6.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.327 -0.858 . . . . 0.0 110.486 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.74 -99.61 0.05 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.6 34.72 3.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -1.04 . . . . 0.0 110.721 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.6 m -140.41 79.15 1.69 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.287 -0.883 . . . . 0.0 109.768 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.569 ' CG ' HG22 ' A' ' 16' ' ' ILE . 26.9 tt0 -163.48 117.38 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -90.91 21.89 3.93 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.434 -0.791 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.569 HG22 ' CG ' ' A' ' 14' ' ' GLN . 3.3 tp -131.65 107.23 14.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.333 -0.855 . . . . 0.0 109.512 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.6 143.98 35.01 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.743 1.391 . . . . 0.0 111.336 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 31.4 m -76.38 158.24 31.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.546 -0.721 . . . . 0.0 109.439 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 89.3 m -57.64 -32.16 66.99 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.9 -93.66 1.94 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.56 178.94 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.603 -0.94 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 1.1 m -104.21 117.55 34.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.9 p -134.89 128.62 32.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.96 52.64 14.04 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.717 -0.615 . . . . 0.0 110.415 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 39.93 31.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.657 -0.652 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HD3' ' HA2' ' A' ' 6' ' ' GLY . 3.8 ttmt -142.78 161.44 38.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 13.9 m -107.28 106.97 17.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.512 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.187 0.518 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.539 ' CD1' HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.08 152.69 62.39 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.574 -0.704 . . . . 0.0 110.535 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.996 1.524 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.4 123.8 10.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.939 1.494 . . . . 0.0 110.782 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.76 -24.28 5.5 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 136.67 96.82 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.128 -1.219 . . . . 0.0 110.099 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.09 134.99 18.33 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.661 1.348 . . . . 0.0 111.204 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.6 p -110.2 124.9 52.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.0 109.848 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -82.39 88.33 6.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.445 -0.784 . . . . 0.0 110.38 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.32 -156.68 53.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 30.87 6.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -1.001 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 m -143.89 90.17 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.845 . . . . 0.0 109.858 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.99 168.88 22.58 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 23.71 2.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.51 107.8 12.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 109.753 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.79 129.89 4.16 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.689 1.363 . . . . 0.0 110.529 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.512 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.3 m -55.28 -43.99 75.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.383 -0.823 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.44 -121.54 3.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.31 173.5 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.559 -0.965 . . . . 0.0 110.025 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.9 114.71 25.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 0.0 110.054 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.64 120.75 21.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.1 45.03 28.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.534 -0.728 . . . . 0.0 109.523 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.42 34.79 20.54 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.763 -0.585 . . . . 0.0 110.685 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.13 164.18 29.79 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.413 -0.805 . . . . 0.0 110.182 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 46.2 m -116.43 112.46 21.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 109.695 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.0 110.508 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.162 0.506 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 19' ' ' CYS . 12.4 t -70.49 156.6 39.17 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.36 -0.837 . . . . 0.0 110.536 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.49 HD21 HG12 ' A' ' 16' ' ' ILE . 88.6 mt -70.76 140.43 86.54 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.456 -0.777 . . . . 0.0 110.399 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 43.7 Cg_endo -70.12 164.16 35.92 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.893 1.47 . . . . 0.0 110.596 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.0 130.63 19.38 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.753 1.396 . . . . 0.0 110.32 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.87 7.46 33.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.452 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.5 mmmt -86.09 125.83 67.1 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.996 -1.297 . . . . 0.0 109.845 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.4 Cg_endo -72.62 107.06 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.68 1.358 . . . . 0.0 110.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.553 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p -86.44 148.67 25.45 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -0.759 . . . . 0.0 110.14 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 78.22 2.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 110.305 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.87 -126.49 41.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.43 6.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.528 -0.984 . . . . 0.0 110.563 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.8 m -106.44 71.01 0.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.29 -0.881 . . . . 0.0 109.742 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -169.3 140.9 2.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.464 -0.772 . . . . 0.0 110.314 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 25.7 2.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.338 -0.851 . . . . 0.0 110.418 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.526 HD12 ' HD2' ' A' ' 17' ' ' PRO . 8.1 tp -116.85 116.5 38.2 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.586 -0.696 . . . . 0.0 109.866 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -76.0 126.88 9.62 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.806 1.424 . . . . 0.0 110.626 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -81.86 147.19 29.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 19.5 m -56.93 -35.67 69.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.397 -0.815 . . . . 0.0 110.305 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.59 -126.09 4.0 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.0 176.15 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.996 . . . . 0.0 109.896 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 m -82.07 113.26 19.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.467 -0.771 . . . . 0.0 109.996 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 44.1 t -119.43 102.6 8.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.919 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 54.06 53.79 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.517 -0.739 . . . . 0.0 109.976 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 64.27 43.88 4.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.727 -0.608 . . . . 0.0 110.608 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 27.2 mtmt -147.67 178.52 8.4 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.602 -0.686 . . . . 0.0 109.916 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.8 m -138.65 120.99 15.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.374 -0.829 . . . . 0.0 110.065 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.832 -1.08 . . . . 0.0 110.402 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 120.929 0.395 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.4 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.9 p -163.01 170.52 17.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.0 110.647 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 1.8 mt -78.64 137.91 58.64 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.539 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 41.5 Cg_endo -66.47 165.1 26.12 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.652 1.343 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.3 Cg_endo -68.43 124.07 11.22 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.084 1.57 . . . . 0.0 110.76 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.3 -19.14 13.36 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.539 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 36.0 mmtt -68.08 158.99 82.26 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.257 -1.143 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.6 155.79 40.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.896 1.472 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' HB3' ' N ' ' A' ' 26' ' ' LYS . 9.2 t -133.29 143.36 49.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.709 . . . . 0.0 109.456 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -122.54 148.14 45.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.432 -0.792 . . . . 0.0 110.768 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.46 144.6 16.53 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 57.29 27.77 14.21 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.791 -0.829 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 15.4 t -177.49 59.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.746 0.784 . . . . 0.0 109.964 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.418 ' HG2' HG21 ' A' ' 16' ' ' ILE . 11.4 tt0 -151.51 104.89 3.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.703 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -90.62 21.47 3.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.334 -0.854 . . . . 0.0 110.498 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 HG23 ' CD1' ' A' ' 3' ' ' LEU . 1.3 tp -138.45 114.19 8.83 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.72 146.81 24.14 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.721 1.379 . . . . 0.0 110.909 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 35.3 m -77.36 153.87 33.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 58.5 m -54.09 -35.13 61.78 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.231 -0.918 . . . . 0.0 109.745 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.82 -97.69 2.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.87 177.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.474 -1.015 . . . . 0.0 109.844 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 1.2 m -100.49 122.58 43.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -139.45 132.87 30.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.415 -0.803 . . . . 0.0 110.128 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.406 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 52.8 m-70 52.17 39.06 26.04 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.688 -0.633 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.82 40.61 7.45 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.458 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 31.0 mtmt -141.0 175.26 9.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.417 -0.802 . . . . 0.0 110.248 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 21.5 m -112.78 105.4 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.623 -0.673 . . . . 0.0 109.268 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.541 -179.615 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.07 0.462 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.503 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.3 p -153.94 174.41 14.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.944 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.563 ' CD1' HG13 ' A' ' 16' ' ' ILE . 1.2 mp -77.59 154.71 81.34 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 164.66 34.91 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.815 1.429 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.76 137.92 30.77 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.9 1.473 . . . . 0.0 110.699 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.63 5.01 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -61.95 123.52 77.95 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.365 -1.08 . . . . 0.0 110.602 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.719 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.09 134.36 23.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.059 1.557 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -94.36 160.14 14.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -112.68 108.01 16.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.25 -0.907 . . . . 0.0 110.439 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.87 -147.49 43.72 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.21 35.9 4.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.94 . . . . 0.0 110.558 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -143.65 96.42 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -153.04 158.8 42.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.564 -0.71 . . . . 0.0 110.614 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.92 22.69 3.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.434 -0.791 . . . . 0.0 110.537 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.563 HG13 ' CD1' ' A' ' 3' ' ' LEU . 5.4 tp -138.7 97.61 9.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.6 138.82 22.08 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.585 1.308 . . . . 0.0 110.968 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' SG ' HD13 ' A' ' 3' ' ' LEU . 67.5 m -80.48 160.41 25.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.561 -0.712 . . . . 0.0 110.03 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.503 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.0 m -61.43 -48.16 82.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.096 -1.002 . . . . 0.0 109.628 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.74 -118.98 4.53 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -133.34 171.74 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.52 -0.988 . . . . 0.0 109.448 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.24 107.51 20.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.431 -0.793 . . . . 0.0 110.47 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.7 p -126.93 145.19 50.77 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 34.43 24.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.28 -0.887 . . . . 0.0 110.275 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.56 35.44 9.25 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.612 -0.68 . . . . 0.0 111.674 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.719 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -161.75 139.89 9.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.065 -1.022 . . . . 0.0 110.118 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 52.6 m -78.84 127.32 31.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.445 -0.784 . . . . 0.0 110.386 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.783 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.5 pttt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.238 0.542 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.511 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 2.4 p -165.12 177.21 7.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.436 -0.79 . . . . 0.0 110.804 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD12 HG23 ' A' ' 16' ' ' ILE . 1.8 mp -78.72 157.59 76.67 Favored Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 121.681 -0.637 . . . . 0.0 110.504 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 42.8 Cg_endo -68.09 167.42 21.87 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.848 1.446 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.39 135.91 30.09 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.882 1.464 . . . . 0.0 110.526 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.58 -18.56 44.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtm -61.36 121.64 64.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.281 -1.129 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.4 Cg_endo -71.44 113.0 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.814 1.429 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 17.6 p -101.71 161.23 13.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.43 -0.794 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.605 ' HB3' HG22 ' A' ' 13' ' ' THR . 73.9 m-85 -100.54 172.9 6.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.234 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.02 -45.53 1.17 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.41 26.52 9.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.376 -1.073 . . . . 0.0 111.352 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 10' ' ' TYR . 14.1 t -170.88 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 110.446 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.98 96.57 2.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.71 24.99 2.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.543 HG23 HD12 ' A' ' 3' ' ' LEU . 4.0 tp -120.12 130.59 24.77 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.38 127.84 10.02 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.8 1.421 . . . . 0.0 110.995 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' SG ' HD13 ' A' ' 3' ' ' LEU . 1.3 m -90.65 163.35 14.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.612 -0.68 . . . . 0.0 109.974 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 86.8 m -68.99 -51.44 39.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.144 -0.972 . . . . 0.0 109.537 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.0 -116.54 2.7 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -137.11 174.0 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.542 -0.975 . . . . 0.0 109.676 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -91.8 97.46 11.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.375 -0.828 . . . . 0.0 110.074 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -128.41 139.45 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.54 -0.725 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.24 40.81 31.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.552 -0.717 . . . . 0.0 110.693 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.17 36.45 25.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.587 -0.695 . . . . 0.0 111.393 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.8 ptmt -159.71 169.51 23.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.145 -0.972 . . . . 0.0 110.39 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 65.3 m -111.68 131.35 55.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.338 -0.851 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.431 HG22 ' HE2' ' A' ' 26' ' ' LYS . 20.9 p . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.595 -0.691 . . . . 0.0 110.045 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.289 0.566 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.2 p -160.75 172.16 17.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.462 -0.774 . . . . 0.0 110.62 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.56 HD12 ' SG ' ' A' ' 18' ' ' CYS . 1.1 mt -78.54 153.32 78.69 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.444 -0.785 . . . . 0.0 109.983 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.36 159.38 46.85 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.81 1.426 . . . . 0.0 110.406 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.64 127.48 10.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.915 1.481 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.66 -28.91 7.51 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.68 140.42 98.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.383 -1.069 . . . . 0.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 43.8 Cg_endo -71.83 131.84 19.07 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.817 1.43 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -112.25 166.92 10.84 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.774 . . . . 0.0 110.5 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.11 149.52 38.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.457 -0.777 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.31 54.81 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 49.48 1.63 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -1.001 . . . . 0.0 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.7 m 56.09 91.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -111.41 160.53 17.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.384 -0.822 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -90.48 21.98 3.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.419 -0.801 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.556 HG13 ' CD1' ' A' ' 3' ' ' LEU . 7.9 tp -136.44 113.1 10.18 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.31 135.19 9.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.845 1.445 . . . . 0.0 111.119 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.56 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.9 m -81.3 152.39 27.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.314 -0.867 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -48.04 80.51 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.471 -0.768 . . . . 0.0 110.048 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.07 -119.13 4.56 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -130.66 175.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.484 -1.009 . . . . 0.0 109.427 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.4 t -108.4 131.58 54.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.449 -0.782 . . . . 0.0 110.661 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.65 125.28 23.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 57.49 43.92 22.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.055 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 2.0 t-20 59.79 34.91 22.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.798 -0.564 . . . . 0.0 110.785 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 5.4 mmpt? -140.14 125.15 18.51 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.443 -0.786 . . . . 0.0 109.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -86.15 134.53 33.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.254 -0.904 . . . . 0.0 110.804 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.538 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.108 0.48 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.61 175.59 8.88 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.449 -0.782 . . . . 0.0 110.639 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.543 HD13 HG23 ' A' ' 16' ' ' ILE . 2.7 mp -65.36 133.4 95.41 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.571 -0.705 . . . . 0.0 110.358 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.13 167.36 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.806 1.424 . . . . 0.0 110.616 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 128.69 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.869 1.458 . . . . 0.0 110.801 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.23 37.57 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -87.66 142.68 32.89 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.234 -1.156 . . . . 0.0 109.569 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.01 134.33 27.2 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.531 1.28 . . . . 0.0 110.743 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.32 144.05 30.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.602 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.449 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 93.2 m-85 -104.18 84.18 2.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.499 -0.751 . . . . 0.0 110.748 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 -147.51 50.1 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.52 40.61 3.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.911 . . . . 0.0 109.801 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.1 t -154.86 70.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.315 -0.865 . . . . 0.0 110.336 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.449 ' HG2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -113.2 161.1 17.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.325 -0.859 . . . . 0.0 110.291 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.4 19.18 5.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.305 -0.872 . . . . 0.0 110.461 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.543 HG23 HD13 ' A' ' 3' ' ' LEU . 3.2 tp -142.47 122.76 8.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.533 -0.73 . . . . 0.0 110.084 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.46 138.94 17.94 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.706 1.372 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.3 m -90.01 155.28 19.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.601 -0.687 . . . . 0.0 110.092 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -63.53 -45.3 91.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.228 -0.92 . . . . 0.0 109.821 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.59 -115.68 3.21 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -136.36 174.82 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.549 -0.971 . . . . 0.0 109.825 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -97.12 104.98 17.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -144.59 146.7 32.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m170 54.76 40.24 31.82 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.6 -0.687 . . . . 0.0 110.925 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.93 35.52 26.48 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.566 -0.709 . . . . 0.0 111.194 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -162.88 177.57 9.14 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.293 -0.88 . . . . 0.0 110.652 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 55.3 m -118.86 134.1 55.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.695 . . . . 0.0 110.604 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.824 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.03 0.443 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.2 p -75.1 169.8 17.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.491 -0.756 . . . . 0.0 110.721 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.495 ' CD1' HG23 ' A' ' 16' ' ' ILE . 1.2 mp -86.34 150.12 51.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.361 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 40.1 Cg_endo -66.06 166.76 19.82 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.788 1.415 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.03 131.57 22.55 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.849 1.447 . . . . 0.0 111.357 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.2 55.53 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mmmt -78.23 149.18 75.69 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.975 -1.309 . . . . 0.0 110.185 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 45.6 Cg_endo -73.23 94.88 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.895 1.471 . . . . 0.0 110.51 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 18.5 p -87.66 144.83 26.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.429 -0.794 . . . . 0.0 110.378 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.565 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 7.0 m-85 -101.35 164.5 11.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.889 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.2 -79.6 0.69 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.45 28.9 7.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.979 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 m -141.27 68.89 1.33 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.228 -0.92 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 10' ' ' TYR . 24.2 tt0 -162.06 120.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.464 -0.772 . . . . 0.0 110.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -90.86 18.96 5.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.0 110.826 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.495 HG23 ' CD1' ' A' ' 3' ' ' LEU . 4.0 tp -142.87 114.36 5.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 110.129 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -76.27 147.84 29.84 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.523 1.275 . . . . 0.0 111.162 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.484 ' HA ' HD13 ' A' ' 3' ' ' LEU . 86.4 m -70.34 160.52 32.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.514 -0.741 . . . . 0.0 109.598 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 93.4 m -60.09 -33.11 71.65 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -89.51 1.86 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.13 177.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.465 -1.02 . . . . 0.0 110.028 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -118.7 110.06 16.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -132.79 135.64 45.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.751 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.9 m170 53.18 38.04 26.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.652 -0.655 . . . . 0.0 109.938 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 1.2 t30 61.74 36.09 16.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.742 -0.599 . . . . 0.0 110.674 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 1.3 mmpt? -135.24 138.12 43.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 31.2 m -83.12 104.45 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.363 -0.835 . . . . 0.0 109.619 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.302 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.178 0.513 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p -71.25 155.06 41.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.9 mp -78.0 143.81 66.7 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 43.6 Cg_endo -71.4 167.07 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.862 1.454 . . . . 0.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.44 120.42 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.878 1.462 . . . . 0.0 110.88 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.87 -25.39 6.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -72.22 130.39 86.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.228 -1.16 . . . . 0.0 110.68 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.699 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 42.5 Cg_endo -70.36 128.23 15.2 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.79 1.416 . . . . 0.0 110.639 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.74 165.7 22.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.512 -0.743 . . . . 0.0 110.398 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.88 141.47 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 110.431 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.55 -152.93 29.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 54.19 41.03 32.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 58.2 m 60.35 107.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.742 -0.598 . . . . 0.0 111.265 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -117.09 147.64 42.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -91.12 24.8 2.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.344 -0.847 . . . . 0.0 110.716 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.36 112.56 11.02 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.94 138.88 9.39 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.866 1.456 . . . . 0.0 110.759 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.35 140.26 29.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.288 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -45.16 73.52 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.04 -131.77 7.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -127.06 172.63 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -1.045 . . . . 0.0 109.463 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.28 107.44 19.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.394 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -132.54 124.18 27.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 0.0 109.434 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 64.5 39.39 6.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.502 -0.748 . . . . 0.0 110.376 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 60.78 47.68 7.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.658 -0.651 . . . . 0.0 111.469 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -167.19 151.87 7.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 88.2 m -103.53 137.26 41.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 110.07 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.427 HG22 ' HE2' ' A' ' 26' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.221 0.534 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.513 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p -119.26 172.89 7.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.475 -0.766 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' CD1' HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.04 152.65 62.47 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.58 -0.7 . . . . 0.0 110.547 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.984 1.518 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.6 Cg_endo -69.41 123.91 10.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.966 1.509 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.6 -24.27 5.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 136.72 96.84 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.188 -1.184 . . . . 0.0 110.13 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.12 135.07 18.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.693 1.365 . . . . 0.0 111.072 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.7 p -110.2 124.96 52.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -82.39 88.28 6.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.559 -0.713 . . . . 0.0 110.457 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 -156.78 53.07 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.93 30.9 6.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.427 -1.043 . . . . 0.0 110.384 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.6 m -143.9 90.22 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.326 -0.859 . . . . 0.0 109.858 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.11 168.75 23.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.446 -0.784 . . . . 0.0 110.562 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 23.69 2.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.564 -0.71 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.54 HG23 ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.5 107.79 12.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.77 129.88 4.18 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.705 1.371 . . . . 0.0 110.492 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.513 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.7 m -55.32 -43.96 75.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.54 -121.48 3.49 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.35 173.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.491 -1.005 . . . . 0.0 110.001 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.82 114.73 25.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.0 110.074 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.63 120.65 20.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.305 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.18 45.01 28.27 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.625 -0.672 . . . . 0.0 109.506 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.45 34.72 20.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.772 -0.58 . . . . 0.0 110.741 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.17 164.34 29.43 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.4 -0.813 . . . . 0.0 110.071 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 45.2 m -116.5 112.5 21.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.395 -0.816 . . . . 0.0 110.454 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.204 0.526 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 p -146.32 163.28 36.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.342 -0.849 . . . . 0.0 110.421 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.567 HD11 HG12 ' A' ' 16' ' ' ILE . 8.5 mp -83.26 149.96 59.64 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.478 -0.764 . . . . 0.0 110.801 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 Cg_endo -72.17 162.66 41.03 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.99 1.521 . . . . 0.0 110.65 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 44.7 Cg_endo -72.1 112.33 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.849 1.447 . . . . 0.0 110.705 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.83 -23.29 3.56 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -68.22 144.13 96.48 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.155 -1.203 . . . . 0.0 110.401 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.03 146.22 41.06 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.792 1.417 . . . . 0.0 111.057 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.613 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 7.7 p -136.43 153.8 50.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.559 -0.713 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' HB3' HG22 ' A' ' 13' ' ' THR . 25.0 m-85 -114.3 175.15 5.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.671 -0.643 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.24 -45.68 1.06 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.98 25.75 4.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -1.152 . . . . 0.0 111.281 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 10' ' ' TYR . 9.2 t -173.31 66.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.253 -0.905 . . . . 0.0 110.245 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.19 93.63 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.921 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 23.65 3.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.491 -0.756 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 3' ' ' LEU . 8.2 tp -135.27 129.63 18.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 16' ' ' ILE . 51.3 Cg_endo -80.47 100.81 1.27 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.731 1.385 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.44 152.57 43.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.344 -0.848 . . . . 0.0 109.787 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -44.37 96.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.37 -0.831 . . . . 0.0 109.781 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.64 -123.88 4.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 t -138.09 174.7 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -1.069 . . . . 0.0 109.753 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 14.0 t -94.14 108.82 20.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.465 -0.772 . . . . 0.0 110.289 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 p -127.33 127.86 44.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.8 t-160 57.56 34.43 24.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.484 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 68.13 25.8 7.3 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.851 -0.531 . . . . 0.0 110.738 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HD2' ' O ' ' A' ' 25' ' ' ASN . 6.5 mmmm -130.23 156.72 44.15 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.369 -0.832 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -104.56 120.64 41.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.98 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.329 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mttm . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.311 0.577 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.87 172.05 9.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 110.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' CYS . 77.8 mt -89.77 149.6 42.37 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.9 Cg_endo -69.98 160.17 50.6 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.65 1.342 . . . . 0.0 110.452 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.22 122.28 8.57 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.976 1.514 . . . . 0.0 110.503 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.82 -34.97 2.87 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 1.7 mmtm -60.44 158.44 29.52 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.562 -0.963 . . . . 0.0 110.555 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.35 161.58 42.34 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.782 1.412 . . . . 0.0 110.816 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -154.72 159.52 40.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.45 -0.781 . . . . 0.0 110.653 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 37.9 m-85 -126.6 144.31 50.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.655 -0.653 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 133.71 11.94 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.26 16.56 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 0.0 111.865 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.469 ' CG2' ' HB3' ' A' ' 10' ' ' TYR . 12.8 t -173.81 69.84 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 110.595 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -150.33 141.79 23.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.997 -1.065 . . . . 0.0 111.045 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.01 11.82 21.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.217 -0.927 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.42 HG23 ' CD1' ' A' ' 3' ' ' LEU . 8.6 tp -150.15 127.55 5.56 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.403 ' HD2' HD13 ' A' ' 16' ' ' ILE . 48.0 Cg_endo -78.83 148.5 22.43 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.727 1.383 . . . . 0.0 111.275 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 92.5 m -88.64 137.04 32.68 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -58.24 -39.05 78.11 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.01 -105.78 2.61 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.93 174.51 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.347 -1.09 . . . . 0.0 109.939 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 99.78 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' ASN . 20.9 m -88.89 -132.71 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.633 -0.667 . . . . 0.0 109.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.11 74.42 0.12 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.492 -0.755 . . . . 0.0 109.753 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' SER . 0.6 OUTLIER 57.47 48.64 14.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.434 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -167.44 146.71 5.05 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.319 -0.863 . . . . 0.0 111.37 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m -79.7 123.27 27.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.663 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p -83.44 168.75 16.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.452 -0.78 . . . . 0.0 110.422 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 49.8 mt -77.67 148.77 76.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.0 Cg_endo -71.7 157.88 54.59 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.713 1.375 . . . . 0.0 109.957 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -74.43 114.46 4.04 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.885 1.466 . . . . 0.0 110.714 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.81 -27.74 5.86 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -57.4 151.85 36.13 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.341 -1.093 . . . . 0.0 110.427 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.28 108.19 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.906 1.477 . . . . 0.0 110.721 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -89.0 145.73 25.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.538 -0.726 . . . . 0.0 110.142 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . 8.3 m-85 -100.29 156.15 17.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.482 -0.761 . . . . 0.0 110.606 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.59 130.94 9.83 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.4 31.67 15.01 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.86 -0.788 . . . . 0.0 111.342 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.1 t -174.82 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.39 -0.819 . . . . 0.0 109.807 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -149.26 122.5 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.316 -0.865 . . . . 0.0 110.916 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -90.96 21.31 4.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.267 -0.895 . . . . 0.0 110.597 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.468 HG21 ' CD1' ' A' ' 3' ' ' LEU . 6.9 tp -137.84 119.66 10.8 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.78 138.41 16.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.702 1.37 . . . . 0.0 111.169 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.4 t -78.6 146.22 34.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.562 -0.711 . . . . 0.0 109.283 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -50.5 60.73 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 109.532 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.19 1.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.0 t -144.76 177.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.493 -1.004 . . . . 0.0 110.111 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.34 112.45 24.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 110.379 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 28' ' ' THR . 5.9 t -95.41 -138.69 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.35 76.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.896 . . . . 0.0 108.962 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.515 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 60.69 35.05 19.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.658 -0.651 . . . . 0.0 110.079 -178.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.515 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 2.8 mmpt? -137.87 165.12 27.28 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.46 -0.775 . . . . 0.0 110.615 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.6 t -111.83 109.57 19.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 109.268 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 23' ' ' SER . 24.5 p . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.482 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.9 tttt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.071 0.462 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.5 p -87.98 172.28 9.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.8 mt -90.32 150.18 42.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.28 161.54 44.16 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.765 1.403 . . . . 0.0 110.943 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 114.51 4.05 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.836 1.44 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.97 -34.3 2.41 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -58.92 141.16 86.15 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.478 -1.013 . . . . 0.0 110.396 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.3 Cg_endo -72.49 137.77 28.53 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.987 1.519 . . . . 0.0 110.744 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.513 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 3.3 p -133.54 163.43 29.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.496 -0.752 . . . . 0.0 110.401 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.7 166.64 11.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.5 -62.31 4.94 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.63 37.46 2.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.558 -0.966 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m -136.55 73.26 1.45 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -164.13 128.18 2.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.511 -0.743 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -91.32 24.54 2.9 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.368 -0.833 . . . . 0.0 111.118 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.503 HD13 ' HD2' ' A' ' 17' ' ' PRO . 7.4 tp -124.49 126.71 25.4 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.379 -0.826 . . . . 0.0 110.246 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.503 ' HD2' HD13 ' A' ' 16' ' ' ILE . 52.8 Cg_endo -76.05 124.79 8.19 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.804 1.423 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.1 m -90.51 138.65 31.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.489 -0.757 . . . . 0.0 109.88 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -40.69 83.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.478 -0.764 . . . . 0.0 110.236 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -130.37 6.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -132.74 173.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.236 -1.155 . . . . 0.0 109.685 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.98 103.59 15.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.446 -0.784 . . . . 0.0 110.455 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 p -133.9 138.25 45.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 56.8 36.13 27.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.569 -0.707 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.06 30.2 17.83 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.577 -0.702 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 10.5 ptmt -156.01 149.41 24.69 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 53.0 m -87.0 128.55 35.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.416 -0.802 . . . . 0.0 110.383 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.612 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 120.664 0.269 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p -67.39 169.08 9.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.278 -0.889 . . . . 0.0 110.46 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 13.4 mt -79.21 142.23 58.84 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 109.782 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.6 160.91 46.95 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.758 1.399 . . . . 0.0 110.108 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.93 110.7 2.98 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.745 1.392 . . . . 0.0 110.333 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.64 -37.36 2.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -56.76 140.01 76.14 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.42 -1.047 . . . . 0.0 110.092 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -69.47 128.07 15.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.64 1.337 . . . . 0.0 111.071 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -102.27 136.97 41.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.0 110.296 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.87 154.69 33.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.57 -0.706 . . . . 0.0 110.541 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 101.7 2.7 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.6 31.64 15.49 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.754 -0.85 . . . . 0.0 111.053 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.4 m -143.35 66.95 1.3 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.0 137.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.55 24.62 2.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.503 HD12 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -140.93 113.8 7.01 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.724 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.69 152.54 47.93 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.681 1.358 . . . . 0.0 111.568 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.535 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -82.21 143.11 31.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.638 -0.663 . . . . 0.0 109.463 179.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -52.98 57.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.492 -0.755 . . . . 0.0 109.439 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.18 -98.97 1.13 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.57 174.02 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.39 -1.065 . . . . 0.0 110.273 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 45.9 t -102.84 97.64 7.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.738 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -136.33 156.45 48.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.0 109.688 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 52.46 33.7 13.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 58.23 42.92 21.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 0.0 110.678 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 ptmt -167.74 163.65 14.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.349 -0.844 . . . . 0.0 111.078 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 35.6 t -88.5 121.19 30.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.683 -0.636 . . . . 0.0 109.626 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.596 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 120.814 0.34 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.439 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.5 p -97.9 169.94 9.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.338 -0.851 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.548 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mt -74.33 136.55 75.29 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 0.0 110.45 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 40.9 Cg_endo -67.65 163.66 34.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.794 1.418 . . . . 0.0 110.644 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.53 131.88 22.49 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.851 1.448 . . . . 0.0 110.352 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.87 -34.01 4.81 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -59.93 156.69 34.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.515 -0.991 . . . . 0.0 110.136 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.24 169.35 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.82 1.432 . . . . 0.0 111.085 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 15.3 t -143.74 144.97 32.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.644 -0.66 . . . . 0.0 109.406 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -97.89 72.84 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 110.771 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.09 -143.44 37.28 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.65 32.45 5.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.934 . . . . 0.0 110.475 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 m -135.8 89.15 2.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -159.35 147.41 17.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.499 -0.75 . . . . 0.0 110.131 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 23.03 3.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.335 -0.853 . . . . 0.0 111.171 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.548 ' CG1' HD11 ' A' ' 3' ' ' LEU . 9.0 tp -119.66 120.73 30.4 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 109.935 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' HD13 ' A' ' 16' ' ' ILE . 55.2 Cg_endo -76.48 124.63 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.869 1.457 . . . . 0.0 111.649 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.545 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.3 m -90.29 148.27 22.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.441 -0.787 . . . . 0.0 108.92 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.6 m -60.41 -36.94 79.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.13 -121.92 4.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.28 175.55 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.487 -1.008 . . . . 0.0 109.768 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 34.6 t -97.72 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.845 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 p -132.17 129.48 39.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.643 -0.661 . . . . 0.0 109.957 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.477 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 91.6 m-70 55.95 36.87 28.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.618 -0.676 . . . . 0.0 110.42 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 2.1 t30 67.56 24.51 8.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.787 -0.57 . . . . 0.0 111.091 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 24' ' ' HIS . 1.1 mmmt -127.8 172.15 11.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 0.0 109.779 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 1.4 m -126.11 124.66 41.07 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.378 -0.826 . . . . 0.0 109.968 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.448 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.229 0.538 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.423 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.2 p -148.9 161.6 41.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.427 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.567 ' HG ' HD13 ' A' ' 16' ' ' ILE . 92.8 mt -90.49 161.12 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.418 -0.801 . . . . 0.0 110.581 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.36 162.79 41.23 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.914 1.481 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.33 112.42 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.861 1.453 . . . . 0.0 110.314 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.56 2.43 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -55.75 129.28 71.02 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.366 -1.079 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.56 130.43 16.0 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.686 1.361 . . . . 0.0 110.847 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 13.3 p -117.15 166.55 12.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.605 -0.684 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.85 172.01 7.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.348 -0.845 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.33 -74.43 1.07 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.18 30.26 6.07 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.931 . . . . 0.0 110.699 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.9 m -145.37 69.28 1.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.38 101.21 5.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -91.55 25.31 2.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.709 . . . . 0.0 110.389 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.603 HD11 ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -134.71 131.91 20.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.603 ' HD2' HD11 ' A' ' 16' ' ' ILE . 51.0 Cg_endo -73.33 117.32 5.04 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.83 1.437 . . . . 0.0 110.768 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.5 141.97 28.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.306 -0.871 . . . . 0.0 109.85 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.423 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -61.4 -45.44 94.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.61 -123.56 4.2 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.5 t -137.91 174.78 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.609 -0.936 . . . . 0.0 109.599 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.9 98.96 11.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -133.54 144.07 49.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.537 -0.727 . . . . 0.0 109.863 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 53.11 40.19 30.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.594 -0.691 . . . . 0.0 110.663 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.84 32.52 22.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.089 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 7.0 ptmt -159.25 169.6 23.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 21.4 m -103.86 129.72 51.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.77 . . . . 0.0 110.21 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.687 179.784 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 p -86.61 161.21 18.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.475 -0.766 . . . . 0.0 110.347 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 16' ' ' ILE . 3.7 mp -87.48 149.44 46.61 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.488 -0.757 . . . . 0.0 110.097 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.27 164.6 35.14 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.986 1.519 . . . . 0.0 110.459 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.56 123.79 9.76 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.978 1.515 . . . . 0.0 110.021 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.63 -39.81 1.72 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -56.34 128.92 74.22 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.682 -0.893 . . . . 0.0 109.909 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.16 127.45 11.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.7 1.368 . . . . 0.0 110.626 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 142.66 35.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.474 -0.766 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -86.51 77.94 9.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.227 -0.921 . . . . 0.0 110.959 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.78 -136.22 33.26 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.77 30.04 6.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.462 -1.022 . . . . 0.0 110.602 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -130.98 88.59 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.66 132.88 29.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 18.44 6.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.57 HG23 HD11 ' A' ' 3' ' ' LEU . 8.8 tp -139.97 122.99 10.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.89 130.37 11.36 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.689 1.363 . . . . 0.0 110.921 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' HD12 ' A' ' 3' ' ' LEU . 12.6 m -83.1 148.0 27.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.75 . . . . 0.0 109.386 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.33 83.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.243 -0.911 . . . . 0.0 109.841 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 -130.47 6.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t -132.07 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.397 -1.061 . . . . 0.0 109.57 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 25' ' ' ASN . 43.5 t -91.67 97.7 11.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.418 -0.801 . . . . 0.0 110.296 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -98.63 113.84 26.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 55.63 46.32 22.98 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 109.089 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.485 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 3.0 t30 63.58 36.63 10.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.809 -0.557 . . . . 0.0 110.595 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 3.1 mmpt? -138.49 114.33 9.95 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 18.5 m -71.21 117.18 12.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 109.701 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.515 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.179 0.514 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.8 p -118.09 169.82 9.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.797 . . . . 0.0 110.647 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 HD11 HG23 ' A' ' 16' ' ' ILE . 1.1 mp -90.11 158.0 44.7 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -72.34 158.69 51.07 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.821 1.432 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 122.11 7.2 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.874 1.46 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.66 -34.74 3.81 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 26.3 mmtm -59.65 148.46 74.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.544 -0.974 . . . . 0.0 110.1 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.1 Cg_endo -70.77 136.27 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.728 1.383 . . . . 0.0 110.799 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -111.24 145.98 37.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.798 -0.564 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -92.87 71.67 4.78 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.363 -0.836 . . . . 0.0 110.562 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.16 -143.94 33.13 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.47 48.48 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.466 -1.02 . . . . 0.0 109.968 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.1 t -150.27 64.67 0.96 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.277 -0.889 . . . . 0.0 110.242 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -138.89 168.15 20.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.355 -0.841 . . . . 0.0 110.275 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 15.8 5.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 0.0 111.246 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.503 HG23 HD11 ' A' ' 3' ' ' LEU . 7.4 tp -147.48 101.48 3.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 110.082 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.56 138.18 23.84 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.523 1.275 . . . . 0.0 111.389 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 t -63.99 145.74 55.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.759 -0.588 . . . . 0.0 109.763 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -50.32 70.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.768 . . . . 0.0 109.353 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.36 -96.7 0.89 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.84 175.57 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.56 -0.965 . . . . 0.0 109.986 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.3 t -105.89 113.61 27.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.512 -0.743 . . . . 0.0 110.031 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.494 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 4.3 t -100.12 -139.57 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -70.22 80.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.784 . . . . 0.0 110.25 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.65 49.58 8.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.768 -0.582 . . . . 0.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 6.3 ptmt -161.8 161.2 29.0 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.292 -0.88 . . . . 0.0 110.74 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -107.07 112.37 25.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.453 -0.78 . . . . 0.0 110.005 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 179.822 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.7 tttp . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.025 0.44 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.419 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 24.9 p -143.27 169.11 18.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 16' ' ' ILE . 1.2 mt -86.51 135.08 36.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.483 -0.761 . . . . 0.0 110.266 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.4 172.37 10.31 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.823 1.433 . . . . 0.0 111.011 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.42 124.89 11.68 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.852 1.448 . . . . 0.0 111.004 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.571 ' HA2' ' HD3' ' A' ' 26' ' ' LYS . . . 107.81 6.03 32.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -88.2 152.84 50.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.101 -1.235 . . . . 0.0 109.787 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD2' ' HE2' ' A' ' 7' ' ' LYS . 45.8 Cg_endo -70.99 135.43 27.5 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.73 1.384 . . . . 0.0 111.032 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 147.05 49.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.01 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -102.45 173.61 6.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.327 -0.858 . . . . 0.0 110.486 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.74 -99.61 0.05 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.6 34.72 3.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -1.04 . . . . 0.0 110.721 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.6 m -140.41 79.15 1.69 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.287 -0.883 . . . . 0.0 109.768 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.569 ' CG ' HG22 ' A' ' 16' ' ' ILE . 26.9 tt0 -163.48 117.38 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -90.91 21.89 3.93 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.434 -0.791 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.569 HG22 ' CG ' ' A' ' 14' ' ' GLN . 3.3 tp -131.65 107.23 14.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.333 -0.855 . . . . 0.0 109.512 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.6 143.98 35.01 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.743 1.391 . . . . 0.0 111.336 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 31.4 m -76.38 158.24 31.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.546 -0.721 . . . . 0.0 109.439 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 89.3 m -57.64 -32.16 66.99 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.9 -93.66 1.94 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -143.56 178.94 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.603 -0.94 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 18' ' ' CYS . 1.1 m -104.21 117.55 34.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.9 p -134.89 128.62 32.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.96 52.64 14.04 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.717 -0.615 . . . . 0.0 110.415 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 39.93 31.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.657 -0.652 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HD3' ' HA2' ' A' ' 6' ' ' GLY . 3.8 ttmt -142.78 161.44 38.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.621 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 13.9 m -107.28 106.97 17.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.512 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p -119.26 172.98 7.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 110.523 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' CD1' HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.08 152.69 62.39 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.574 -0.704 . . . . 0.0 110.535 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.996 1.524 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.4 123.8 10.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.939 1.494 . . . . 0.0 110.782 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.76 -24.28 5.5 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 136.67 96.82 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.128 -1.219 . . . . 0.0 110.099 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.09 134.99 18.33 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.661 1.348 . . . . 0.0 111.204 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.6 p -110.2 124.9 52.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.0 109.848 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -82.39 88.33 6.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.445 -0.784 . . . . 0.0 110.38 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.32 -156.68 53.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 30.87 6.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -1.001 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 m -143.89 90.17 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.845 . . . . 0.0 109.858 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.99 168.88 22.58 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 23.71 2.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.51 107.8 12.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 109.753 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.79 129.89 4.16 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.689 1.363 . . . . 0.0 110.529 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.512 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.3 m -55.28 -43.99 75.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.383 -0.823 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.44 -121.54 3.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.4 t -139.31 173.5 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.559 -0.965 . . . . 0.0 110.025 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.9 114.71 25.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 0.0 110.054 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.64 120.75 21.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.1 45.03 28.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.534 -0.728 . . . . 0.0 109.523 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.42 34.79 20.54 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.763 -0.585 . . . . 0.0 110.685 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.13 164.18 29.79 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.413 -0.805 . . . . 0.0 110.182 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 46.2 m -116.43 112.46 21.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 109.695 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.0 110.508 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 19' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.205 0.526 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.601 HD11 ' CG1' ' A' ' 16' ' ' ILE . 88.6 mt -70.76 140.43 86.54 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.456 -0.777 . . . . 0.0 110.399 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 43.7 Cg_endo -70.12 164.16 35.92 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.893 1.47 . . . . 0.0 110.596 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.0 130.63 19.38 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.753 1.396 . . . . 0.0 110.32 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.87 7.46 33.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.5 mmmt -86.09 125.83 67.1 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.996 -1.297 . . . . 0.0 109.845 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.4 Cg_endo -72.62 107.06 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.68 1.358 . . . . 0.0 110.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p -86.44 148.67 25.45 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -0.759 . . . . 0.0 110.14 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 78.22 2.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 110.305 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.87 -126.49 41.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.43 6.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.528 -0.984 . . . . 0.0 110.563 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.8 m -106.44 71.01 0.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.29 -0.881 . . . . 0.0 109.742 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' HG22 ' A' ' 16' ' ' ILE . 17.3 pt20 -169.3 140.9 2.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.464 -0.772 . . . . 0.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 25.7 2.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.338 -0.851 . . . . 0.0 110.418 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.601 ' CG1' HD11 ' A' ' 3' ' ' LEU . 8.1 tp -116.85 116.5 38.2 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.586 -0.696 . . . . 0.0 109.866 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -76.0 126.88 9.62 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.806 1.424 . . . . 0.0 110.626 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.2 m -81.86 147.19 29.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 19.5 m -56.93 -35.67 69.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.397 -0.815 . . . . 0.0 110.305 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.59 -126.09 4.0 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -131.0 176.15 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.996 . . . . 0.0 109.896 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 m -82.07 113.26 19.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.467 -0.771 . . . . 0.0 109.996 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.1 t -119.43 102.6 8.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.919 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 54.06 53.79 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.517 -0.739 . . . . 0.0 109.976 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 64.27 43.88 4.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.727 -0.608 . . . . 0.0 110.608 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 27.2 mtmt -147.67 178.52 8.4 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.602 -0.686 . . . . 0.0 109.916 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.8 m -138.65 120.99 15.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.374 -0.829 . . . . 0.0 110.065 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.832 -1.08 . . . . 0.0 110.402 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.9 p . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.766 HD11 HG23 ' A' ' 16' ' ' ILE . 1.8 mt -78.64 137.91 58.64 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 41.5 Cg_endo -66.47 165.1 26.12 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.652 1.343 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.3 Cg_endo -68.43 124.07 11.22 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.084 1.57 . . . . 0.0 110.76 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.3 -19.14 13.36 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 36.0 mmtt -68.08 158.99 82.26 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.257 -1.143 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.6 155.79 40.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.896 1.472 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.421 ' HB3' ' N ' ' A' ' 26' ' ' LYS . 9.2 t -133.29 143.36 49.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.709 . . . . 0.0 109.456 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -122.54 148.14 45.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.432 -0.792 . . . . 0.0 110.768 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' THR . . . -101.46 144.6 16.53 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 57.29 27.77 14.21 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.791 -0.829 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' THR . 15.4 t -177.49 59.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.746 0.784 . . . . 0.0 109.964 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -151.51 104.89 3.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -90.62 21.47 3.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.334 -0.854 . . . . 0.0 110.498 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.766 HG23 HD11 ' A' ' 3' ' ' LEU . 1.3 tp -138.45 114.19 8.83 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.72 146.81 24.14 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.721 1.379 . . . . 0.0 110.909 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 35.3 m -77.36 153.87 33.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.406 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 58.5 m -54.09 -35.13 61.78 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.231 -0.918 . . . . 0.0 109.745 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.82 -97.69 2.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -143.87 177.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.474 -1.015 . . . . 0.0 109.844 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 1.2 m -100.49 122.58 43.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -139.45 132.87 30.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.415 -0.803 . . . . 0.0 110.128 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.431 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 52.8 m-70 52.17 39.06 26.04 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.688 -0.633 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.82 40.61 7.45 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.458 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 31.0 mtmt -141.0 175.26 9.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.417 -0.802 . . . . 0.0 110.248 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 21.5 m -112.78 105.4 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.623 -0.673 . . . . 0.0 109.268 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.541 -179.615 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.3 p . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.249 0.547 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.971 HD11 HG13 ' A' ' 16' ' ' ILE . 1.2 mp -77.59 154.71 81.34 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 164.66 34.91 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.815 1.429 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.76 137.92 30.77 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.9 1.473 . . . . 0.0 110.699 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.63 5.01 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 123.52 77.95 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.365 -1.08 . . . . 0.0 110.602 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.09 134.36 23.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.059 1.557 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -94.36 160.14 14.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -112.68 108.01 16.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.25 -0.907 . . . . 0.0 110.439 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.87 -147.49 43.72 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.21 35.9 4.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.94 . . . . 0.0 110.558 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -143.65 96.42 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -153.04 158.8 42.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.564 -0.71 . . . . 0.0 110.614 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.92 22.69 3.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.434 -0.791 . . . . 0.0 110.537 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.971 HG13 HD11 ' A' ' 3' ' ' LEU . 5.4 tp -138.7 97.61 9.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.6 138.82 22.08 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.585 1.308 . . . . 0.0 110.968 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.5 m -80.48 160.41 25.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.561 -0.712 . . . . 0.0 110.03 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.0 m -61.43 -48.16 82.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.096 -1.002 . . . . 0.0 109.628 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.74 -118.98 4.53 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -133.34 171.74 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.52 -0.988 . . . . 0.0 109.448 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.24 107.51 20.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.431 -0.793 . . . . 0.0 110.47 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.7 p -126.93 145.19 50.77 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 34.43 24.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.28 -0.887 . . . . 0.0 110.275 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.56 35.44 9.25 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.612 -0.68 . . . . 0.0 111.674 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -161.75 139.89 9.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.065 -1.022 . . . . 0.0 110.118 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 52.6 m -78.84 127.32 31.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.445 -0.784 . . . . 0.0 110.386 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.783 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 2.4 p . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.834 HD11 ' CG1' ' A' ' 16' ' ' ILE . 1.8 mp -78.72 157.59 76.67 Favored Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 121.681 -0.637 . . . . 0.0 110.504 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 42.8 Cg_endo -68.09 167.42 21.87 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.848 1.446 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.39 135.91 30.09 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.882 1.464 . . . . 0.0 110.526 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.58 -18.56 44.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtm -61.36 121.64 64.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.281 -1.129 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.4 Cg_endo -71.44 113.0 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.814 1.429 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 17.6 p -101.71 161.23 13.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.43 -0.794 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.54 172.9 6.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.02 -45.53 1.17 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.41 26.52 9.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.376 -1.073 . . . . 0.0 111.352 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 13' ' ' THR . 14.1 t -170.88 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 110.446 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 16' ' ' ILE . 1.8 tt0 -144.98 96.57 2.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.71 24.99 2.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.834 ' CG1' HD11 ' A' ' 3' ' ' LEU . 4.0 tp -120.12 130.59 24.77 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.38 127.84 10.02 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.8 1.421 . . . . 0.0 110.995 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.414 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -90.65 163.35 14.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.612 -0.68 . . . . 0.0 109.974 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.528 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 86.8 m -68.99 -51.44 39.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.144 -0.972 . . . . 0.0 109.537 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.0 -116.54 2.7 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -137.11 174.0 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.542 -0.975 . . . . 0.0 109.676 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -91.8 97.46 11.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.375 -0.828 . . . . 0.0 110.074 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -128.41 139.45 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.54 -0.725 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.24 40.81 31.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.552 -0.717 . . . . 0.0 110.693 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.17 36.45 25.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.587 -0.695 . . . . 0.0 111.393 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.8 ptmt -159.71 169.51 23.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.145 -0.972 . . . . 0.0 110.39 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 65.3 m -111.68 131.35 55.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.338 -0.851 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.595 -0.691 . . . . 0.0 110.045 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.2 p . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.963 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mt -78.54 153.32 78.69 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.444 -0.785 . . . . 0.0 109.983 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.36 159.38 46.85 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.81 1.426 . . . . 0.0 110.406 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.64 127.48 10.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.915 1.481 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.66 -28.91 7.51 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.68 140.42 98.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.383 -1.069 . . . . 0.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 43.8 Cg_endo -71.83 131.84 19.07 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.817 1.43 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -112.25 166.92 10.84 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.774 . . . . 0.0 110.5 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.11 149.52 38.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.457 -0.777 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.31 54.81 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 49.48 1.63 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -1.001 . . . . 0.0 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.7 m 56.09 91.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -111.41 160.53 17.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.384 -0.822 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -90.48 21.98 3.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.419 -0.801 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.963 HG13 HD11 ' A' ' 3' ' ' LEU . 7.9 tp -136.44 113.1 10.18 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.31 135.19 9.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.845 1.445 . . . . 0.0 111.119 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HD13 ' A' ' 3' ' ' LEU . 1.9 m -81.3 152.39 27.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.314 -0.867 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -48.04 80.51 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.471 -0.768 . . . . 0.0 110.048 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.07 -119.13 4.56 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -130.66 175.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.484 -1.009 . . . . 0.0 109.427 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.4 t -108.4 131.58 54.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.449 -0.782 . . . . 0.0 110.661 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.65 125.28 23.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 57.49 43.92 22.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.055 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 2.0 t-20 59.79 34.91 22.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.798 -0.564 . . . . 0.0 110.785 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 5.4 mmpt? -140.14 125.15 18.51 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.443 -0.786 . . . . 0.0 109.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -86.15 134.53 33.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.254 -0.904 . . . . 0.0 110.804 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.538 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.162 0.506 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.608 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mp -65.36 133.4 95.41 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.571 -0.705 . . . . 0.0 110.358 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.13 167.36 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.806 1.424 . . . . 0.0 110.616 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 128.69 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.869 1.458 . . . . 0.0 110.801 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.23 37.57 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HD2' HD23 ' A' ' 3' ' ' LEU . 4.0 mmtt -87.66 142.68 32.89 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.234 -1.156 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.01 134.33 27.2 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.531 1.28 . . . . 0.0 110.743 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.32 144.05 30.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.602 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 93.2 m-85 -104.18 84.18 2.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.499 -0.751 . . . . 0.0 110.748 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 -147.51 50.1 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.52 40.61 3.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.911 . . . . 0.0 109.801 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 13' ' ' THR . 10.1 t -154.86 70.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.315 -0.865 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -113.2 161.1 17.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.325 -0.859 . . . . 0.0 110.291 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.4 19.18 5.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.305 -0.872 . . . . 0.0 110.461 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.608 ' CG1' HD11 ' A' ' 3' ' ' LEU . 3.2 tp -142.47 122.76 8.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.533 -0.73 . . . . 0.0 110.084 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.46 138.94 17.94 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.706 1.372 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.3 m -90.01 155.28 19.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.601 -0.687 . . . . 0.0 110.092 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -63.53 -45.3 91.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.228 -0.92 . . . . 0.0 109.821 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.59 -115.68 3.21 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -136.36 174.82 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.549 -0.971 . . . . 0.0 109.825 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -97.12 104.98 17.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -144.59 146.7 32.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m170 54.76 40.24 31.82 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.6 -0.687 . . . . 0.0 110.925 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.93 35.52 26.48 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.566 -0.709 . . . . 0.0 111.194 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -162.88 177.57 9.14 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.293 -0.88 . . . . 0.0 110.652 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 55.3 m -118.86 134.1 55.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.695 . . . . 0.0 110.604 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.824 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.2 p . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 121.176 0.513 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.807 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mp -86.34 150.12 51.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.361 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 40.1 Cg_endo -66.06 166.76 19.82 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.788 1.415 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.03 131.57 22.55 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.849 1.447 . . . . 0.0 111.357 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.2 55.53 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mmmt -78.23 149.18 75.69 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.975 -1.309 . . . . 0.0 110.185 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 45.6 Cg_endo -73.23 94.88 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.895 1.471 . . . . 0.0 110.51 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 18.5 p -87.66 144.83 26.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.429 -0.794 . . . . 0.0 110.378 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 7.0 m-85 -101.35 164.5 11.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.889 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.2 -79.6 0.69 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.45 28.9 7.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.979 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 m -141.27 68.89 1.33 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.228 -0.92 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 10' ' ' TYR . 24.2 tt0 -162.06 120.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.464 -0.772 . . . . 0.0 110.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -90.86 18.96 5.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.0 110.826 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 3' ' ' LEU . 4.0 tp -142.87 114.36 5.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 110.129 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 3' ' ' LEU . 51.6 Cg_endo -76.27 147.84 29.84 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.523 1.275 . . . . 0.0 111.162 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.34 160.52 32.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.514 -0.741 . . . . 0.0 109.598 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 93.4 m -60.09 -33.11 71.65 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -89.51 1.86 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.8 t -142.13 177.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.465 -1.02 . . . . 0.0 110.028 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 21' ' ' VAL . 7.9 t -118.7 110.06 16.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -132.79 135.64 45.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.751 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.9 m170 53.18 38.04 26.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.652 -0.655 . . . . 0.0 109.938 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 1.2 t30 61.74 36.09 16.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.742 -0.599 . . . . 0.0 110.674 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 1.3 mmpt? -135.24 138.12 43.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 31.2 m -83.12 104.45 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.363 -0.835 . . . . 0.0 109.619 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.302 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 16' ' ' ILE . 8.9 mp -78.0 143.81 66.7 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 110.175 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 43.6 Cg_endo -71.4 167.07 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.862 1.454 . . . . 0.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.44 120.42 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.878 1.462 . . . . 0.0 110.88 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.87 -25.39 6.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -72.22 130.39 86.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.228 -1.16 . . . . 0.0 110.68 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 42.5 Cg_endo -70.36 128.23 15.2 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.79 1.416 . . . . 0.0 110.639 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.74 165.7 22.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.512 -0.743 . . . . 0.0 110.398 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.88 141.47 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 110.431 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.55 -152.93 29.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 54.19 41.03 32.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 58.2 m 60.35 107.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.742 -0.598 . . . . 0.0 111.265 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -117.09 147.64 42.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -91.12 24.8 2.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.344 -0.847 . . . . 0.0 110.716 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -135.36 112.56 11.02 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.94 138.88 9.39 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.866 1.456 . . . . 0.0 110.759 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.35 140.26 29.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.288 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -45.16 73.52 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.04 -131.77 7.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -127.06 172.63 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -1.045 . . . . 0.0 109.463 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.28 107.44 19.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.394 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 30.0 m -132.54 124.18 27.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 0.0 109.434 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 64.5 39.39 6.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.502 -0.748 . . . . 0.0 110.376 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 60.78 47.68 7.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.658 -0.651 . . . . 0.0 111.469 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -167.19 151.87 7.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 88.2 m -103.53 137.26 41.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 110.07 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.54 HG23 ' HE2' ' A' ' 26' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.521 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.197 0.522 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.951 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.04 152.65 62.47 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.58 -0.7 . . . . 0.0 110.547 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.984 1.518 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.6 Cg_endo -69.41 123.91 10.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.966 1.509 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.6 -24.27 5.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 136.72 96.84 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.188 -1.184 . . . . 0.0 110.13 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.12 135.07 18.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.693 1.365 . . . . 0.0 111.072 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.7 p -110.2 124.96 52.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -82.39 88.28 6.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.559 -0.713 . . . . 0.0 110.457 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 -156.78 53.07 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.93 30.9 6.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.427 -1.043 . . . . 0.0 110.384 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.6 m -143.9 90.22 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.326 -0.859 . . . . 0.0 109.858 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.11 168.75 23.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.446 -0.784 . . . . 0.0 110.562 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 23.69 2.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.564 -0.71 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.5 107.79 12.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.77 129.88 4.18 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.705 1.371 . . . . 0.0 110.492 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.7 m -55.32 -43.96 75.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.54 -121.48 3.49 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.35 173.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.491 -1.005 . . . . 0.0 110.001 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 42.0 t -88.82 114.73 25.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.0 110.074 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.63 120.65 20.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.305 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.18 45.01 28.27 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.625 -0.672 . . . . 0.0 109.506 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.45 34.72 20.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.772 -0.58 . . . . 0.0 110.741 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.17 164.34 29.43 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.4 -0.813 . . . . 0.0 110.071 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 45.2 m -116.5 112.5 21.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.395 -0.816 . . . . 0.0 110.454 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.077 0.465 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 16' ' ' ILE . 8.5 mp -83.26 149.96 59.64 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.478 -0.764 . . . . 0.0 110.801 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 Cg_endo -72.17 162.66 41.03 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.99 1.521 . . . . 0.0 110.65 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 44.7 Cg_endo -72.1 112.33 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.849 1.447 . . . . 0.0 110.705 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.83 -23.29 3.56 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -68.22 144.13 96.48 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.155 -1.203 . . . . 0.0 110.401 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.8 Cg_endo -73.03 146.22 41.06 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.792 1.417 . . . . 0.0 111.057 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 7.7 p -136.43 153.8 50.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.559 -0.713 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 13' ' ' THR . 25.0 m-85 -114.3 175.15 5.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.671 -0.643 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.24 -45.68 1.06 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.98 25.75 4.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -1.152 . . . . 0.0 111.281 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 13' ' ' THR . 9.2 t -173.31 66.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.253 -0.905 . . . . 0.0 110.245 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.19 93.63 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.921 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 23.65 3.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.491 -0.756 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HD2' ' A' ' 17' ' ' PRO . 8.2 tp -135.27 129.63 18.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 16' ' ' ILE . 51.3 Cg_endo -80.47 100.81 1.27 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.731 1.385 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.44 152.57 43.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.344 -0.848 . . . . 0.0 109.787 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -44.37 96.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.37 -0.831 . . . . 0.0 109.781 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.64 -123.88 4.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -138.09 174.7 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -1.069 . . . . 0.0 109.753 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 14.0 t -94.14 108.82 20.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.465 -0.772 . . . . 0.0 110.289 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 p -127.33 127.86 44.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.466 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.8 t-160 57.56 34.43 24.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 68.13 25.8 7.3 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.851 -0.531 . . . . 0.0 110.738 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 25' ' ' ASN . 6.5 mmmm -130.23 156.72 44.15 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.369 -0.832 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -104.56 120.64 41.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.98 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.329 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 16' ' ' ILE . 77.8 mt -89.77 149.6 42.37 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.9 Cg_endo -69.98 160.17 50.6 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.65 1.342 . . . . 0.0 110.452 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.22 122.28 8.57 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.976 1.514 . . . . 0.0 110.503 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.82 -34.97 2.87 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 1.7 mmtm -60.44 158.44 29.52 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.562 -0.963 . . . . 0.0 110.555 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.35 161.58 42.34 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.782 1.412 . . . . 0.0 110.816 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -154.72 159.52 40.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.45 -0.781 . . . . 0.0 110.653 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 13' ' ' THR . 37.9 m-85 -126.6 144.31 50.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.655 -0.653 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 133.71 11.94 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.26 16.56 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 0.0 111.865 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 13' ' ' THR . 12.8 t -173.81 69.84 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 110.595 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -150.33 141.79 23.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.997 -1.065 . . . . 0.0 111.045 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.01 11.82 21.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.217 -0.927 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.713 ' CG2' HD11 ' A' ' 3' ' ' LEU . 8.6 tp -150.15 127.55 5.56 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.83 148.5 22.43 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.727 1.383 . . . . 0.0 111.275 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 92.5 m -88.64 137.04 32.68 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -58.24 -39.05 78.11 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.01 -105.78 2.61 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.93 174.51 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.347 -1.09 . . . . 0.0 109.939 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 99.78 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' ASN . 20.9 m -88.89 -132.71 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.633 -0.667 . . . . 0.0 109.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.11 74.42 0.12 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.492 -0.755 . . . . 0.0 109.753 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' SER . 0.6 OUTLIER 57.47 48.64 14.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.434 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -167.44 146.71 5.05 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.319 -0.863 . . . . 0.0 111.37 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m -79.7 123.27 27.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.663 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 16' ' ' ILE . 49.8 mt -77.67 148.77 76.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.558 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.0 Cg_endo -71.7 157.88 54.59 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.713 1.375 . . . . 0.0 109.957 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -74.43 114.46 4.04 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.885 1.466 . . . . 0.0 110.714 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.81 -27.74 5.86 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -57.4 151.85 36.13 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.341 -1.093 . . . . 0.0 110.427 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.28 108.19 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.906 1.477 . . . . 0.0 110.721 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -89.0 145.73 25.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.538 -0.726 . . . . 0.0 110.142 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . 8.3 m-85 -100.29 156.15 17.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.482 -0.761 . . . . 0.0 110.606 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 13' ' ' THR . . . -112.59 130.94 9.83 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.4 31.67 15.01 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.86 -0.788 . . . . 0.0 111.342 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' THR . 15.1 t -174.82 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.39 -0.819 . . . . 0.0 109.807 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -149.26 122.5 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.316 -0.865 . . . . 0.0 110.916 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -90.96 21.31 4.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.267 -0.895 . . . . 0.0 110.597 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.83 HG23 HD11 ' A' ' 3' ' ' LEU . 6.9 tp -137.84 119.66 10.8 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.78 138.41 16.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.702 1.37 . . . . 0.0 111.169 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.4 t -78.6 146.22 34.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.562 -0.711 . . . . 0.0 109.283 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -50.5 60.73 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 109.532 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.19 1.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.0 t -144.76 177.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.493 -1.004 . . . . 0.0 110.111 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.5 t -97.34 112.45 24.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 t -95.41 -138.69 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.35 76.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.896 . . . . 0.0 108.962 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.525 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 60.69 35.05 19.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.658 -0.651 . . . . 0.0 110.079 -178.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 2.8 mmpt? -137.87 165.12 27.28 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.46 -0.775 . . . . 0.0 110.615 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.6 t -111.83 109.57 19.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 109.268 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.482 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD12 ' SG ' ' A' ' 18' ' ' CYS . 96.8 mt -90.32 150.18 42.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 47.3 Cg_endo -72.28 161.54 44.16 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.765 1.403 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 114.51 4.05 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.836 1.44 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.97 -34.3 2.41 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 5.4 mmtm -58.92 141.16 86.15 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.478 -1.013 . . . . 0.0 110.396 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.3 Cg_endo -72.49 137.77 28.53 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.987 1.519 . . . . 0.0 110.744 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 3.3 p -133.54 163.43 29.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.496 -0.752 . . . . 0.0 110.401 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.7 166.64 11.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.5 -62.31 4.94 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.63 37.46 2.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.558 -0.966 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m -136.55 73.26 1.45 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -164.13 128.18 2.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.511 -0.743 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -91.32 24.54 2.9 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.368 -0.833 . . . . 0.0 111.118 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.806 HD12 ' HD2' ' A' ' 17' ' ' PRO . 7.4 tp -124.49 126.71 25.4 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.379 -0.826 . . . . 0.0 110.246 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.806 ' HD2' HD12 ' A' ' 16' ' ' ILE . 52.8 Cg_endo -76.05 124.79 8.19 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.804 1.423 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.1 m -90.51 138.65 31.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.489 -0.757 . . . . 0.0 109.88 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -40.69 83.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.478 -0.764 . . . . 0.0 110.236 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -130.37 6.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -132.74 173.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.236 -1.155 . . . . 0.0 109.685 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.98 103.59 15.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.446 -0.784 . . . . 0.0 110.455 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 p -133.9 138.25 45.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 56.8 36.13 27.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.569 -0.707 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.06 30.2 17.83 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.577 -0.702 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 10.5 ptmt -156.01 149.41 24.69 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 53.0 m -87.0 128.55 35.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.416 -0.802 . . . . 0.0 110.383 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.612 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.361 0.6 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 16' ' ' ILE . 13.4 mt -79.21 142.23 58.84 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 109.782 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.6 160.91 46.95 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.758 1.399 . . . . 0.0 110.108 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.93 110.7 2.98 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.745 1.392 . . . . 0.0 110.333 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.64 -37.36 2.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -56.76 140.01 76.14 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.42 -1.047 . . . . 0.0 110.092 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -69.47 128.07 15.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.64 1.337 . . . . 0.0 111.071 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -102.27 136.97 41.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.0 110.296 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.87 154.69 33.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.57 -0.706 . . . . 0.0 110.541 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 101.7 2.7 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.6 31.64 15.49 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.754 -0.85 . . . . 0.0 111.053 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.4 m -143.35 66.95 1.3 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.0 137.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.55 24.62 2.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.865 HD12 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -140.93 113.8 7.01 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.724 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' N ' HD13 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -73.69 152.54 47.93 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.681 1.358 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -82.21 143.11 31.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.638 -0.663 . . . . 0.0 109.463 179.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -52.98 57.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.492 -0.755 . . . . 0.0 109.439 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.18 -98.97 1.13 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.6 t -144.57 174.02 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.39 -1.065 . . . . 0.0 110.273 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' H ' HG12 ' A' ' 21' ' ' VAL . 45.9 t -102.84 97.64 7.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -136.33 156.45 48.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.0 109.688 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 52.46 33.7 13.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 58.23 42.92 21.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 0.0 110.678 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 ptmt -167.74 163.65 14.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.349 -0.844 . . . . 0.0 111.078 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 35.6 t -88.5 121.19 30.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.683 -0.636 . . . . 0.0 109.626 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.596 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.445 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.5 p . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 121.415 0.626 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.698 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mt -74.33 136.55 75.29 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 0.0 110.45 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 40.9 Cg_endo -67.65 163.66 34.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.794 1.418 . . . . 0.0 110.644 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.53 131.88 22.49 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.851 1.448 . . . . 0.0 110.352 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.87 -34.01 4.81 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -59.93 156.69 34.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.515 -0.991 . . . . 0.0 110.136 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.24 169.35 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.82 1.432 . . . . 0.0 111.085 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 15.3 t -143.74 144.97 32.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.644 -0.66 . . . . 0.0 109.406 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -97.89 72.84 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 110.771 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.09 -143.44 37.28 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.65 32.45 5.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.934 . . . . 0.0 110.475 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 m -135.8 89.15 2.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -159.35 147.41 17.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.499 -0.75 . . . . 0.0 110.131 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 23.03 3.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.335 -0.853 . . . . 0.0 111.171 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' HD2' ' A' ' 17' ' ' PRO . 9.0 tp -119.66 120.73 30.4 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 109.935 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 16' ' ' ILE . 55.2 Cg_endo -76.48 124.63 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.869 1.457 . . . . 0.0 111.649 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.29 148.27 22.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.441 -0.787 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.445 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.6 m -60.41 -36.94 79.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.13 -121.92 4.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -133.28 175.55 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.487 -1.008 . . . . 0.0 109.768 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 34.6 t -97.72 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.845 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 p -132.17 129.48 39.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.643 -0.661 . . . . 0.0 109.957 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 91.6 m-70 55.95 36.87 28.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.618 -0.676 . . . . 0.0 110.42 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 2.1 t30 67.56 24.51 8.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.787 -0.57 . . . . 0.0 111.091 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 24' ' ' HIS . 1.1 mmmt -127.8 172.15 11.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 0.0 109.779 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 1.4 m -126.11 124.66 41.07 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.378 -0.826 . . . . 0.0 109.968 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.448 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.429 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.2 p . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.137 0.494 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 16' ' ' ILE . 92.8 mt -90.49 161.12 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.418 -0.801 . . . . 0.0 110.581 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.36 162.79 41.23 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.914 1.481 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.9 Cg_endo -71.33 112.42 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.861 1.453 . . . . 0.0 110.314 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.56 2.43 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -55.75 129.28 71.02 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.366 -1.079 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.56 130.43 16.0 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.686 1.361 . . . . 0.0 110.847 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 13.3 p -117.15 166.55 12.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.605 -0.684 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.85 172.01 7.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.348 -0.845 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.33 -74.43 1.07 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.18 30.26 6.07 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.931 . . . . 0.0 110.699 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.9 m -145.37 69.28 1.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.38 101.21 5.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -91.55 25.31 2.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.709 . . . . 0.0 110.389 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -134.71 131.91 20.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 51.0 Cg_endo -73.33 117.32 5.04 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.83 1.437 . . . . 0.0 110.768 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.5 141.97 28.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.306 -0.871 . . . . 0.0 109.85 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -61.4 -45.44 94.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.61 -123.56 4.2 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.5 t -137.91 174.78 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.609 -0.936 . . . . 0.0 109.599 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.9 98.96 11.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -133.54 144.07 49.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.537 -0.727 . . . . 0.0 109.863 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 53.11 40.19 30.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.594 -0.691 . . . . 0.0 110.663 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.84 32.52 22.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.089 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 7.0 ptmt -159.25 169.6 23.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 21.4 m -103.86 129.72 51.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.77 . . . . 0.0 110.21 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.687 179.784 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.224 0.535 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 16' ' ' ILE . 3.7 mp -87.48 149.44 46.61 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.488 -0.757 . . . . 0.0 110.097 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.27 164.6 35.14 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.986 1.519 . . . . 0.0 110.459 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.56 123.79 9.76 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.978 1.515 . . . . 0.0 110.021 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.63 -39.81 1.72 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -56.34 128.92 74.22 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.682 -0.893 . . . . 0.0 109.909 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.16 127.45 11.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.7 1.368 . . . . 0.0 110.626 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 142.66 35.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.474 -0.766 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -86.51 77.94 9.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.227 -0.921 . . . . 0.0 110.959 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.78 -136.22 33.26 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.77 30.04 6.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.462 -1.022 . . . . 0.0 110.602 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -130.98 88.59 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.66 132.88 29.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 18.44 6.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.859 HG13 HD11 ' A' ' 3' ' ' LEU . 8.8 tp -139.97 122.99 10.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.89 130.37 11.36 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.689 1.363 . . . . 0.0 110.921 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 3' ' ' LEU . 12.6 m -83.1 148.0 27.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.75 . . . . 0.0 109.386 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.33 83.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.243 -0.911 . . . . 0.0 109.841 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 -130.47 6.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.2 t -132.07 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.397 -1.061 . . . . 0.0 109.57 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 25' ' ' ASN . 43.5 t -91.67 97.7 11.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.418 -0.801 . . . . 0.0 110.296 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -98.63 113.84 26.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 55.63 46.32 22.98 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 109.089 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 3.0 t30 63.58 36.63 10.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.809 -0.557 . . . . 0.0 110.595 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 3.1 mmpt? -138.49 114.33 9.95 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 18.5 m -71.21 117.18 12.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 109.701 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.515 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mp -90.11 158.0 44.7 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -72.34 158.69 51.07 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.821 1.432 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 122.11 7.2 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.874 1.46 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.66 -34.74 3.81 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 26.3 mmtm -59.65 148.46 74.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.544 -0.974 . . . . 0.0 110.1 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.1 Cg_endo -70.77 136.27 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.728 1.383 . . . . 0.0 110.799 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -111.24 145.98 37.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.798 -0.564 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -92.87 71.67 4.78 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.363 -0.836 . . . . 0.0 110.562 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.16 -143.94 33.13 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.47 48.48 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.466 -1.02 . . . . 0.0 109.968 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 13' ' ' THR . 12.1 t -150.27 64.67 0.96 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.277 -0.889 . . . . 0.0 110.242 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.89 168.15 20.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.355 -0.841 . . . . 0.0 110.275 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 15.8 5.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 0.0 111.246 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 16' ' ' ILE . 7.4 tp -147.48 101.48 3.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 110.082 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.56 138.18 23.84 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.523 1.275 . . . . 0.0 111.389 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 t -63.99 145.74 55.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.759 -0.588 . . . . 0.0 109.763 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -50.32 70.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.768 . . . . 0.0 109.353 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.36 -96.7 0.89 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -144.84 175.57 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.56 -0.965 . . . . 0.0 109.986 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' H ' HG12 ' A' ' 21' ' ' VAL . 38.3 t -105.89 113.61 27.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.512 -0.743 . . . . 0.0 110.031 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 4.3 t -100.12 -139.57 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -70.22 80.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.784 . . . . 0.0 110.25 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.65 49.58 8.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.768 -0.582 . . . . 0.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 6.3 ptmt -161.8 161.2 29.0 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.292 -0.88 . . . . 0.0 110.74 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -107.07 112.37 25.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.453 -0.78 . . . . 0.0 110.005 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 179.822 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.427 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 24.9 p . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mt -86.51 135.08 36.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.483 -0.761 . . . . 0.0 110.266 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.4 172.37 10.31 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.823 1.433 . . . . 0.0 111.011 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.42 124.89 11.68 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.852 1.448 . . . . 0.0 111.004 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.572 ' HA2' ' HD3' ' A' ' 26' ' ' LYS . . . 107.81 6.03 32.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.2 152.84 50.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.101 -1.235 . . . . 0.0 109.787 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HE2' ' A' ' 7' ' ' LYS . 45.8 Cg_endo -70.99 135.43 27.5 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.73 1.384 . . . . 0.0 111.032 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 147.05 49.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.01 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -102.45 173.61 6.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.327 -0.858 . . . . 0.0 110.486 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.74 -99.61 0.05 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.6 34.72 3.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -1.04 . . . . 0.0 110.721 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.6 m -140.41 79.15 1.69 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.287 -0.883 . . . . 0.0 109.768 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 16' ' ' ILE . 26.9 tt0 -163.48 117.38 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -90.91 21.89 3.93 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.434 -0.791 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' ILE . 3.3 tp -131.65 107.23 14.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.333 -0.855 . . . . 0.0 109.512 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.6 143.98 35.01 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.743 1.391 . . . . 0.0 111.336 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 31.4 m -76.38 158.24 31.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.546 -0.721 . . . . 0.0 109.439 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 89.3 m -57.64 -32.16 66.99 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.9 -93.66 1.94 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.1 t -143.56 178.94 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.603 -0.94 . . . . 0.0 110.083 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.538 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.1 m -104.21 117.55 34.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.9 p -134.89 128.62 32.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.96 52.64 14.04 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.717 -0.615 . . . . 0.0 110.415 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 39.93 31.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.657 -0.652 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HD3' ' HA2' ' A' ' 6' ' ' GLY . 3.8 ttmt -142.78 161.44 38.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 13.9 m -107.28 106.97 17.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.519 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.187 0.518 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.08 152.69 62.39 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.574 -0.704 . . . . 0.0 110.535 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.996 1.524 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.4 123.8 10.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.939 1.494 . . . . 0.0 110.782 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.76 -24.28 5.5 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 136.67 96.82 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.128 -1.219 . . . . 0.0 110.099 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.09 134.99 18.33 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.661 1.348 . . . . 0.0 111.204 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.6 p -110.2 124.9 52.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.0 109.848 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -82.39 88.33 6.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.445 -0.784 . . . . 0.0 110.38 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.32 -156.68 53.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 30.87 6.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -1.001 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 m -143.89 90.17 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.845 . . . . 0.0 109.858 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.99 168.88 22.58 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 23.71 2.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.51 107.8 12.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 109.753 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.79 129.89 4.16 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.689 1.363 . . . . 0.0 110.529 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.3 m -55.28 -43.99 75.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.383 -0.823 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.44 -121.54 3.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.31 173.5 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.559 -0.965 . . . . 0.0 110.025 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 41.9 t -88.9 114.71 25.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 0.0 110.054 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.64 120.75 21.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.1 45.03 28.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.534 -0.728 . . . . 0.0 109.523 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.42 34.79 20.54 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.763 -0.585 . . . . 0.0 110.685 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.13 164.18 29.79 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.413 -0.805 . . . . 0.0 110.182 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 46.2 m -116.43 112.46 21.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 109.695 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.0 110.508 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.162 0.506 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 19' ' ' CYS . 12.4 t -70.49 156.6 39.17 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.36 -0.837 . . . . 0.0 110.536 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.601 HD11 ' CG1' ' A' ' 16' ' ' ILE . 88.6 mt -70.76 140.43 86.54 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.456 -0.777 . . . . 0.0 110.399 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 43.7 Cg_endo -70.12 164.16 35.92 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.893 1.47 . . . . 0.0 110.596 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.0 130.63 19.38 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.753 1.396 . . . . 0.0 110.32 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.87 7.46 33.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.5 mmmt -86.09 125.83 67.1 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.996 -1.297 . . . . 0.0 109.845 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.4 Cg_endo -72.62 107.06 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.68 1.358 . . . . 0.0 110.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p -86.44 148.67 25.45 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -0.759 . . . . 0.0 110.14 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 78.22 2.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 110.305 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.87 -126.49 41.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.43 6.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.528 -0.984 . . . . 0.0 110.563 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.8 m -106.44 71.01 0.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.29 -0.881 . . . . 0.0 109.742 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' HG22 ' A' ' 16' ' ' ILE . 17.3 pt20 -169.3 140.9 2.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.464 -0.772 . . . . 0.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 25.7 2.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.338 -0.851 . . . . 0.0 110.418 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.601 ' CG1' HD11 ' A' ' 3' ' ' LEU . 8.1 tp -116.85 116.5 38.2 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.586 -0.696 . . . . 0.0 109.866 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -76.0 126.88 9.62 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.806 1.424 . . . . 0.0 110.626 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.2 m -81.86 147.19 29.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 19.5 m -56.93 -35.67 69.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.397 -0.815 . . . . 0.0 110.305 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.59 -126.09 4.0 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -131.0 176.15 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.996 . . . . 0.0 109.896 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 m -82.07 113.26 19.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.467 -0.771 . . . . 0.0 109.996 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.1 t -119.43 102.6 8.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.919 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 54.06 53.79 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.517 -0.739 . . . . 0.0 109.976 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 64.27 43.88 4.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.727 -0.608 . . . . 0.0 110.608 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 27.2 mtmt -147.67 178.52 8.4 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.602 -0.686 . . . . 0.0 109.916 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.8 m -138.65 120.99 15.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.374 -0.829 . . . . 0.0 110.065 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.832 -1.08 . . . . 0.0 110.402 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 120.929 0.395 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.9 p -163.01 170.52 17.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.0 110.647 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.766 HD11 HG23 ' A' ' 16' ' ' ILE . 1.8 mt -78.64 137.91 58.64 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 41.5 Cg_endo -66.47 165.1 26.12 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.652 1.343 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.3 Cg_endo -68.43 124.07 11.22 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.084 1.57 . . . . 0.0 110.76 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.3 -19.14 13.36 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 36.0 mmtt -68.08 158.99 82.26 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.257 -1.143 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.6 155.79 40.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.896 1.472 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.421 ' HB3' ' N ' ' A' ' 26' ' ' LYS . 9.2 t -133.29 143.36 49.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.709 . . . . 0.0 109.456 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -122.54 148.14 45.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.432 -0.792 . . . . 0.0 110.768 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' THR . . . -101.46 144.6 16.53 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 57.29 27.77 14.21 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.791 -0.829 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' THR . 15.4 t -177.49 59.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.746 0.784 . . . . 0.0 109.964 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -151.51 104.89 3.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -90.62 21.47 3.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.334 -0.854 . . . . 0.0 110.498 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.766 HG23 HD11 ' A' ' 3' ' ' LEU . 1.3 tp -138.45 114.19 8.83 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.72 146.81 24.14 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.721 1.379 . . . . 0.0 110.909 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 35.3 m -77.36 153.87 33.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.406 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 58.5 m -54.09 -35.13 61.78 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.231 -0.918 . . . . 0.0 109.745 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.82 -97.69 2.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -143.87 177.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.474 -1.015 . . . . 0.0 109.844 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 1.2 m -100.49 122.58 43.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -139.45 132.87 30.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.415 -0.803 . . . . 0.0 110.128 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.431 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 52.8 m-70 52.17 39.06 26.04 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.688 -0.633 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.82 40.61 7.45 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.458 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 31.0 mtmt -141.0 175.26 9.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.417 -0.802 . . . . 0.0 110.248 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 21.5 m -112.78 105.4 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.623 -0.673 . . . . 0.0 109.268 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.541 -179.615 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.07 0.462 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.3 p -153.94 174.41 14.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.944 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.971 HD11 HG13 ' A' ' 16' ' ' ILE . 1.2 mp -77.59 154.71 81.34 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 164.66 34.91 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.815 1.429 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.76 137.92 30.77 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.9 1.473 . . . . 0.0 110.699 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.63 5.01 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 123.52 77.95 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.365 -1.08 . . . . 0.0 110.602 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.09 134.36 23.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.059 1.557 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -94.36 160.14 14.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -112.68 108.01 16.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.25 -0.907 . . . . 0.0 110.439 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.87 -147.49 43.72 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.21 35.9 4.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.94 . . . . 0.0 110.558 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -143.65 96.42 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -153.04 158.8 42.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.564 -0.71 . . . . 0.0 110.614 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.92 22.69 3.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.434 -0.791 . . . . 0.0 110.537 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.971 HG13 HD11 ' A' ' 3' ' ' LEU . 5.4 tp -138.7 97.61 9.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.6 138.82 22.08 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.585 1.308 . . . . 0.0 110.968 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.5 m -80.48 160.41 25.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.561 -0.712 . . . . 0.0 110.03 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.0 m -61.43 -48.16 82.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.096 -1.002 . . . . 0.0 109.628 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.74 -118.98 4.53 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -133.34 171.74 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.52 -0.988 . . . . 0.0 109.448 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.24 107.51 20.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.431 -0.793 . . . . 0.0 110.47 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.7 p -126.93 145.19 50.77 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 34.43 24.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.28 -0.887 . . . . 0.0 110.275 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.56 35.44 9.25 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.612 -0.68 . . . . 0.0 111.674 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -161.75 139.89 9.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.065 -1.022 . . . . 0.0 110.118 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 52.6 m -78.84 127.32 31.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.445 -0.784 . . . . 0.0 110.386 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.783 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.5 pttt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.238 0.542 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 2.4 p -165.12 177.21 7.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.436 -0.79 . . . . 0.0 110.804 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.834 HD11 ' CG1' ' A' ' 16' ' ' ILE . 1.8 mp -78.72 157.59 76.67 Favored Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 121.681 -0.637 . . . . 0.0 110.504 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 42.8 Cg_endo -68.09 167.42 21.87 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.848 1.446 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.39 135.91 30.09 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.882 1.464 . . . . 0.0 110.526 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.58 -18.56 44.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtm -61.36 121.64 64.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.281 -1.129 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.4 Cg_endo -71.44 113.0 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.814 1.429 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 17.6 p -101.71 161.23 13.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.43 -0.794 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.54 172.9 6.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.02 -45.53 1.17 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.41 26.52 9.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.376 -1.073 . . . . 0.0 111.352 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 13' ' ' THR . 14.1 t -170.88 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 110.446 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 16' ' ' ILE . 1.8 tt0 -144.98 96.57 2.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.71 24.99 2.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.834 ' CG1' HD11 ' A' ' 3' ' ' LEU . 4.0 tp -120.12 130.59 24.77 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.38 127.84 10.02 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.8 1.421 . . . . 0.0 110.995 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.414 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -90.65 163.35 14.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.612 -0.68 . . . . 0.0 109.974 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.528 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 86.8 m -68.99 -51.44 39.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.144 -0.972 . . . . 0.0 109.537 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.0 -116.54 2.7 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -137.11 174.0 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.542 -0.975 . . . . 0.0 109.676 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -91.8 97.46 11.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.375 -0.828 . . . . 0.0 110.074 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -128.41 139.45 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.54 -0.725 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.24 40.81 31.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.552 -0.717 . . . . 0.0 110.693 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.17 36.45 25.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.587 -0.695 . . . . 0.0 111.393 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.8 ptmt -159.71 169.51 23.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.145 -0.972 . . . . 0.0 110.39 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 65.3 m -111.68 131.35 55.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.338 -0.851 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.595 -0.691 . . . . 0.0 110.045 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.289 0.566 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.2 p -160.75 172.16 17.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.462 -0.774 . . . . 0.0 110.62 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.963 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mt -78.54 153.32 78.69 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.444 -0.785 . . . . 0.0 109.983 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.36 159.38 46.85 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.81 1.426 . . . . 0.0 110.406 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.64 127.48 10.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.915 1.481 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.66 -28.91 7.51 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.68 140.42 98.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.383 -1.069 . . . . 0.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 43.8 Cg_endo -71.83 131.84 19.07 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.817 1.43 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -112.25 166.92 10.84 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.774 . . . . 0.0 110.5 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.11 149.52 38.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.457 -0.777 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.31 54.81 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 49.48 1.63 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -1.001 . . . . 0.0 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.7 m 56.09 91.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -111.41 160.53 17.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.384 -0.822 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -90.48 21.98 3.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.419 -0.801 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.963 HG13 HD11 ' A' ' 3' ' ' LEU . 7.9 tp -136.44 113.1 10.18 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.31 135.19 9.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.845 1.445 . . . . 0.0 111.119 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HD13 ' A' ' 3' ' ' LEU . 1.9 m -81.3 152.39 27.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.314 -0.867 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -48.04 80.51 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.471 -0.768 . . . . 0.0 110.048 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.07 -119.13 4.56 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -130.66 175.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.484 -1.009 . . . . 0.0 109.427 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.4 t -108.4 131.58 54.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.449 -0.782 . . . . 0.0 110.661 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.65 125.28 23.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 57.49 43.92 22.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.055 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 2.0 t-20 59.79 34.91 22.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.798 -0.564 . . . . 0.0 110.785 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 5.4 mmpt? -140.14 125.15 18.51 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.443 -0.786 . . . . 0.0 109.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -86.15 134.53 33.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.254 -0.904 . . . . 0.0 110.804 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.538 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.108 0.48 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.61 175.59 8.88 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.449 -0.782 . . . . 0.0 110.639 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.608 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mp -65.36 133.4 95.41 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.571 -0.705 . . . . 0.0 110.358 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.13 167.36 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.806 1.424 . . . . 0.0 110.616 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 128.69 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.869 1.458 . . . . 0.0 110.801 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.23 37.57 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HD2' HD23 ' A' ' 3' ' ' LEU . 4.0 mmtt -87.66 142.68 32.89 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.234 -1.156 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.01 134.33 27.2 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.531 1.28 . . . . 0.0 110.743 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.32 144.05 30.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.602 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 93.2 m-85 -104.18 84.18 2.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.499 -0.751 . . . . 0.0 110.748 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 -147.51 50.1 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.52 40.61 3.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.911 . . . . 0.0 109.801 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 13' ' ' THR . 10.1 t -154.86 70.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.315 -0.865 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -113.2 161.1 17.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.325 -0.859 . . . . 0.0 110.291 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.4 19.18 5.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.305 -0.872 . . . . 0.0 110.461 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.608 ' CG1' HD11 ' A' ' 3' ' ' LEU . 3.2 tp -142.47 122.76 8.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.533 -0.73 . . . . 0.0 110.084 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.46 138.94 17.94 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.706 1.372 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.3 m -90.01 155.28 19.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.601 -0.687 . . . . 0.0 110.092 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -63.53 -45.3 91.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.228 -0.92 . . . . 0.0 109.821 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.59 -115.68 3.21 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -136.36 174.82 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.549 -0.971 . . . . 0.0 109.825 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -97.12 104.98 17.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -144.59 146.7 32.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m170 54.76 40.24 31.82 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.6 -0.687 . . . . 0.0 110.925 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.93 35.52 26.48 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.566 -0.709 . . . . 0.0 111.194 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -162.88 177.57 9.14 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.293 -0.88 . . . . 0.0 110.652 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 55.3 m -118.86 134.1 55.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.695 . . . . 0.0 110.604 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.824 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.03 0.443 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.2 p -75.1 169.8 17.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.491 -0.756 . . . . 0.0 110.721 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.807 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mp -86.34 150.12 51.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.361 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 40.1 Cg_endo -66.06 166.76 19.82 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.788 1.415 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.03 131.57 22.55 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.849 1.447 . . . . 0.0 111.357 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.2 55.53 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mmmt -78.23 149.18 75.69 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.975 -1.309 . . . . 0.0 110.185 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 45.6 Cg_endo -73.23 94.88 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.895 1.471 . . . . 0.0 110.51 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 18.5 p -87.66 144.83 26.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.429 -0.794 . . . . 0.0 110.378 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 7.0 m-85 -101.35 164.5 11.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.889 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.2 -79.6 0.69 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.45 28.9 7.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.979 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 m -141.27 68.89 1.33 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.228 -0.92 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 10' ' ' TYR . 24.2 tt0 -162.06 120.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.464 -0.772 . . . . 0.0 110.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -90.86 18.96 5.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.0 110.826 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 3' ' ' LEU . 4.0 tp -142.87 114.36 5.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 110.129 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 3' ' ' LEU . 51.6 Cg_endo -76.27 147.84 29.84 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.523 1.275 . . . . 0.0 111.162 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.34 160.52 32.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.514 -0.741 . . . . 0.0 109.598 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 93.4 m -60.09 -33.11 71.65 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -89.51 1.86 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.8 t -142.13 177.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.465 -1.02 . . . . 0.0 110.028 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 21' ' ' VAL . 7.9 t -118.7 110.06 16.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -132.79 135.64 45.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.751 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.9 m170 53.18 38.04 26.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.652 -0.655 . . . . 0.0 109.938 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 1.2 t30 61.74 36.09 16.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.742 -0.599 . . . . 0.0 110.674 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 1.3 mmpt? -135.24 138.12 43.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 31.2 m -83.12 104.45 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.363 -0.835 . . . . 0.0 109.619 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.302 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.178 0.513 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p -71.25 155.06 41.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 16' ' ' ILE . 8.9 mp -78.0 143.81 66.7 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 110.175 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 43.6 Cg_endo -71.4 167.07 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.862 1.454 . . . . 0.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.44 120.42 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.878 1.462 . . . . 0.0 110.88 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.87 -25.39 6.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -72.22 130.39 86.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.228 -1.16 . . . . 0.0 110.68 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 42.5 Cg_endo -70.36 128.23 15.2 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.79 1.416 . . . . 0.0 110.639 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.74 165.7 22.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.512 -0.743 . . . . 0.0 110.398 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.88 141.47 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 110.431 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.55 -152.93 29.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 54.19 41.03 32.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 58.2 m 60.35 107.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.742 -0.598 . . . . 0.0 111.265 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -117.09 147.64 42.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -91.12 24.8 2.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.344 -0.847 . . . . 0.0 110.716 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -135.36 112.56 11.02 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.94 138.88 9.39 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.866 1.456 . . . . 0.0 110.759 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.35 140.26 29.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.288 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -45.16 73.52 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.04 -131.77 7.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -127.06 172.63 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -1.045 . . . . 0.0 109.463 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.28 107.44 19.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.394 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 30.0 m -132.54 124.18 27.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 0.0 109.434 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 64.5 39.39 6.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.502 -0.748 . . . . 0.0 110.376 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 60.78 47.68 7.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.658 -0.651 . . . . 0.0 111.469 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -167.19 151.87 7.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 88.2 m -103.53 137.26 41.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 110.07 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.54 HG23 ' HE2' ' A' ' 26' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.221 0.534 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.521 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p -119.26 172.89 7.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.475 -0.766 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.951 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.04 152.65 62.47 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.58 -0.7 . . . . 0.0 110.547 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.984 1.518 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.6 Cg_endo -69.41 123.91 10.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.966 1.509 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.6 -24.27 5.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 136.72 96.84 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.188 -1.184 . . . . 0.0 110.13 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.12 135.07 18.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.693 1.365 . . . . 0.0 111.072 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.7 p -110.2 124.96 52.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -82.39 88.28 6.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.559 -0.713 . . . . 0.0 110.457 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 -156.78 53.07 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.93 30.9 6.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.427 -1.043 . . . . 0.0 110.384 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.6 m -143.9 90.22 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.326 -0.859 . . . . 0.0 109.858 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.11 168.75 23.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.446 -0.784 . . . . 0.0 110.562 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 23.69 2.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.564 -0.71 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.5 107.79 12.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.77 129.88 4.18 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.705 1.371 . . . . 0.0 110.492 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.7 m -55.32 -43.96 75.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.54 -121.48 3.49 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.35 173.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.491 -1.005 . . . . 0.0 110.001 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 42.0 t -88.82 114.73 25.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.0 110.074 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.63 120.65 20.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.305 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.18 45.01 28.27 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.625 -0.672 . . . . 0.0 109.506 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.45 34.72 20.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.772 -0.58 . . . . 0.0 110.741 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.17 164.34 29.43 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.4 -0.813 . . . . 0.0 110.071 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 45.2 m -116.5 112.5 21.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.395 -0.816 . . . . 0.0 110.454 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.204 0.526 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 p -146.32 163.28 36.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.342 -0.849 . . . . 0.0 110.421 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 16' ' ' ILE . 8.5 mp -83.26 149.96 59.64 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.478 -0.764 . . . . 0.0 110.801 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 Cg_endo -72.17 162.66 41.03 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.99 1.521 . . . . 0.0 110.65 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 44.7 Cg_endo -72.1 112.33 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.849 1.447 . . . . 0.0 110.705 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.83 -23.29 3.56 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -68.22 144.13 96.48 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.155 -1.203 . . . . 0.0 110.401 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.8 Cg_endo -73.03 146.22 41.06 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.792 1.417 . . . . 0.0 111.057 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 7.7 p -136.43 153.8 50.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.559 -0.713 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 13' ' ' THR . 25.0 m-85 -114.3 175.15 5.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.671 -0.643 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.24 -45.68 1.06 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.98 25.75 4.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -1.152 . . . . 0.0 111.281 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 13' ' ' THR . 9.2 t -173.31 66.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.253 -0.905 . . . . 0.0 110.245 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.19 93.63 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.921 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 23.65 3.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.491 -0.756 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HD2' ' A' ' 17' ' ' PRO . 8.2 tp -135.27 129.63 18.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 16' ' ' ILE . 51.3 Cg_endo -80.47 100.81 1.27 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.731 1.385 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.44 152.57 43.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.344 -0.848 . . . . 0.0 109.787 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -44.37 96.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.37 -0.831 . . . . 0.0 109.781 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.64 -123.88 4.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -138.09 174.7 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -1.069 . . . . 0.0 109.753 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 14.0 t -94.14 108.82 20.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.465 -0.772 . . . . 0.0 110.289 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 p -127.33 127.86 44.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.466 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.8 t-160 57.56 34.43 24.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 68.13 25.8 7.3 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.851 -0.531 . . . . 0.0 110.738 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 25' ' ' ASN . 6.5 mmmm -130.23 156.72 44.15 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.369 -0.832 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -104.56 120.64 41.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.98 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.329 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mttm . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.311 0.577 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.87 172.05 9.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 110.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 16' ' ' ILE . 77.8 mt -89.77 149.6 42.37 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.9 Cg_endo -69.98 160.17 50.6 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.65 1.342 . . . . 0.0 110.452 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.22 122.28 8.57 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.976 1.514 . . . . 0.0 110.503 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.82 -34.97 2.87 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 1.7 mmtm -60.44 158.44 29.52 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.562 -0.963 . . . . 0.0 110.555 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.35 161.58 42.34 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.782 1.412 . . . . 0.0 110.816 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -154.72 159.52 40.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.45 -0.781 . . . . 0.0 110.653 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 13' ' ' THR . 37.9 m-85 -126.6 144.31 50.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.655 -0.653 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 133.71 11.94 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.26 16.56 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 0.0 111.865 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 13' ' ' THR . 12.8 t -173.81 69.84 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 110.595 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -150.33 141.79 23.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.997 -1.065 . . . . 0.0 111.045 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.01 11.82 21.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.217 -0.927 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.713 ' CG2' HD11 ' A' ' 3' ' ' LEU . 8.6 tp -150.15 127.55 5.56 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.83 148.5 22.43 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.727 1.383 . . . . 0.0 111.275 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 92.5 m -88.64 137.04 32.68 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -58.24 -39.05 78.11 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.01 -105.78 2.61 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.93 174.51 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.347 -1.09 . . . . 0.0 109.939 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 99.78 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' ASN . 20.9 m -88.89 -132.71 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.633 -0.667 . . . . 0.0 109.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.11 74.42 0.12 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.492 -0.755 . . . . 0.0 109.753 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' SER . 0.6 OUTLIER 57.47 48.64 14.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.434 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -167.44 146.71 5.05 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.319 -0.863 . . . . 0.0 111.37 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m -79.7 123.27 27.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.663 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p -83.44 168.75 16.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.452 -0.78 . . . . 0.0 110.422 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 16' ' ' ILE . 49.8 mt -77.67 148.77 76.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.558 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.0 Cg_endo -71.7 157.88 54.59 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.713 1.375 . . . . 0.0 109.957 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -74.43 114.46 4.04 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.885 1.466 . . . . 0.0 110.714 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.81 -27.74 5.86 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -57.4 151.85 36.13 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.341 -1.093 . . . . 0.0 110.427 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.28 108.19 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.906 1.477 . . . . 0.0 110.721 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -89.0 145.73 25.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.538 -0.726 . . . . 0.0 110.142 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . 8.3 m-85 -100.29 156.15 17.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.482 -0.761 . . . . 0.0 110.606 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 13' ' ' THR . . . -112.59 130.94 9.83 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.4 31.67 15.01 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.86 -0.788 . . . . 0.0 111.342 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' THR . 15.1 t -174.82 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.39 -0.819 . . . . 0.0 109.807 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -149.26 122.5 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.316 -0.865 . . . . 0.0 110.916 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -90.96 21.31 4.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.267 -0.895 . . . . 0.0 110.597 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.83 HG23 HD11 ' A' ' 3' ' ' LEU . 6.9 tp -137.84 119.66 10.8 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.78 138.41 16.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.702 1.37 . . . . 0.0 111.169 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.4 t -78.6 146.22 34.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.562 -0.711 . . . . 0.0 109.283 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -50.5 60.73 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 109.532 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.19 1.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.0 t -144.76 177.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.493 -1.004 . . . . 0.0 110.111 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.5 t -97.34 112.45 24.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 t -95.41 -138.69 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.35 76.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.896 . . . . 0.0 108.962 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.525 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 60.69 35.05 19.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.658 -0.651 . . . . 0.0 110.079 -178.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 2.8 mmpt? -137.87 165.12 27.28 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.46 -0.775 . . . . 0.0 110.615 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.6 t -111.83 109.57 19.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 109.268 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.482 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.9 tttt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.071 0.462 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.5 p -87.98 172.28 9.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD12 ' SG ' ' A' ' 18' ' ' CYS . 96.8 mt -90.32 150.18 42.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 47.3 Cg_endo -72.28 161.54 44.16 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.765 1.403 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 114.51 4.05 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.836 1.44 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.97 -34.3 2.41 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 5.4 mmtm -58.92 141.16 86.15 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.478 -1.013 . . . . 0.0 110.396 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.3 Cg_endo -72.49 137.77 28.53 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.987 1.519 . . . . 0.0 110.744 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 3.3 p -133.54 163.43 29.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.496 -0.752 . . . . 0.0 110.401 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.7 166.64 11.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.5 -62.31 4.94 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.63 37.46 2.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.558 -0.966 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m -136.55 73.26 1.45 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -164.13 128.18 2.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.511 -0.743 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -91.32 24.54 2.9 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.368 -0.833 . . . . 0.0 111.118 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.806 HD12 ' HD2' ' A' ' 17' ' ' PRO . 7.4 tp -124.49 126.71 25.4 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.379 -0.826 . . . . 0.0 110.246 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.806 ' HD2' HD12 ' A' ' 16' ' ' ILE . 52.8 Cg_endo -76.05 124.79 8.19 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.804 1.423 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.1 m -90.51 138.65 31.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.489 -0.757 . . . . 0.0 109.88 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -40.69 83.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.478 -0.764 . . . . 0.0 110.236 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -130.37 6.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -132.74 173.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.236 -1.155 . . . . 0.0 109.685 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.98 103.59 15.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.446 -0.784 . . . . 0.0 110.455 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 p -133.9 138.25 45.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 56.8 36.13 27.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.569 -0.707 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.06 30.2 17.83 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.577 -0.702 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 10.5 ptmt -156.01 149.41 24.69 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 53.0 m -87.0 128.55 35.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.416 -0.802 . . . . 0.0 110.383 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.612 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 120.664 0.269 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p -67.39 169.08 9.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.278 -0.889 . . . . 0.0 110.46 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 16' ' ' ILE . 13.4 mt -79.21 142.23 58.84 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 109.782 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.6 160.91 46.95 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.758 1.399 . . . . 0.0 110.108 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.93 110.7 2.98 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.745 1.392 . . . . 0.0 110.333 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.64 -37.36 2.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -56.76 140.01 76.14 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.42 -1.047 . . . . 0.0 110.092 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -69.47 128.07 15.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.64 1.337 . . . . 0.0 111.071 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -102.27 136.97 41.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.0 110.296 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.87 154.69 33.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.57 -0.706 . . . . 0.0 110.541 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 101.7 2.7 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.6 31.64 15.49 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.754 -0.85 . . . . 0.0 111.053 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.4 m -143.35 66.95 1.3 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.0 137.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.55 24.62 2.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.865 HD12 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -140.93 113.8 7.01 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.724 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' N ' HD13 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -73.69 152.54 47.93 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.681 1.358 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -82.21 143.11 31.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.638 -0.663 . . . . 0.0 109.463 179.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -52.98 57.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.492 -0.755 . . . . 0.0 109.439 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.18 -98.97 1.13 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.6 t -144.57 174.02 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.39 -1.065 . . . . 0.0 110.273 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' H ' HG12 ' A' ' 21' ' ' VAL . 45.9 t -102.84 97.64 7.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -136.33 156.45 48.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.0 109.688 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 52.46 33.7 13.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 58.23 42.92 21.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 0.0 110.678 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 ptmt -167.74 163.65 14.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.349 -0.844 . . . . 0.0 111.078 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 35.6 t -88.5 121.19 30.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.683 -0.636 . . . . 0.0 109.626 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.596 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 120.814 0.34 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.445 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.5 p -97.9 169.94 9.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.338 -0.851 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.698 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mt -74.33 136.55 75.29 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 0.0 110.45 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 40.9 Cg_endo -67.65 163.66 34.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.794 1.418 . . . . 0.0 110.644 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.53 131.88 22.49 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.851 1.448 . . . . 0.0 110.352 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.87 -34.01 4.81 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -59.93 156.69 34.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.515 -0.991 . . . . 0.0 110.136 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.24 169.35 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.82 1.432 . . . . 0.0 111.085 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 15.3 t -143.74 144.97 32.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.644 -0.66 . . . . 0.0 109.406 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -97.89 72.84 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 110.771 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.09 -143.44 37.28 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.65 32.45 5.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.934 . . . . 0.0 110.475 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 m -135.8 89.15 2.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -159.35 147.41 17.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.499 -0.75 . . . . 0.0 110.131 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 23.03 3.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.335 -0.853 . . . . 0.0 111.171 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' HD2' ' A' ' 17' ' ' PRO . 9.0 tp -119.66 120.73 30.4 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 109.935 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 16' ' ' ILE . 55.2 Cg_endo -76.48 124.63 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.869 1.457 . . . . 0.0 111.649 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.29 148.27 22.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.441 -0.787 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.6 m -60.41 -36.94 79.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.13 -121.92 4.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -133.28 175.55 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.487 -1.008 . . . . 0.0 109.768 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 34.6 t -97.72 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.845 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 p -132.17 129.48 39.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.643 -0.661 . . . . 0.0 109.957 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 91.6 m-70 55.95 36.87 28.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.618 -0.676 . . . . 0.0 110.42 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 2.1 t30 67.56 24.51 8.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.787 -0.57 . . . . 0.0 111.091 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 24' ' ' HIS . 1.1 mmmt -127.8 172.15 11.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 0.0 109.779 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 1.4 m -126.11 124.66 41.07 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.378 -0.826 . . . . 0.0 109.968 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.448 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.229 0.538 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.429 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.2 p -148.9 161.6 41.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.427 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 16' ' ' ILE . 92.8 mt -90.49 161.12 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.418 -0.801 . . . . 0.0 110.581 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.36 162.79 41.23 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.914 1.481 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.9 Cg_endo -71.33 112.42 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.861 1.453 . . . . 0.0 110.314 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.56 2.43 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -55.75 129.28 71.02 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.366 -1.079 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.56 130.43 16.0 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.686 1.361 . . . . 0.0 110.847 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 13.3 p -117.15 166.55 12.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.605 -0.684 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.85 172.01 7.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.348 -0.845 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.33 -74.43 1.07 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.18 30.26 6.07 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.931 . . . . 0.0 110.699 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.9 m -145.37 69.28 1.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.38 101.21 5.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -91.55 25.31 2.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.709 . . . . 0.0 110.389 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -134.71 131.91 20.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 51.0 Cg_endo -73.33 117.32 5.04 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.83 1.437 . . . . 0.0 110.768 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.5 141.97 28.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.306 -0.871 . . . . 0.0 109.85 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -61.4 -45.44 94.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.61 -123.56 4.2 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.5 t -137.91 174.78 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.609 -0.936 . . . . 0.0 109.599 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.9 98.96 11.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -133.54 144.07 49.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.537 -0.727 . . . . 0.0 109.863 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 53.11 40.19 30.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.594 -0.691 . . . . 0.0 110.663 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.84 32.52 22.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.089 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 7.0 ptmt -159.25 169.6 23.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 21.4 m -103.86 129.72 51.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.77 . . . . 0.0 110.21 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.687 179.784 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 p -86.61 161.21 18.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.475 -0.766 . . . . 0.0 110.347 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 16' ' ' ILE . 3.7 mp -87.48 149.44 46.61 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.488 -0.757 . . . . 0.0 110.097 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.27 164.6 35.14 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.986 1.519 . . . . 0.0 110.459 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.56 123.79 9.76 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.978 1.515 . . . . 0.0 110.021 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.63 -39.81 1.72 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -56.34 128.92 74.22 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.682 -0.893 . . . . 0.0 109.909 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.16 127.45 11.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.7 1.368 . . . . 0.0 110.626 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 142.66 35.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.474 -0.766 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -86.51 77.94 9.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.227 -0.921 . . . . 0.0 110.959 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.78 -136.22 33.26 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.77 30.04 6.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.462 -1.022 . . . . 0.0 110.602 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -130.98 88.59 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.66 132.88 29.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 18.44 6.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.859 HG13 HD11 ' A' ' 3' ' ' LEU . 8.8 tp -139.97 122.99 10.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.89 130.37 11.36 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.689 1.363 . . . . 0.0 110.921 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 3' ' ' LEU . 12.6 m -83.1 148.0 27.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.75 . . . . 0.0 109.386 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.33 83.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.243 -0.911 . . . . 0.0 109.841 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 -130.47 6.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.2 t -132.07 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.397 -1.061 . . . . 0.0 109.57 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 25' ' ' ASN . 43.5 t -91.67 97.7 11.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.418 -0.801 . . . . 0.0 110.296 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -98.63 113.84 26.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 55.63 46.32 22.98 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 109.089 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 3.0 t30 63.58 36.63 10.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.809 -0.557 . . . . 0.0 110.595 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 3.1 mmpt? -138.49 114.33 9.95 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 18.5 m -71.21 117.18 12.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 109.701 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.515 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.179 0.514 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.8 p -118.09 169.82 9.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.797 . . . . 0.0 110.647 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mp -90.11 158.0 44.7 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -72.34 158.69 51.07 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.821 1.432 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 122.11 7.2 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.874 1.46 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.66 -34.74 3.81 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 26.3 mmtm -59.65 148.46 74.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.544 -0.974 . . . . 0.0 110.1 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.1 Cg_endo -70.77 136.27 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.728 1.383 . . . . 0.0 110.799 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -111.24 145.98 37.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.798 -0.564 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -92.87 71.67 4.78 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.363 -0.836 . . . . 0.0 110.562 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.16 -143.94 33.13 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.47 48.48 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.466 -1.02 . . . . 0.0 109.968 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 13' ' ' THR . 12.1 t -150.27 64.67 0.96 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.277 -0.889 . . . . 0.0 110.242 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -138.89 168.15 20.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.355 -0.841 . . . . 0.0 110.275 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 15.8 5.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 0.0 111.246 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 16' ' ' ILE . 7.4 tp -147.48 101.48 3.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 110.082 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.56 138.18 23.84 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.523 1.275 . . . . 0.0 111.389 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 t -63.99 145.74 55.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.759 -0.588 . . . . 0.0 109.763 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -50.32 70.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.768 . . . . 0.0 109.353 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.36 -96.7 0.89 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -144.84 175.57 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.56 -0.965 . . . . 0.0 109.986 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' H ' HG12 ' A' ' 21' ' ' VAL . 38.3 t -105.89 113.61 27.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.512 -0.743 . . . . 0.0 110.031 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 4.3 t -100.12 -139.57 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -70.22 80.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.784 . . . . 0.0 110.25 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.65 49.58 8.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.768 -0.582 . . . . 0.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 6.3 ptmt -161.8 161.2 29.0 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.292 -0.88 . . . . 0.0 110.74 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -107.07 112.37 25.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.453 -0.78 . . . . 0.0 110.005 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 179.822 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.7 tttp . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.025 0.44 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.427 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 24.9 p -143.27 169.11 18.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mt -86.51 135.08 36.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.483 -0.761 . . . . 0.0 110.266 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.4 172.37 10.31 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.823 1.433 . . . . 0.0 111.011 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.42 124.89 11.68 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.852 1.448 . . . . 0.0 111.004 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.572 ' HA2' ' HD3' ' A' ' 26' ' ' LYS . . . 107.81 6.03 32.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.2 152.84 50.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.101 -1.235 . . . . 0.0 109.787 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HE2' ' A' ' 7' ' ' LYS . 45.8 Cg_endo -70.99 135.43 27.5 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.73 1.384 . . . . 0.0 111.032 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 147.05 49.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.01 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -102.45 173.61 6.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.327 -0.858 . . . . 0.0 110.486 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.74 -99.61 0.05 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.6 34.72 3.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -1.04 . . . . 0.0 110.721 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.6 m -140.41 79.15 1.69 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.287 -0.883 . . . . 0.0 109.768 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 16' ' ' ILE . 26.9 tt0 -163.48 117.38 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -90.91 21.89 3.93 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.434 -0.791 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' ILE . 3.3 tp -131.65 107.23 14.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.333 -0.855 . . . . 0.0 109.512 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.6 143.98 35.01 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.743 1.391 . . . . 0.0 111.336 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 31.4 m -76.38 158.24 31.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.546 -0.721 . . . . 0.0 109.439 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 89.3 m -57.64 -32.16 66.99 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.9 -93.66 1.94 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.1 t -143.56 178.94 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.603 -0.94 . . . . 0.0 110.083 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.538 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.1 m -104.21 117.55 34.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.9 p -134.89 128.62 32.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.96 52.64 14.04 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.717 -0.615 . . . . 0.0 110.415 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 39.93 31.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.657 -0.652 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HD3' ' HA2' ' A' ' 6' ' ' GLY . 3.8 ttmt -142.78 161.44 38.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 13.9 m -107.28 106.97 17.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.519 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p -119.26 172.98 7.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 110.523 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.08 152.69 62.39 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.574 -0.704 . . . . 0.0 110.535 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.996 1.524 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.4 123.8 10.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.939 1.494 . . . . 0.0 110.782 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.76 -24.28 5.5 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 136.67 96.82 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.128 -1.219 . . . . 0.0 110.099 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.09 134.99 18.33 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.661 1.348 . . . . 0.0 111.204 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.6 p -110.2 124.9 52.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.0 109.848 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -82.39 88.33 6.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.445 -0.784 . . . . 0.0 110.38 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.32 -156.68 53.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 30.87 6.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -1.001 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 m -143.89 90.17 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.845 . . . . 0.0 109.858 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.99 168.88 22.58 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 23.71 2.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.51 107.8 12.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 109.753 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.79 129.89 4.16 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.689 1.363 . . . . 0.0 110.529 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.3 m -55.28 -43.99 75.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.383 -0.823 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.44 -121.54 3.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.31 173.5 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.559 -0.965 . . . . 0.0 110.025 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 41.9 t -88.9 114.71 25.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 0.0 110.054 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.64 120.75 21.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.1 45.03 28.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.534 -0.728 . . . . 0.0 109.523 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.42 34.79 20.54 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.763 -0.585 . . . . 0.0 110.685 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.13 164.18 29.79 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.413 -0.805 . . . . 0.0 110.182 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 46.2 m -116.43 112.46 21.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 109.695 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.0 110.508 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 19' ' ' CYS . 12.4 t . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.205 0.526 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.601 HD11 ' CG1' ' A' ' 16' ' ' ILE . 88.6 mt -70.76 140.43 86.54 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.456 -0.777 . . . . 0.0 110.399 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 43.7 Cg_endo -70.12 164.16 35.92 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.893 1.47 . . . . 0.0 110.596 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.0 130.63 19.38 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.753 1.396 . . . . 0.0 110.32 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.87 7.46 33.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.5 mmmt -86.09 125.83 67.1 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.996 -1.297 . . . . 0.0 109.845 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.4 Cg_endo -72.62 107.06 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.68 1.358 . . . . 0.0 110.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p -86.44 148.67 25.45 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -0.759 . . . . 0.0 110.14 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 78.22 2.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 110.305 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.87 -126.49 41.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.43 6.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.528 -0.984 . . . . 0.0 110.563 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.8 m -106.44 71.01 0.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.29 -0.881 . . . . 0.0 109.742 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' HG22 ' A' ' 16' ' ' ILE . 17.3 pt20 -169.3 140.9 2.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.464 -0.772 . . . . 0.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 25.7 2.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.338 -0.851 . . . . 0.0 110.418 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.601 ' CG1' HD11 ' A' ' 3' ' ' LEU . 8.1 tp -116.85 116.5 38.2 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.586 -0.696 . . . . 0.0 109.866 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -76.0 126.88 9.62 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.806 1.424 . . . . 0.0 110.626 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.2 m -81.86 147.19 29.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 19.5 m -56.93 -35.67 69.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.397 -0.815 . . . . 0.0 110.305 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.59 -126.09 4.0 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -131.0 176.15 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.996 . . . . 0.0 109.896 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 m -82.07 113.26 19.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.467 -0.771 . . . . 0.0 109.996 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.1 t -119.43 102.6 8.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.919 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 54.06 53.79 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.517 -0.739 . . . . 0.0 109.976 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 64.27 43.88 4.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.727 -0.608 . . . . 0.0 110.608 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 27.2 mtmt -147.67 178.52 8.4 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.602 -0.686 . . . . 0.0 109.916 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.8 m -138.65 120.99 15.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.374 -0.829 . . . . 0.0 110.065 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.832 -1.08 . . . . 0.0 110.402 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.9 p . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.255 0.55 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.766 HD11 HG23 ' A' ' 16' ' ' ILE . 1.8 mt -78.64 137.91 58.64 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 41.5 Cg_endo -66.47 165.1 26.12 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.652 1.343 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.3 Cg_endo -68.43 124.07 11.22 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.084 1.57 . . . . 0.0 110.76 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.3 -19.14 13.36 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 36.0 mmtt -68.08 158.99 82.26 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.257 -1.143 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.6 155.79 40.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.896 1.472 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.421 ' HB3' ' N ' ' A' ' 26' ' ' LYS . 9.2 t -133.29 143.36 49.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.709 . . . . 0.0 109.456 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -122.54 148.14 45.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.432 -0.792 . . . . 0.0 110.768 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' THR . . . -101.46 144.6 16.53 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 57.29 27.77 14.21 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.791 -0.829 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' THR . 15.4 t -177.49 59.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.746 0.784 . . . . 0.0 109.964 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -151.51 104.89 3.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -90.62 21.47 3.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.334 -0.854 . . . . 0.0 110.498 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.766 HG23 HD11 ' A' ' 3' ' ' LEU . 1.3 tp -138.45 114.19 8.83 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.72 146.81 24.14 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.721 1.379 . . . . 0.0 110.909 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 35.3 m -77.36 153.87 33.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.406 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 58.5 m -54.09 -35.13 61.78 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.231 -0.918 . . . . 0.0 109.745 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.82 -97.69 2.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -143.87 177.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.474 -1.015 . . . . 0.0 109.844 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 1.2 m -100.49 122.58 43.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -139.45 132.87 30.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.415 -0.803 . . . . 0.0 110.128 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.431 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 52.8 m-70 52.17 39.06 26.04 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.688 -0.633 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.82 40.61 7.45 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.458 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 31.0 mtmt -141.0 175.26 9.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.417 -0.802 . . . . 0.0 110.248 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 21.5 m -112.78 105.4 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.623 -0.673 . . . . 0.0 109.268 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.541 -179.615 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.3 p . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 121.249 0.547 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.971 HD11 HG13 ' A' ' 16' ' ' ILE . 1.2 mp -77.59 154.71 81.34 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 164.66 34.91 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.815 1.429 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.76 137.92 30.77 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.9 1.473 . . . . 0.0 110.699 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.63 5.01 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 123.52 77.95 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.365 -1.08 . . . . 0.0 110.602 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.09 134.36 23.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.059 1.557 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -94.36 160.14 14.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -112.68 108.01 16.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.25 -0.907 . . . . 0.0 110.439 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.87 -147.49 43.72 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.21 35.9 4.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.94 . . . . 0.0 110.558 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -143.65 96.42 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -153.04 158.8 42.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.564 -0.71 . . . . 0.0 110.614 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.92 22.69 3.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.434 -0.791 . . . . 0.0 110.537 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.971 HG13 HD11 ' A' ' 3' ' ' LEU . 5.4 tp -138.7 97.61 9.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.6 138.82 22.08 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.585 1.308 . . . . 0.0 110.968 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.5 m -80.48 160.41 25.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.561 -0.712 . . . . 0.0 110.03 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.0 m -61.43 -48.16 82.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.096 -1.002 . . . . 0.0 109.628 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.74 -118.98 4.53 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -133.34 171.74 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.52 -0.988 . . . . 0.0 109.448 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.24 107.51 20.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.431 -0.793 . . . . 0.0 110.47 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.7 p -126.93 145.19 50.77 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 34.43 24.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.28 -0.887 . . . . 0.0 110.275 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.56 35.44 9.25 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.612 -0.68 . . . . 0.0 111.674 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -161.75 139.89 9.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.065 -1.022 . . . . 0.0 110.118 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 52.6 m -78.84 127.32 31.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.445 -0.784 . . . . 0.0 110.386 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.783 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 2.4 p . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 121.313 0.578 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.834 HD11 ' CG1' ' A' ' 16' ' ' ILE . 1.8 mp -78.72 157.59 76.67 Favored Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 121.681 -0.637 . . . . 0.0 110.504 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 42.8 Cg_endo -68.09 167.42 21.87 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.848 1.446 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.39 135.91 30.09 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.882 1.464 . . . . 0.0 110.526 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.58 -18.56 44.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtm -61.36 121.64 64.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.281 -1.129 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.4 Cg_endo -71.44 113.0 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.814 1.429 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 17.6 p -101.71 161.23 13.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.43 -0.794 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.54 172.9 6.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.02 -45.53 1.17 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.41 26.52 9.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.376 -1.073 . . . . 0.0 111.352 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 13' ' ' THR . 14.1 t -170.88 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 110.446 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 16' ' ' ILE . 1.8 tt0 -144.98 96.57 2.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.71 24.99 2.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.834 ' CG1' HD11 ' A' ' 3' ' ' LEU . 4.0 tp -120.12 130.59 24.77 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.38 127.84 10.02 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.8 1.421 . . . . 0.0 110.995 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.414 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -90.65 163.35 14.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.612 -0.68 . . . . 0.0 109.974 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.528 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 86.8 m -68.99 -51.44 39.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.144 -0.972 . . . . 0.0 109.537 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.0 -116.54 2.7 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -137.11 174.0 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.542 -0.975 . . . . 0.0 109.676 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -91.8 97.46 11.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.375 -0.828 . . . . 0.0 110.074 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -128.41 139.45 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.54 -0.725 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.24 40.81 31.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.552 -0.717 . . . . 0.0 110.693 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.17 36.45 25.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.587 -0.695 . . . . 0.0 111.393 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.8 ptmt -159.71 169.51 23.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.145 -0.972 . . . . 0.0 110.39 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 65.3 m -111.68 131.35 55.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.338 -0.851 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.595 -0.691 . . . . 0.0 110.045 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.2 p . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.115 0.484 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.963 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mt -78.54 153.32 78.69 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.444 -0.785 . . . . 0.0 109.983 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.36 159.38 46.85 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.81 1.426 . . . . 0.0 110.406 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.64 127.48 10.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.915 1.481 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.66 -28.91 7.51 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.68 140.42 98.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.383 -1.069 . . . . 0.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 43.8 Cg_endo -71.83 131.84 19.07 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.817 1.43 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -112.25 166.92 10.84 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.774 . . . . 0.0 110.5 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.11 149.52 38.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.457 -0.777 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.31 54.81 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 49.48 1.63 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -1.001 . . . . 0.0 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.7 m 56.09 91.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -111.41 160.53 17.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.384 -0.822 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -90.48 21.98 3.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.419 -0.801 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.963 HG13 HD11 ' A' ' 3' ' ' LEU . 7.9 tp -136.44 113.1 10.18 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.31 135.19 9.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.845 1.445 . . . . 0.0 111.119 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HD13 ' A' ' 3' ' ' LEU . 1.9 m -81.3 152.39 27.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.314 -0.867 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -48.04 80.51 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.471 -0.768 . . . . 0.0 110.048 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.07 -119.13 4.56 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -130.66 175.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.484 -1.009 . . . . 0.0 109.427 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.4 t -108.4 131.58 54.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.449 -0.782 . . . . 0.0 110.661 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.65 125.28 23.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 57.49 43.92 22.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.055 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 2.0 t-20 59.79 34.91 22.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.798 -0.564 . . . . 0.0 110.785 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 5.4 mmpt? -140.14 125.15 18.51 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.443 -0.786 . . . . 0.0 109.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -86.15 134.53 33.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.254 -0.904 . . . . 0.0 110.804 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.538 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.162 0.506 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.608 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mp -65.36 133.4 95.41 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.571 -0.705 . . . . 0.0 110.358 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.13 167.36 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.806 1.424 . . . . 0.0 110.616 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 128.69 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.869 1.458 . . . . 0.0 110.801 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.23 37.57 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HD2' HD23 ' A' ' 3' ' ' LEU . 4.0 mmtt -87.66 142.68 32.89 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.234 -1.156 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.01 134.33 27.2 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.531 1.28 . . . . 0.0 110.743 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.32 144.05 30.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.602 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 93.2 m-85 -104.18 84.18 2.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.499 -0.751 . . . . 0.0 110.748 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 -147.51 50.1 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.52 40.61 3.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.911 . . . . 0.0 109.801 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 13' ' ' THR . 10.1 t -154.86 70.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.315 -0.865 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -113.2 161.1 17.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.325 -0.859 . . . . 0.0 110.291 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.4 19.18 5.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.305 -0.872 . . . . 0.0 110.461 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.608 ' CG1' HD11 ' A' ' 3' ' ' LEU . 3.2 tp -142.47 122.76 8.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.533 -0.73 . . . . 0.0 110.084 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.46 138.94 17.94 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.706 1.372 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.3 m -90.01 155.28 19.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.601 -0.687 . . . . 0.0 110.092 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -63.53 -45.3 91.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.228 -0.92 . . . . 0.0 109.821 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.59 -115.68 3.21 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -136.36 174.82 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.549 -0.971 . . . . 0.0 109.825 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -97.12 104.98 17.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -144.59 146.7 32.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m170 54.76 40.24 31.82 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.6 -0.687 . . . . 0.0 110.925 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.93 35.52 26.48 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.566 -0.709 . . . . 0.0 111.194 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -162.88 177.57 9.14 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.293 -0.88 . . . . 0.0 110.652 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 55.3 m -118.86 134.1 55.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.695 . . . . 0.0 110.604 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.824 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.2 p . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 121.176 0.513 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.807 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mp -86.34 150.12 51.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.361 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 40.1 Cg_endo -66.06 166.76 19.82 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.788 1.415 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.03 131.57 22.55 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.849 1.447 . . . . 0.0 111.357 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.2 55.53 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mmmt -78.23 149.18 75.69 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.975 -1.309 . . . . 0.0 110.185 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 45.6 Cg_endo -73.23 94.88 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.895 1.471 . . . . 0.0 110.51 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 18.5 p -87.66 144.83 26.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.429 -0.794 . . . . 0.0 110.378 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 7.0 m-85 -101.35 164.5 11.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.889 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.2 -79.6 0.69 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.45 28.9 7.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.979 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 m -141.27 68.89 1.33 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.228 -0.92 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 10' ' ' TYR . 24.2 tt0 -162.06 120.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.464 -0.772 . . . . 0.0 110.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -90.86 18.96 5.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.0 110.826 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 3' ' ' LEU . 4.0 tp -142.87 114.36 5.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 110.129 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 3' ' ' LEU . 51.6 Cg_endo -76.27 147.84 29.84 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.523 1.275 . . . . 0.0 111.162 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.34 160.52 32.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.514 -0.741 . . . . 0.0 109.598 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 93.4 m -60.09 -33.11 71.65 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -89.51 1.86 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.8 t -142.13 177.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.465 -1.02 . . . . 0.0 110.028 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 21' ' ' VAL . 7.9 t -118.7 110.06 16.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -132.79 135.64 45.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.751 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.9 m170 53.18 38.04 26.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.652 -0.655 . . . . 0.0 109.938 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 1.2 t30 61.74 36.09 16.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.742 -0.599 . . . . 0.0 110.674 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 1.3 mmpt? -135.24 138.12 43.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 31.2 m -83.12 104.45 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.363 -0.835 . . . . 0.0 109.619 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.302 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.208 0.528 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 16' ' ' ILE . 8.9 mp -78.0 143.81 66.7 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 110.175 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 43.6 Cg_endo -71.4 167.07 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.862 1.454 . . . . 0.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.44 120.42 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.878 1.462 . . . . 0.0 110.88 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.87 -25.39 6.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -72.22 130.39 86.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.228 -1.16 . . . . 0.0 110.68 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 42.5 Cg_endo -70.36 128.23 15.2 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.79 1.416 . . . . 0.0 110.639 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.74 165.7 22.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.512 -0.743 . . . . 0.0 110.398 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.88 141.47 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 110.431 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.55 -152.93 29.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 54.19 41.03 32.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 58.2 m 60.35 107.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.742 -0.598 . . . . 0.0 111.265 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -117.09 147.64 42.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -91.12 24.8 2.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.344 -0.847 . . . . 0.0 110.716 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -135.36 112.56 11.02 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.94 138.88 9.39 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.866 1.456 . . . . 0.0 110.759 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.35 140.26 29.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.288 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -45.16 73.52 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.04 -131.77 7.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -127.06 172.63 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -1.045 . . . . 0.0 109.463 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.28 107.44 19.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.394 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 30.0 m -132.54 124.18 27.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 0.0 109.434 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 64.5 39.39 6.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.502 -0.748 . . . . 0.0 110.376 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 60.78 47.68 7.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.658 -0.651 . . . . 0.0 111.469 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -167.19 151.87 7.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 88.2 m -103.53 137.26 41.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 110.07 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.54 HG23 ' HE2' ' A' ' 26' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.521 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.197 0.522 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.951 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.04 152.65 62.47 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.58 -0.7 . . . . 0.0 110.547 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.984 1.518 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.6 Cg_endo -69.41 123.91 10.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.966 1.509 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.6 -24.27 5.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 136.72 96.84 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.188 -1.184 . . . . 0.0 110.13 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.12 135.07 18.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.693 1.365 . . . . 0.0 111.072 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.7 p -110.2 124.96 52.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -82.39 88.28 6.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.559 -0.713 . . . . 0.0 110.457 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 -156.78 53.07 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.93 30.9 6.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.427 -1.043 . . . . 0.0 110.384 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.6 m -143.9 90.22 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.326 -0.859 . . . . 0.0 109.858 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.11 168.75 23.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.446 -0.784 . . . . 0.0 110.562 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 23.69 2.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.564 -0.71 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.5 107.79 12.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.77 129.88 4.18 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.705 1.371 . . . . 0.0 110.492 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.7 m -55.32 -43.96 75.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.54 -121.48 3.49 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.35 173.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.491 -1.005 . . . . 0.0 110.001 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 42.0 t -88.82 114.73 25.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.0 110.074 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.63 120.65 20.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.305 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.18 45.01 28.27 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.625 -0.672 . . . . 0.0 109.506 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.45 34.72 20.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.772 -0.58 . . . . 0.0 110.741 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.17 164.34 29.43 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.4 -0.813 . . . . 0.0 110.071 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 45.2 m -116.5 112.5 21.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.395 -0.816 . . . . 0.0 110.454 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.077 0.465 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 16' ' ' ILE . 8.5 mp -83.26 149.96 59.64 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.478 -0.764 . . . . 0.0 110.801 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 Cg_endo -72.17 162.66 41.03 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.99 1.521 . . . . 0.0 110.65 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 44.7 Cg_endo -72.1 112.33 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.849 1.447 . . . . 0.0 110.705 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.83 -23.29 3.56 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -68.22 144.13 96.48 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.155 -1.203 . . . . 0.0 110.401 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.8 Cg_endo -73.03 146.22 41.06 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.792 1.417 . . . . 0.0 111.057 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 7.7 p -136.43 153.8 50.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.559 -0.713 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 13' ' ' THR . 25.0 m-85 -114.3 175.15 5.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.671 -0.643 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.24 -45.68 1.06 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.98 25.75 4.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -1.152 . . . . 0.0 111.281 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 13' ' ' THR . 9.2 t -173.31 66.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.253 -0.905 . . . . 0.0 110.245 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.19 93.63 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.921 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 23.65 3.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.491 -0.756 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HD2' ' A' ' 17' ' ' PRO . 8.2 tp -135.27 129.63 18.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 16' ' ' ILE . 51.3 Cg_endo -80.47 100.81 1.27 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.731 1.385 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.44 152.57 43.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.344 -0.848 . . . . 0.0 109.787 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -44.37 96.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.37 -0.831 . . . . 0.0 109.781 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.64 -123.88 4.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -138.09 174.7 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -1.069 . . . . 0.0 109.753 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 14.0 t -94.14 108.82 20.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.465 -0.772 . . . . 0.0 110.289 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 p -127.33 127.86 44.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.466 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.8 t-160 57.56 34.43 24.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 68.13 25.8 7.3 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.851 -0.531 . . . . 0.0 110.738 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 25' ' ' ASN . 6.5 mmmm -130.23 156.72 44.15 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.369 -0.832 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -104.56 120.64 41.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.98 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.329 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 121.101 0.477 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 16' ' ' ILE . 77.8 mt -89.77 149.6 42.37 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.9 Cg_endo -69.98 160.17 50.6 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.65 1.342 . . . . 0.0 110.452 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.22 122.28 8.57 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.976 1.514 . . . . 0.0 110.503 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.82 -34.97 2.87 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 1.7 mmtm -60.44 158.44 29.52 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.562 -0.963 . . . . 0.0 110.555 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.35 161.58 42.34 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.782 1.412 . . . . 0.0 110.816 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -154.72 159.52 40.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.45 -0.781 . . . . 0.0 110.653 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 13' ' ' THR . 37.9 m-85 -126.6 144.31 50.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.655 -0.653 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 133.71 11.94 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.26 16.56 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 0.0 111.865 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 13' ' ' THR . 12.8 t -173.81 69.84 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 110.595 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -150.33 141.79 23.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.997 -1.065 . . . . 0.0 111.045 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.01 11.82 21.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.217 -0.927 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.713 ' CG2' HD11 ' A' ' 3' ' ' LEU . 8.6 tp -150.15 127.55 5.56 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.83 148.5 22.43 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.727 1.383 . . . . 0.0 111.275 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 92.5 m -88.64 137.04 32.68 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -58.24 -39.05 78.11 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.01 -105.78 2.61 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.93 174.51 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.347 -1.09 . . . . 0.0 109.939 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 99.78 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' ASN . 20.9 m -88.89 -132.71 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.633 -0.667 . . . . 0.0 109.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.11 74.42 0.12 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.492 -0.755 . . . . 0.0 109.753 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' SER . 0.6 OUTLIER 57.47 48.64 14.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.434 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -167.44 146.71 5.05 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.319 -0.863 . . . . 0.0 111.37 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m -79.7 123.27 27.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.663 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.146 0.498 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 16' ' ' ILE . 49.8 mt -77.67 148.77 76.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.558 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.0 Cg_endo -71.7 157.88 54.59 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.713 1.375 . . . . 0.0 109.957 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -74.43 114.46 4.04 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.885 1.466 . . . . 0.0 110.714 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.81 -27.74 5.86 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -57.4 151.85 36.13 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.341 -1.093 . . . . 0.0 110.427 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.28 108.19 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.906 1.477 . . . . 0.0 110.721 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -89.0 145.73 25.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.538 -0.726 . . . . 0.0 110.142 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . 8.3 m-85 -100.29 156.15 17.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.482 -0.761 . . . . 0.0 110.606 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 13' ' ' THR . . . -112.59 130.94 9.83 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.4 31.67 15.01 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.86 -0.788 . . . . 0.0 111.342 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' THR . 15.1 t -174.82 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.39 -0.819 . . . . 0.0 109.807 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -149.26 122.5 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.316 -0.865 . . . . 0.0 110.916 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -90.96 21.31 4.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.267 -0.895 . . . . 0.0 110.597 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.83 HG23 HD11 ' A' ' 3' ' ' LEU . 6.9 tp -137.84 119.66 10.8 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.78 138.41 16.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.702 1.37 . . . . 0.0 111.169 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.4 t -78.6 146.22 34.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.562 -0.711 . . . . 0.0 109.283 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -50.5 60.73 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 109.532 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.19 1.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.0 t -144.76 177.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.493 -1.004 . . . . 0.0 110.111 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.5 t -97.34 112.45 24.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 t -95.41 -138.69 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.35 76.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.896 . . . . 0.0 108.962 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.525 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 60.69 35.05 19.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.658 -0.651 . . . . 0.0 110.079 -178.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 2.8 mmpt? -137.87 165.12 27.28 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.46 -0.775 . . . . 0.0 110.615 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.6 t -111.83 109.57 19.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 109.268 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.482 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.232 0.539 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD12 ' SG ' ' A' ' 18' ' ' CYS . 96.8 mt -90.32 150.18 42.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 47.3 Cg_endo -72.28 161.54 44.16 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.765 1.403 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 114.51 4.05 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.836 1.44 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.97 -34.3 2.41 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 5.4 mmtm -58.92 141.16 86.15 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.478 -1.013 . . . . 0.0 110.396 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.3 Cg_endo -72.49 137.77 28.53 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.987 1.519 . . . . 0.0 110.744 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 3.3 p -133.54 163.43 29.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.496 -0.752 . . . . 0.0 110.401 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.7 166.64 11.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.5 -62.31 4.94 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.63 37.46 2.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.558 -0.966 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m -136.55 73.26 1.45 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -164.13 128.18 2.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.511 -0.743 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -91.32 24.54 2.9 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.368 -0.833 . . . . 0.0 111.118 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.806 HD12 ' HD2' ' A' ' 17' ' ' PRO . 7.4 tp -124.49 126.71 25.4 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.379 -0.826 . . . . 0.0 110.246 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.806 ' HD2' HD12 ' A' ' 16' ' ' ILE . 52.8 Cg_endo -76.05 124.79 8.19 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.804 1.423 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.1 m -90.51 138.65 31.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.489 -0.757 . . . . 0.0 109.88 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -40.69 83.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.478 -0.764 . . . . 0.0 110.236 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -130.37 6.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -132.74 173.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.236 -1.155 . . . . 0.0 109.685 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.98 103.59 15.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.446 -0.784 . . . . 0.0 110.455 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 p -133.9 138.25 45.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 56.8 36.13 27.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.569 -0.707 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.06 30.2 17.83 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.577 -0.702 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 10.5 ptmt -156.01 149.41 24.69 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 53.0 m -87.0 128.55 35.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.416 -0.802 . . . . 0.0 110.383 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.612 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.361 0.6 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 16' ' ' ILE . 13.4 mt -79.21 142.23 58.84 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 109.782 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.6 160.91 46.95 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.758 1.399 . . . . 0.0 110.108 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.93 110.7 2.98 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.745 1.392 . . . . 0.0 110.333 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.64 -37.36 2.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -56.76 140.01 76.14 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.42 -1.047 . . . . 0.0 110.092 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -69.47 128.07 15.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.64 1.337 . . . . 0.0 111.071 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -102.27 136.97 41.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.0 110.296 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.87 154.69 33.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.57 -0.706 . . . . 0.0 110.541 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 101.7 2.7 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.6 31.64 15.49 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.754 -0.85 . . . . 0.0 111.053 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.4 m -143.35 66.95 1.3 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.0 137.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.55 24.62 2.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.865 HD12 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -140.93 113.8 7.01 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.724 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' N ' HD13 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -73.69 152.54 47.93 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.681 1.358 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -82.21 143.11 31.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.638 -0.663 . . . . 0.0 109.463 179.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -52.98 57.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.492 -0.755 . . . . 0.0 109.439 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.18 -98.97 1.13 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.6 t -144.57 174.02 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.39 -1.065 . . . . 0.0 110.273 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' H ' HG12 ' A' ' 21' ' ' VAL . 45.9 t -102.84 97.64 7.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -136.33 156.45 48.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.0 109.688 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 52.46 33.7 13.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 58.23 42.92 21.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 0.0 110.678 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 ptmt -167.74 163.65 14.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.349 -0.844 . . . . 0.0 111.078 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 35.6 t -88.5 121.19 30.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.683 -0.636 . . . . 0.0 109.626 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.596 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.445 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.5 p . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 121.415 0.626 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.698 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mt -74.33 136.55 75.29 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 0.0 110.45 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 40.9 Cg_endo -67.65 163.66 34.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.794 1.418 . . . . 0.0 110.644 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.53 131.88 22.49 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.851 1.448 . . . . 0.0 110.352 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.87 -34.01 4.81 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -59.93 156.69 34.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.515 -0.991 . . . . 0.0 110.136 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.24 169.35 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.82 1.432 . . . . 0.0 111.085 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 15.3 t -143.74 144.97 32.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.644 -0.66 . . . . 0.0 109.406 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -97.89 72.84 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 110.771 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.09 -143.44 37.28 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.65 32.45 5.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.934 . . . . 0.0 110.475 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 m -135.8 89.15 2.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -159.35 147.41 17.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.499 -0.75 . . . . 0.0 110.131 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 23.03 3.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.335 -0.853 . . . . 0.0 111.171 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' HD2' ' A' ' 17' ' ' PRO . 9.0 tp -119.66 120.73 30.4 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 109.935 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 16' ' ' ILE . 55.2 Cg_endo -76.48 124.63 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.869 1.457 . . . . 0.0 111.649 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.29 148.27 22.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.441 -0.787 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.445 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.6 m -60.41 -36.94 79.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.13 -121.92 4.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -133.28 175.55 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.487 -1.008 . . . . 0.0 109.768 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 34.6 t -97.72 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.845 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 p -132.17 129.48 39.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.643 -0.661 . . . . 0.0 109.957 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 91.6 m-70 55.95 36.87 28.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.618 -0.676 . . . . 0.0 110.42 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 2.1 t30 67.56 24.51 8.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.787 -0.57 . . . . 0.0 111.091 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 24' ' ' HIS . 1.1 mmmt -127.8 172.15 11.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 0.0 109.779 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 1.4 m -126.11 124.66 41.07 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.378 -0.826 . . . . 0.0 109.968 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.448 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.429 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.2 p . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.137 0.494 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 16' ' ' ILE . 92.8 mt -90.49 161.12 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.418 -0.801 . . . . 0.0 110.581 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.36 162.79 41.23 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.914 1.481 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.9 Cg_endo -71.33 112.42 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.861 1.453 . . . . 0.0 110.314 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.56 2.43 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -55.75 129.28 71.02 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.366 -1.079 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.56 130.43 16.0 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.686 1.361 . . . . 0.0 110.847 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 13.3 p -117.15 166.55 12.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.605 -0.684 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.85 172.01 7.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.348 -0.845 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.33 -74.43 1.07 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.18 30.26 6.07 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.931 . . . . 0.0 110.699 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.9 m -145.37 69.28 1.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.38 101.21 5.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -91.55 25.31 2.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.709 . . . . 0.0 110.389 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -134.71 131.91 20.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 51.0 Cg_endo -73.33 117.32 5.04 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.83 1.437 . . . . 0.0 110.768 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.5 141.97 28.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.306 -0.871 . . . . 0.0 109.85 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -61.4 -45.44 94.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.61 -123.56 4.2 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.5 t -137.91 174.78 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.609 -0.936 . . . . 0.0 109.599 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.9 98.96 11.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -133.54 144.07 49.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.537 -0.727 . . . . 0.0 109.863 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 53.11 40.19 30.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.594 -0.691 . . . . 0.0 110.663 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.84 32.52 22.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.089 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 7.0 ptmt -159.25 169.6 23.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 21.4 m -103.86 129.72 51.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.77 . . . . 0.0 110.21 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.687 179.784 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.224 0.535 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 16' ' ' ILE . 3.7 mp -87.48 149.44 46.61 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.488 -0.757 . . . . 0.0 110.097 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.27 164.6 35.14 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.986 1.519 . . . . 0.0 110.459 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.56 123.79 9.76 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.978 1.515 . . . . 0.0 110.021 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.63 -39.81 1.72 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -56.34 128.92 74.22 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.682 -0.893 . . . . 0.0 109.909 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.16 127.45 11.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.7 1.368 . . . . 0.0 110.626 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 142.66 35.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.474 -0.766 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -86.51 77.94 9.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.227 -0.921 . . . . 0.0 110.959 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.78 -136.22 33.26 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.77 30.04 6.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.462 -1.022 . . . . 0.0 110.602 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -130.98 88.59 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.66 132.88 29.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 18.44 6.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.859 HG13 HD11 ' A' ' 3' ' ' LEU . 8.8 tp -139.97 122.99 10.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.89 130.37 11.36 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.689 1.363 . . . . 0.0 110.921 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 3' ' ' LEU . 12.6 m -83.1 148.0 27.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.75 . . . . 0.0 109.386 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.33 83.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.243 -0.911 . . . . 0.0 109.841 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 -130.47 6.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.2 t -132.07 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.397 -1.061 . . . . 0.0 109.57 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 25' ' ' ASN . 43.5 t -91.67 97.7 11.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.418 -0.801 . . . . 0.0 110.296 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -98.63 113.84 26.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 55.63 46.32 22.98 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 109.089 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 3.0 t30 63.58 36.63 10.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.809 -0.557 . . . . 0.0 110.595 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 3.1 mmpt? -138.49 114.33 9.95 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 18.5 m -71.21 117.18 12.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 109.701 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.515 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mp -90.11 158.0 44.7 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -72.34 158.69 51.07 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.821 1.432 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 122.11 7.2 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.874 1.46 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.66 -34.74 3.81 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 26.3 mmtm -59.65 148.46 74.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.544 -0.974 . . . . 0.0 110.1 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.1 Cg_endo -70.77 136.27 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.728 1.383 . . . . 0.0 110.799 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -111.24 145.98 37.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.798 -0.564 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -92.87 71.67 4.78 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.363 -0.836 . . . . 0.0 110.562 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.16 -143.94 33.13 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.47 48.48 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.466 -1.02 . . . . 0.0 109.968 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 13' ' ' THR . 12.1 t -150.27 64.67 0.96 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.277 -0.889 . . . . 0.0 110.242 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -138.89 168.15 20.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.355 -0.841 . . . . 0.0 110.275 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 15.8 5.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 0.0 111.246 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 16' ' ' ILE . 7.4 tp -147.48 101.48 3.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 110.082 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.56 138.18 23.84 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.523 1.275 . . . . 0.0 111.389 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 t -63.99 145.74 55.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.759 -0.588 . . . . 0.0 109.763 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -50.32 70.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.768 . . . . 0.0 109.353 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.36 -96.7 0.89 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -144.84 175.57 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.56 -0.965 . . . . 0.0 109.986 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' H ' HG12 ' A' ' 21' ' ' VAL . 38.3 t -105.89 113.61 27.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.512 -0.743 . . . . 0.0 110.031 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 4.3 t -100.12 -139.57 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -70.22 80.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.784 . . . . 0.0 110.25 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.65 49.58 8.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.768 -0.582 . . . . 0.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 6.3 ptmt -161.8 161.2 29.0 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.292 -0.88 . . . . 0.0 110.74 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -107.07 112.37 25.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.453 -0.78 . . . . 0.0 110.005 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 179.822 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.427 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 24.9 p . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mt -86.51 135.08 36.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.483 -0.761 . . . . 0.0 110.266 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.4 172.37 10.31 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.823 1.433 . . . . 0.0 111.011 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.42 124.89 11.68 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.852 1.448 . . . . 0.0 111.004 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.572 ' HA2' ' HD3' ' A' ' 26' ' ' LYS . . . 107.81 6.03 32.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.2 152.84 50.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.101 -1.235 . . . . 0.0 109.787 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HE2' ' A' ' 7' ' ' LYS . 45.8 Cg_endo -70.99 135.43 27.5 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.73 1.384 . . . . 0.0 111.032 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 147.05 49.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.01 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -102.45 173.61 6.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.327 -0.858 . . . . 0.0 110.486 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.74 -99.61 0.05 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.6 34.72 3.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -1.04 . . . . 0.0 110.721 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.6 m -140.41 79.15 1.69 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.287 -0.883 . . . . 0.0 109.768 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 16' ' ' ILE . 26.9 tt0 -163.48 117.38 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -90.91 21.89 3.93 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.434 -0.791 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' ILE . 3.3 tp -131.65 107.23 14.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.333 -0.855 . . . . 0.0 109.512 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.6 143.98 35.01 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.743 1.391 . . . . 0.0 111.336 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 31.4 m -76.38 158.24 31.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.546 -0.721 . . . . 0.0 109.439 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 89.3 m -57.64 -32.16 66.99 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.9 -93.66 1.94 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.1 t -143.56 178.94 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.603 -0.94 . . . . 0.0 110.083 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.538 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.1 m -104.21 117.55 34.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.9 p -134.89 128.62 32.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.96 52.64 14.04 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.717 -0.615 . . . . 0.0 110.415 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 39.93 31.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.657 -0.652 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HD3' ' HA2' ' A' ' 6' ' ' GLY . 3.8 ttmt -142.78 161.44 38.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 13.9 m -107.28 106.97 17.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.519 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.187 0.518 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.08 152.69 62.39 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.574 -0.704 . . . . 0.0 110.535 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.996 1.524 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.4 123.8 10.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.939 1.494 . . . . 0.0 110.782 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.76 -24.28 5.5 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 136.67 96.82 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.128 -1.219 . . . . 0.0 110.099 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.09 134.99 18.33 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.661 1.348 . . . . 0.0 111.204 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.6 p -110.2 124.9 52.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.0 109.848 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -82.39 88.33 6.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.445 -0.784 . . . . 0.0 110.38 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.32 -156.68 53.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 30.87 6.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -1.001 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 m -143.89 90.17 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.845 . . . . 0.0 109.858 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.99 168.88 22.58 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 23.71 2.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.51 107.8 12.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 109.753 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.79 129.89 4.16 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.689 1.363 . . . . 0.0 110.529 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.3 m -55.28 -43.99 75.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.383 -0.823 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.44 -121.54 3.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.31 173.5 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.559 -0.965 . . . . 0.0 110.025 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 41.9 t -88.9 114.71 25.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 0.0 110.054 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.64 120.75 21.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.1 45.03 28.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.534 -0.728 . . . . 0.0 109.523 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.42 34.79 20.54 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.763 -0.585 . . . . 0.0 110.685 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.13 164.18 29.79 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.413 -0.805 . . . . 0.0 110.182 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 46.2 m -116.43 112.46 21.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 109.695 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.0 110.508 -179.804 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.162 0.506 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 19' ' ' CYS . 12.4 t -70.49 156.6 39.17 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.36 -0.837 . . . . 0.0 110.536 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.601 HD11 ' CG1' ' A' ' 16' ' ' ILE . 88.6 mt -70.76 140.43 86.54 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.456 -0.777 . . . . 0.0 110.399 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 43.7 Cg_endo -70.12 164.16 35.92 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.893 1.47 . . . . 0.0 110.596 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -70.0 130.63 19.38 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.753 1.396 . . . . 0.0 110.32 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.87 7.46 33.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.5 mmmt -86.09 125.83 67.1 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 120.996 -1.297 . . . . 0.0 109.845 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.4 Cg_endo -72.62 107.06 2.22 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.68 1.358 . . . . 0.0 110.892 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.561 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 28.2 p -86.44 148.67 25.45 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -0.759 . . . . 0.0 110.14 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 78.22 2.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 110.305 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.87 -126.49 41.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.43 6.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.528 -0.984 . . . . 0.0 110.563 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.8 m -106.44 71.01 0.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.29 -0.881 . . . . 0.0 109.742 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' HG22 ' A' ' 16' ' ' ILE . 17.3 pt20 -169.3 140.9 2.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.464 -0.772 . . . . 0.0 110.314 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 25.7 2.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.338 -0.851 . . . . 0.0 110.418 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.601 ' CG1' HD11 ' A' ' 3' ' ' LEU . 8.1 tp -116.85 116.5 38.2 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.586 -0.696 . . . . 0.0 109.866 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -76.0 126.88 9.62 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.806 1.424 . . . . 0.0 110.626 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.2 m -81.86 147.19 29.46 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.254 -0.904 . . . . 0.0 109.439 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 19.5 m -56.93 -35.67 69.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.397 -0.815 . . . . 0.0 110.305 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.59 -126.09 4.0 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -131.0 176.15 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.507 -0.996 . . . . 0.0 109.896 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 7.2 m -82.07 113.26 19.81 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.467 -0.771 . . . . 0.0 109.996 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.1 t -119.43 102.6 8.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.537 -0.727 . . . . 0.0 109.919 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 54.06 53.79 10.61 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.517 -0.739 . . . . 0.0 109.976 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER 64.27 43.88 4.61 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.727 -0.608 . . . . 0.0 110.608 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 27.2 mtmt -147.67 178.52 8.4 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.602 -0.686 . . . . 0.0 109.916 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.8 m -138.65 120.99 15.95 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.374 -0.829 . . . . 0.0 110.065 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.832 -1.08 . . . . 0.0 110.402 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 120.929 0.395 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.9 p -163.01 170.52 17.9 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.385 -0.822 . . . . 0.0 110.647 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.766 HD11 HG23 ' A' ' 16' ' ' ILE . 1.8 mt -78.64 137.91 58.64 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 41.5 Cg_endo -66.47 165.1 26.12 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.652 1.343 . . . . 0.0 111.16 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.3 Cg_endo -68.43 124.07 11.22 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.084 1.57 . . . . 0.0 110.76 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.3 -19.14 13.36 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.54 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 36.0 mmtt -68.08 158.99 82.26 Favored Pre-proline 0 N--CA 1.498 1.975 0 O-C-N 121.257 -1.143 . . . . 0.0 110.766 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -75.6 155.79 40.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.896 1.472 . . . . 0.0 110.979 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.421 ' HB3' ' N ' ' A' ' 26' ' ' LYS . 9.2 t -133.29 143.36 49.0 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.566 -0.709 . . . . 0.0 109.456 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -122.54 148.14 45.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.432 -0.792 . . . . 0.0 110.768 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' THR . . . -101.46 144.6 16.53 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 57.29 27.77 14.21 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.791 -0.829 . . . . 0.0 111.263 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' THR . 15.4 t -177.49 59.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.746 0.784 . . . . 0.0 109.964 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -151.51 104.89 3.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.703 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptm -90.62 21.47 3.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.334 -0.854 . . . . 0.0 110.498 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.766 HG23 HD11 ' A' ' 3' ' ' LEU . 1.3 tp -138.45 114.19 8.83 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -77.72 146.81 24.14 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.721 1.379 . . . . 0.0 110.909 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 35.3 m -77.36 153.87 33.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.566 -0.709 . . . . 0.0 109.527 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.406 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 58.5 m -54.09 -35.13 61.78 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.231 -0.918 . . . . 0.0 109.745 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.82 -97.69 2.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -143.87 177.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.474 -1.015 . . . . 0.0 109.844 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 1.2 m -100.49 122.58 43.44 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.395 -0.815 . . . . 0.0 109.89 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.0 m -139.45 132.87 30.15 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.415 -0.803 . . . . 0.0 110.128 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.431 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 52.8 m-70 52.17 39.06 26.04 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.688 -0.633 . . . . 0.0 110.159 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.82 40.61 7.45 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.702 -0.624 . . . . 0.0 110.458 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' CYS . 31.0 mtmt -141.0 175.26 9.77 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.417 -0.802 . . . . 0.0 110.248 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 21.5 m -112.78 105.4 13.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.623 -0.673 . . . . 0.0 109.268 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.541 -179.615 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 121.07 0.462 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 3.3 p -153.94 174.41 14.67 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.435 -0.791 . . . . 0.0 110.944 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.971 HD11 HG13 ' A' ' 16' ' ' ILE . 1.2 mp -77.59 154.71 81.34 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.581 -0.699 . . . . 0.0 110.564 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.92 164.66 34.91 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.815 1.429 . . . . 0.0 110.528 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.76 137.92 30.77 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.9 1.473 . . . . 0.0 110.699 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.78 -34.63 5.01 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.95 123.52 77.95 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.365 -1.08 . . . . 0.0 110.602 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.09 134.36 23.11 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 124.059 1.557 . . . . 0.0 110.853 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -94.36 160.14 14.8 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 109.902 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -112.68 108.01 16.9 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.25 -0.907 . . . . 0.0 110.439 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 59.87 -147.49 43.72 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.21 35.9 4.05 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.94 . . . . 0.0 110.558 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -143.65 96.42 2.9 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.242 -0.911 . . . . 0.0 110.093 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -153.04 158.8 42.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.564 -0.71 . . . . 0.0 110.614 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.92 22.69 3.51 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.434 -0.791 . . . . 0.0 110.537 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.971 HG13 HD11 ' A' ' 3' ' ' LEU . 5.4 tp -138.7 97.61 9.06 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.6 138.82 22.08 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.585 1.308 . . . . 0.0 110.968 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 67.5 m -80.48 160.41 25.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.561 -0.712 . . . . 0.0 110.03 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.514 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.0 m -61.43 -48.16 82.43 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.096 -1.002 . . . . 0.0 109.628 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.74 -118.98 4.53 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 0.6 OUTLIER -133.34 171.74 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.52 -0.988 . . . . 0.0 109.448 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 t -98.24 107.51 20.0 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.431 -0.793 . . . . 0.0 110.47 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.7 p -126.93 145.19 50.77 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 56.31 34.43 24.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.28 -0.887 . . . . 0.0 110.275 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.56 35.44 9.25 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.612 -0.68 . . . . 0.0 111.674 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.707 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -161.75 139.89 9.16 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.065 -1.022 . . . . 0.0 110.118 179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 52.6 m -78.84 127.32 31.88 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.445 -0.784 . . . . 0.0 110.386 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.783 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.5 pttt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.238 0.542 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.528 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 2.4 p -165.12 177.21 7.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.436 -0.79 . . . . 0.0 110.804 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.834 HD11 ' CG1' ' A' ' 16' ' ' ILE . 1.8 mp -78.72 157.59 76.67 Favored Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 121.681 -0.637 . . . . 0.0 110.504 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 42.8 Cg_endo -68.09 167.42 21.87 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.848 1.446 . . . . 0.0 111.009 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.39 135.91 30.09 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.882 1.464 . . . . 0.0 110.526 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.58 -18.56 44.09 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 6.8 mmtm -61.36 121.64 64.79 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.281 -1.129 . . . . 0.0 110.395 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.4 Cg_endo -71.44 113.0 3.48 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.814 1.429 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 17.6 p -101.71 161.23 13.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.43 -0.794 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -100.54 172.9 6.83 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.234 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.02 -45.53 1.17 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.41 26.52 9.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.376 -1.073 . . . . 0.0 111.352 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 13' ' ' THR . 14.1 t -170.88 63.01 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.14 -0.975 . . . . 0.0 110.446 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.552 ' HG2' HG22 ' A' ' 16' ' ' ILE . 1.8 tt0 -144.98 96.57 2.88 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.71 24.99 2.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.39 -0.819 . . . . 0.0 111.195 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.834 ' CG1' HD11 ' A' ' 3' ' ' LEU . 4.0 tp -120.12 130.59 24.77 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.232 -0.917 . . . . 0.0 110.424 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.462 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.38 127.84 10.02 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.8 1.421 . . . . 0.0 110.995 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.414 ' C ' ' HB2' ' A' ' 2' ' ' CYS . 1.3 m -90.65 163.35 14.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.612 -0.68 . . . . 0.0 109.974 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.528 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 86.8 m -68.99 -51.44 39.29 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.144 -0.972 . . . . 0.0 109.537 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.0 -116.54 2.7 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -137.11 174.0 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.542 -0.975 . . . . 0.0 109.676 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -91.8 97.46 11.01 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.375 -0.828 . . . . 0.0 110.074 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -128.41 139.45 52.36 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.54 -0.725 . . . . 0.0 109.721 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 55.24 40.81 31.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.552 -0.717 . . . . 0.0 110.693 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 58.17 36.45 25.82 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.587 -0.695 . . . . 0.0 111.393 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.8 ptmt -159.71 169.51 23.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.145 -0.972 . . . . 0.0 110.39 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 65.3 m -111.68 131.35 55.35 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.338 -0.851 . . . . 0.0 110.782 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.498 1.975 0 O-C-N 121.595 -0.691 . . . . 0.0 110.045 179.812 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.289 0.566 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.2 p -160.75 172.16 17.56 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.462 -0.774 . . . . 0.0 110.62 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.963 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mt -78.54 153.32 78.69 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.444 -0.785 . . . . 0.0 109.983 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.36 159.38 46.85 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.81 1.426 . . . . 0.0 110.406 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.64 127.48 10.28 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.915 1.481 . . . . 0.0 110.146 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.66 -28.91 7.51 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.68 140.42 98.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.383 -1.069 . . . . 0.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 43.8 Cg_endo -71.83 131.84 19.07 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.817 1.43 . . . . 0.0 110.612 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 0.4 OUTLIER -112.25 166.92 10.84 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.462 -0.774 . . . . 0.0 110.5 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.11 149.52 38.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.457 -0.777 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.31 54.81 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.33 49.48 1.63 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -1.001 . . . . 0.0 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 99.7 m 56.09 91.95 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.472 0.653 . . . . 0.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -111.41 160.53 17.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.384 -0.822 . . . . 0.0 110.366 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -90.48 21.98 3.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.419 -0.801 . . . . 0.0 110.835 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.963 HG13 HD11 ' A' ' 3' ' ' LEU . 7.9 tp -136.44 113.1 10.18 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.302 -0.874 . . . . 0.0 110.373 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -81.31 135.19 9.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.845 1.445 . . . . 0.0 111.119 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HD13 ' A' ' 3' ' ' LEU . 1.9 m -81.3 152.39 27.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.314 -0.867 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.01 -48.04 80.51 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.471 -0.768 . . . . 0.0 110.048 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.07 -119.13 4.56 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -130.66 175.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.484 -1.009 . . . . 0.0 109.427 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG12 ' A' ' 21' ' ' VAL . 4.4 t -108.4 131.58 54.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.449 -0.782 . . . . 0.0 110.661 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.65 125.28 23.75 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 57.49 43.92 22.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.055 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 2.0 t-20 59.79 34.91 22.01 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.798 -0.564 . . . . 0.0 110.785 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 5.4 mmpt? -140.14 125.15 18.51 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.443 -0.786 . . . . 0.0 109.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -86.15 134.53 33.8 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.254 -0.904 . . . . 0.0 110.804 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.538 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.108 0.48 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.61 175.59 8.88 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.449 -0.782 . . . . 0.0 110.639 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.608 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mp -65.36 133.4 95.41 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.571 -0.705 . . . . 0.0 110.358 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.13 167.36 22.1 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.806 1.424 . . . . 0.0 110.616 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 128.69 16.51 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.869 1.458 . . . . 0.0 110.801 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.28 5.23 37.57 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HD2' HD23 ' A' ' 3' ' ' LEU . 4.0 mmtt -87.66 142.68 32.89 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.234 -1.156 . . . . 0.0 109.569 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.01 134.33 27.2 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.531 1.28 . . . . 0.0 110.743 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.1 t -101.32 144.05 30.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.652 -0.655 . . . . 0.0 109.602 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . 93.2 m-85 -104.18 84.18 2.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.499 -0.751 . . . . 0.0 110.748 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 62.8 -147.51 50.1 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.52 40.61 3.56 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.651 -0.911 . . . . 0.0 109.801 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 13' ' ' THR . 10.1 t -154.86 70.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.315 -0.865 . . . . 0.0 110.336 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -113.2 161.1 17.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.325 -0.859 . . . . 0.0 110.291 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.4 19.18 5.4 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.305 -0.872 . . . . 0.0 110.461 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.608 ' CG1' HD11 ' A' ' 3' ' ' LEU . 3.2 tp -142.47 122.76 8.16 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.533 -0.73 . . . . 0.0 110.084 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.46 138.94 17.94 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.706 1.372 . . . . 0.0 111.251 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.3 m -90.01 155.28 19.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.601 -0.687 . . . . 0.0 110.092 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.3 m -63.53 -45.3 91.23 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.228 -0.92 . . . . 0.0 109.821 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.59 -115.68 3.21 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.6 t -136.36 174.82 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.549 -0.971 . . . . 0.0 109.825 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.9 t -97.12 104.98 17.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.829 . . . . 0.0 109.965 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -144.59 146.7 32.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.535 -0.728 . . . . 0.0 110.165 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.2 m170 54.76 40.24 31.82 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.6 -0.687 . . . . 0.0 110.925 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.93 35.52 26.48 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.566 -0.709 . . . . 0.0 111.194 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -162.88 177.57 9.14 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.293 -0.88 . . . . 0.0 110.652 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 55.3 m -118.86 134.1 55.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.695 . . . . 0.0 110.604 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.824 179.517 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.03 0.443 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.449 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 21.2 p -75.1 169.8 17.3 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.491 -0.756 . . . . 0.0 110.721 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.807 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mp -86.34 150.12 51.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.361 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 40.1 Cg_endo -66.06 166.76 19.82 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.788 1.415 . . . . 0.0 110.899 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.03 131.57 22.55 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 O-C-N 123.849 1.447 . . . . 0.0 111.357 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.46 2.2 55.53 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 3.7 mmmt -78.23 149.18 75.69 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.975 -1.309 . . . . 0.0 110.185 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 45.6 Cg_endo -73.23 94.88 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.895 1.471 . . . . 0.0 110.51 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HA ' ' OE1' ' A' ' 14' ' ' GLN . 18.5 p -87.66 144.83 26.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.429 -0.794 . . . . 0.0 110.378 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' HB2' ' HB2' ' A' ' 14' ' ' GLN . 7.0 m-85 -101.35 164.5 11.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.277 -0.889 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.2 -79.6 0.69 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.45 28.9 7.89 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.535 -0.979 . . . . 0.0 110.922 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 31.1 m -141.27 68.89 1.33 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.228 -0.92 . . . . 0.0 110.017 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 10' ' ' TYR . 24.2 tt0 -162.06 120.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.464 -0.772 . . . . 0.0 110.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -90.86 18.96 5.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.415 -0.803 . . . . 0.0 110.826 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 3' ' ' LEU . 4.0 tp -142.87 114.36 5.95 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 110.129 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.443 ' O ' HD12 ' A' ' 3' ' ' LEU . 51.6 Cg_endo -76.27 147.84 29.84 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.523 1.275 . . . . 0.0 111.162 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.4 m -70.34 160.52 32.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.514 -0.741 . . . . 0.0 109.598 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.449 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 93.4 m -60.09 -33.11 71.65 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.273 -0.892 . . . . 0.0 109.788 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.06 -89.51 1.86 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.8 t -142.13 177.8 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.465 -1.02 . . . . 0.0 110.028 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.488 ' H ' HG12 ' A' ' 21' ' ' VAL . 7.9 t -118.7 110.06 16.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.4 -0.812 . . . . 0.0 109.717 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 t -132.79 135.64 45.82 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.499 -0.751 . . . . 0.0 109.883 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.9 m170 53.18 38.04 26.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.652 -0.655 . . . . 0.0 109.938 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 1.2 t30 61.74 36.09 16.5 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.742 -0.599 . . . . 0.0 110.674 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 1.3 mmpt? -135.24 138.12 43.26 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 31.2 m -83.12 104.45 13.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.363 -0.835 . . . . 0.0 109.619 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.7 p . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.302 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 121.178 0.513 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.3 p -71.25 155.06 41.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD13 HG23 ' A' ' 16' ' ' ILE . 8.9 mp -78.0 143.81 66.7 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.0 110.175 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 43.6 Cg_endo -71.4 167.07 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.862 1.454 . . . . 0.0 110.595 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.44 120.42 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.878 1.462 . . . . 0.0 110.88 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.87 -25.39 6.15 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.553 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -72.22 130.39 86.34 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.228 -1.16 . . . . 0.0 110.68 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 42.5 Cg_endo -70.36 128.23 15.2 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 O-C-N 123.79 1.416 . . . . 0.0 110.639 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.74 165.7 22.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.512 -0.743 . . . . 0.0 110.398 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.88 141.47 52.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.771 . . . . 0.0 110.431 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.55 -152.93 29.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 13' ' ' THR . . . 54.19 41.03 32.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.663 -0.904 . . . . 0.0 110.924 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' ALA . 58.2 m 60.35 107.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.742 -0.598 . . . . 0.0 111.265 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -117.09 147.64 42.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.257 -0.902 . . . . 0.0 110.166 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -91.12 24.8 2.7 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.344 -0.847 . . . . 0.0 110.716 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.58 HG23 HD13 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -135.36 112.56 11.02 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.304 -0.873 . . . . 0.0 109.862 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -82.94 138.88 9.39 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.866 1.456 . . . . 0.0 110.759 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.35 140.26 29.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.448 -0.782 . . . . 0.0 110.288 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -45.16 73.52 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.04 -131.77 7.28 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -127.06 172.63 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.423 -1.045 . . . . 0.0 109.463 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.28 107.44 19.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.262 -0.899 . . . . 0.0 110.394 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 30.0 m -132.54 124.18 27.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 0.0 109.434 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 64.5 39.39 6.85 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.502 -0.748 . . . . 0.0 110.376 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 60.78 47.68 7.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.658 -0.651 . . . . 0.0 111.469 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.698 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -167.19 151.87 7.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.401 -0.812 . . . . 0.0 110.484 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 88.2 m -103.53 137.26 41.85 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 110.07 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.54 HG23 ' HE2' ' A' ' 26' ' ' LYS . 1.3 p . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.221 0.534 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.521 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p -119.26 172.89 7.28 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.475 -0.766 . . . . 0.0 110.557 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.951 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.04 152.65 62.47 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.58 -0.7 . . . . 0.0 110.547 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.984 1.518 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.6 Cg_endo -69.41 123.91 10.69 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.966 1.509 . . . . 0.0 110.732 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.6 -24.27 5.55 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.58 136.72 96.84 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.188 -1.184 . . . . 0.0 110.13 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.12 135.07 18.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.693 1.365 . . . . 0.0 111.072 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.7 p -110.2 124.96 52.53 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.793 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -82.39 88.28 6.58 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.559 -0.713 . . . . 0.0 110.457 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 -156.78 53.07 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.93 30.9 6.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.427 -1.043 . . . . 0.0 110.384 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.6 m -143.9 90.22 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.326 -0.859 . . . . 0.0 109.858 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.11 168.75 23.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.446 -0.784 . . . . 0.0 110.562 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 23.69 2.58 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.564 -0.71 . . . . 0.0 110.506 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.951 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.5 107.79 12.08 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.782 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.77 129.88 4.18 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 O-C-N 123.705 1.371 . . . . 0.0 110.492 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.327 -0.858 . . . . 0.0 110.038 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.7 m -55.32 -43.96 75.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.54 -121.48 3.49 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.35 173.48 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.491 -1.005 . . . . 0.0 110.001 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 42.0 t -88.82 114.73 25.76 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.473 -0.767 . . . . 0.0 110.074 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.63 120.65 20.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.58 -0.7 . . . . 0.0 109.305 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.18 45.01 28.27 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.625 -0.672 . . . . 0.0 109.506 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.45 34.72 20.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.772 -0.58 . . . . 0.0 110.741 -179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.17 164.34 29.43 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.4 -0.813 . . . . 0.0 110.071 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 45.2 m -116.5 112.5 21.47 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.395 -0.816 . . . . 0.0 110.454 -179.735 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.204 0.526 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.6 p -146.32 163.28 36.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.342 -0.849 . . . . 0.0 110.421 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 16' ' ' ILE . 8.5 mp -83.26 149.96 59.64 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.478 -0.764 . . . . 0.0 110.801 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 46.4 Cg_endo -72.17 162.66 41.03 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 123.99 1.521 . . . . 0.0 110.65 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 44.7 Cg_endo -72.1 112.33 3.39 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.849 1.447 . . . . 0.0 110.705 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.83 -23.29 3.56 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HG3' ' HD2' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -68.22 144.13 96.48 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.155 -1.203 . . . . 0.0 110.401 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 25' ' ' ASN . 46.8 Cg_endo -73.03 146.22 41.06 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.792 1.417 . . . . 0.0 111.057 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.627 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 7.7 p -136.43 153.8 50.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.559 -0.713 . . . . 0.0 110.722 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' HB3' HG22 ' A' ' 13' ' ' THR . 25.0 m-85 -114.3 175.15 5.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.671 -0.643 . . . . 0.0 110.203 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.24 -45.68 1.06 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.98 25.75 4.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.241 -1.152 . . . . 0.0 111.281 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 13' ' ' THR . 9.2 t -173.31 66.17 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.253 -0.905 . . . . 0.0 110.245 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.19 93.63 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 109.921 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.92 23.65 3.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.491 -0.756 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HD2' ' A' ' 17' ' ' PRO . 8.2 tp -135.27 129.63 18.88 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 110.405 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.63 ' HD2' HD12 ' A' ' 16' ' ' ILE . 51.3 Cg_endo -80.47 100.81 1.27 Allowed 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.731 1.385 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.44 152.57 43.61 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.344 -0.848 . . . . 0.0 109.787 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -44.37 96.27 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.37 -0.831 . . . . 0.0 109.781 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.64 -123.88 4.55 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.129 -1.589 . . . . 0.0 109.129 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.3 t -138.09 174.7 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.383 -1.069 . . . . 0.0 109.753 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 14.0 t -94.14 108.82 20.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.465 -0.772 . . . . 0.0 110.289 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 p -127.33 127.86 44.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.588 -0.695 . . . . 0.0 109.19 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.466 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 1.8 t-160 57.56 34.43 24.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.506 -0.746 . . . . 0.0 109.266 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.49 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 68.13 25.8 7.3 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.851 -0.531 . . . . 0.0 110.738 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 25' ' ' ASN . 6.5 mmmm -130.23 156.72 44.15 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.369 -0.832 . . . . 0.0 110.361 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 1.6 m -104.56 120.64 41.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.433 -0.792 . . . . 0.0 109.98 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 118.079 -0.963 . . . . 0.0 110.329 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mttm . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.311 0.577 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.87 172.05 9.46 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.446 -0.784 . . . . 0.0 110.076 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 16' ' ' ILE . 77.8 mt -89.77 149.6 42.37 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.364 -0.835 . . . . 0.0 110.169 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.9 Cg_endo -69.98 160.17 50.6 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.65 1.342 . . . . 0.0 110.452 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.22 122.28 8.57 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.976 1.514 . . . . 0.0 110.503 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.82 -34.97 2.87 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 1.7 mmtm -60.44 158.44 29.52 Favored Pre-proline 0 N--CA 1.5 2.049 0 O-C-N 121.562 -0.963 . . . . 0.0 110.555 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.35 161.58 42.34 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.782 1.412 . . . . 0.0 110.816 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -154.72 159.52 40.75 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.45 -0.781 . . . . 0.0 110.653 179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.641 ' HB3' HG23 ' A' ' 13' ' ' THR . 37.9 m-85 -126.6 144.31 50.94 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.655 -0.653 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 133.71 11.94 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 57.34 29.26 16.56 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.896 -0.767 . . . . 0.0 111.865 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 13' ' ' THR . 12.8 t -173.81 69.84 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 110.595 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -150.33 141.79 23.41 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.997 -1.065 . . . . 0.0 111.045 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.01 11.82 21.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.217 -0.927 . . . . 0.0 110.713 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.713 ' CG2' HD11 ' A' ' 3' ' ' LEU . 8.6 tp -150.15 127.55 5.56 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 110.299 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -78.83 148.5 22.43 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.727 1.383 . . . . 0.0 111.275 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 9' ' ' CYS . 92.5 m -88.64 137.04 32.68 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.654 -0.654 . . . . 0.0 109.495 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -58.24 -39.05 78.11 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.234 -0.916 . . . . 0.0 110.423 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -99.01 -105.78 2.61 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.6 t -135.93 174.51 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.347 -1.09 . . . . 0.0 109.939 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.76 99.78 10.65 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' ASN . 20.9 m -88.89 -132.71 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.633 -0.667 . . . . 0.0 109.735 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.11 74.42 0.12 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.492 -0.755 . . . . 0.0 109.753 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' SER . 0.6 OUTLIER 57.47 48.64 14.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.434 -179.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -167.44 146.71 5.05 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.319 -0.863 . . . . 0.0 111.37 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.5 m -79.7 123.27 27.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.705 -0.622 . . . . 0.0 109.663 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.228 0.537 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.7 p -83.44 168.75 16.24 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.452 -0.78 . . . . 0.0 110.422 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 16' ' ' ILE . 49.8 mt -77.67 148.77 76.92 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.011 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.558 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 44.0 Cg_endo -71.7 157.88 54.59 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.713 1.375 . . . . 0.0 109.957 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.3 Cg_endo -74.43 114.46 4.04 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.885 1.466 . . . . 0.0 110.714 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 122.81 -27.74 5.86 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -57.4 151.85 36.13 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.341 -1.093 . . . . 0.0 110.427 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.28 108.19 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 O-C-N 123.906 1.477 . . . . 0.0 110.721 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.3 t -89.0 145.73 25.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.538 -0.726 . . . . 0.0 110.142 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . 8.3 m-85 -100.29 156.15 17.39 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.482 -0.761 . . . . 0.0 110.606 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 13' ' ' THR . . . -112.59 130.94 9.83 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.4 31.67 15.01 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.86 -0.788 . . . . 0.0 111.342 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' THR . 15.1 t -174.82 59.5 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.39 -0.819 . . . . 0.0 109.807 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.563 ' HB3' ' HB2' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -149.26 122.5 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.316 -0.865 . . . . 0.0 110.916 -179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -90.96 21.31 4.26 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.267 -0.895 . . . . 0.0 110.597 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.83 HG23 HD11 ' A' ' 3' ' ' LEU . 6.9 tp -137.84 119.66 10.8 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -77.78 138.41 16.83 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.702 1.37 . . . . 0.0 111.169 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.561 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 1.4 t -78.6 146.22 34.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.562 -0.711 . . . . 0.0 109.283 178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -50.5 60.73 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.409 -0.807 . . . . 0.0 109.532 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.19 1.44 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.0 t -144.76 177.4 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.493 -1.004 . . . . 0.0 110.111 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' H ' HG12 ' A' ' 21' ' ' VAL . 6.5 t -97.34 112.45 24.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.645 -0.659 . . . . 0.0 110.379 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 t -95.41 -138.69 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.35 76.88 0.38 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.896 . . . . 0.0 108.962 178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.525 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.8 OUTLIER 60.69 35.05 19.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.658 -0.651 . . . . 0.0 110.079 -178.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 2.8 mmpt? -137.87 165.12 27.28 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.46 -0.775 . . . . 0.0 110.615 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 7.6 t -111.83 109.57 19.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.524 -0.735 . . . . 0.0 109.268 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 118.335 -0.84 . . . . 0.0 110.482 -179.793 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.9 tttt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.071 0.462 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.5 p -87.98 172.28 9.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.436 -0.79 . . . . 0.0 110.45 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD12 ' SG ' ' A' ' 18' ' ' CYS . 96.8 mt -90.32 150.18 42.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 47.3 Cg_endo -72.28 161.54 44.16 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.765 1.403 . . . . 0.0 110.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.17 114.51 4.05 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.836 1.44 . . . . 0.0 110.281 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.97 -34.3 2.41 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 5.4 mmtm -58.92 141.16 86.15 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.478 -1.013 . . . . 0.0 110.396 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.3 Cg_endo -72.49 137.77 28.53 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.987 1.519 . . . . 0.0 110.744 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 3.3 p -133.54 163.43 29.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.496 -0.752 . . . . 0.0 110.401 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.7 166.64 11.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.5 -62.31 4.94 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.63 37.46 2.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.558 -0.966 . . . . 0.0 110.296 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m -136.55 73.26 1.45 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -164.13 128.18 2.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.511 -0.743 . . . . 0.0 110.062 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -91.32 24.54 2.9 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.368 -0.833 . . . . 0.0 111.118 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.806 HD12 ' HD2' ' A' ' 17' ' ' PRO . 7.4 tp -124.49 126.71 25.4 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.379 -0.826 . . . . 0.0 110.246 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.806 ' HD2' HD12 ' A' ' 16' ' ' ILE . 52.8 Cg_endo -76.05 124.79 8.19 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.804 1.423 . . . . 0.0 111.091 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 3' ' ' LEU . 1.1 m -90.51 138.65 31.39 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.489 -0.757 . . . . 0.0 109.88 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -58.55 -40.69 83.73 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.478 -0.764 . . . . 0.0 110.236 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.35 -130.37 6.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -132.74 173.34 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.236 -1.155 . . . . 0.0 109.685 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.98 103.59 15.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.446 -0.784 . . . . 0.0 110.455 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 p -133.9 138.25 45.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 56.8 36.13 27.25 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.569 -0.707 . . . . 0.0 110.484 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.06 30.2 17.83 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.577 -0.702 . . . . 0.0 111.406 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 10.5 ptmt -156.01 149.41 24.69 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 9' ' ' CYS . 53.0 m -87.0 128.55 35.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.416 -0.802 . . . . 0.0 110.383 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.413 -0.803 . . . . 0.0 110.612 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 120.664 0.269 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.2 p -67.39 169.08 9.55 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.278 -0.889 . . . . 0.0 110.46 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 16' ' ' ILE . 13.4 mt -79.21 142.23 58.84 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 109.782 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.6 160.91 46.95 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.758 1.399 . . . . 0.0 110.108 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.93 110.7 2.98 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.745 1.392 . . . . 0.0 110.333 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.64 -37.36 2.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -56.76 140.01 76.14 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.42 -1.047 . . . . 0.0 110.092 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.9 Cg_endo -69.47 128.07 15.75 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.64 1.337 . . . . 0.0 111.071 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.6 p -102.27 136.97 41.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.606 -0.684 . . . . 0.0 110.296 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -76.87 154.69 33.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.57 -0.706 . . . . 0.0 110.541 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 101.7 2.7 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 54.6 31.64 15.49 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.754 -0.85 . . . . 0.0 111.053 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 59.4 m -143.35 66.95 1.3 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.426 -0.796 . . . . 0.0 109.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.0 137.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.618 -0.676 . . . . 0.0 110.347 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.55 24.62 2.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 110.685 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.865 HD12 ' HG ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -140.93 113.8 7.01 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.805 . . . . 0.0 109.724 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' N ' HD13 ' A' ' 16' ' ' ILE . 50.9 Cg_endo -73.69 152.54 47.93 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.681 1.358 . . . . 0.0 111.568 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 3' ' ' LEU . 0.6 OUTLIER -82.21 143.11 31.61 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.638 -0.663 . . . . 0.0 109.463 179.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -52.98 57.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.492 -0.755 . . . . 0.0 109.439 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.18 -98.97 1.13 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.6 t -144.57 174.02 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.39 -1.065 . . . . 0.0 110.273 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' H ' HG12 ' A' ' 21' ' ' VAL . 45.9 t -102.84 97.64 7.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.738 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.7 p -136.33 156.45 48.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.0 109.688 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 52.46 33.7 13.74 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 0.0 110.128 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 58.23 42.92 21.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 0.0 110.678 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 ptmt -167.74 163.65 14.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.349 -0.844 . . . . 0.0 111.078 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 35.6 t -88.5 121.19 30.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.683 -0.636 . . . . 0.0 109.626 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.596 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 120.814 0.34 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.445 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.5 p -97.9 169.94 9.3 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.338 -0.851 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.698 HD11 ' CG1' ' A' ' 16' ' ' ILE . 2.7 mt -74.33 136.55 75.29 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 0.0 110.45 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.473 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 40.9 Cg_endo -67.65 163.66 34.24 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.794 1.418 . . . . 0.0 110.644 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 42.6 Cg_endo -69.53 131.88 22.49 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.851 1.448 . . . . 0.0 110.352 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.87 -34.01 4.81 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -59.93 156.69 34.73 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.515 -0.991 . . . . 0.0 110.136 179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.24 169.35 22.66 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.82 1.432 . . . . 0.0 111.085 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 15.3 t -143.74 144.97 32.06 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.644 -0.66 . . . . 0.0 109.406 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -97.89 72.84 2.25 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.0 110.771 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.09 -143.44 37.28 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.65 32.45 5.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.613 -0.934 . . . . 0.0 110.475 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.9 m -135.8 89.15 2.46 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -159.35 147.41 17.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.499 -0.75 . . . . 0.0 110.131 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.22 23.03 3.49 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.335 -0.853 . . . . 0.0 111.171 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.707 HD12 ' HD2' ' A' ' 17' ' ' PRO . 9.0 tp -119.66 120.73 30.4 Favored Pre-proline 0 N--CA 1.498 1.931 0 O-C-N 121.385 -0.822 . . . . 0.0 109.935 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 16' ' ' ILE . 55.2 Cg_endo -76.48 124.63 7.81 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.869 1.457 . . . . 0.0 111.649 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.29 148.27 22.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.441 -0.787 . . . . 0.0 108.92 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.445 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 98.6 m -60.41 -36.94 79.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.232 -0.917 . . . . 0.0 110.413 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.13 -121.92 4.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.7 t -133.28 175.55 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.487 -1.008 . . . . 0.0 109.768 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 34.6 t -97.72 110.99 23.45 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.845 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.9 p -132.17 129.48 39.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.643 -0.661 . . . . 0.0 109.957 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 91.6 m-70 55.95 36.87 28.13 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.618 -0.676 . . . . 0.0 110.42 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 26' ' ' LYS . 2.1 t30 67.56 24.51 8.59 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.787 -0.57 . . . . 0.0 111.091 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 24' ' ' HIS . 1.1 mmmt -127.8 172.15 11.1 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 0.0 109.779 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 1.4 m -126.11 124.66 41.07 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.378 -0.826 . . . . 0.0 109.968 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 118.318 -0.849 . . . . 0.0 110.448 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.229 0.538 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.429 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 9.2 p -148.9 161.6 41.53 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.427 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.649 ' CD1' HD12 ' A' ' 16' ' ' ILE . 92.8 mt -90.49 161.12 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.418 -0.801 . . . . 0.0 110.581 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.36 162.79 41.23 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.914 1.481 . . . . 0.0 110.39 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 46.9 Cg_endo -71.33 112.42 3.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.861 1.453 . . . . 0.0 110.314 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.2 -31.56 2.43 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -55.75 129.28 71.02 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.366 -1.079 . . . . 0.0 110.403 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 45.2 Cg_endo -72.56 130.43 16.0 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.686 1.361 . . . . 0.0 110.847 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 13.3 p -117.15 166.55 12.11 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.605 -0.684 . . . . 0.0 110.336 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.85 172.01 7.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.348 -0.845 . . . . 0.0 110.616 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.33 -74.43 1.07 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.18 30.26 6.07 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.931 . . . . 0.0 110.699 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.9 m -145.37 69.28 1.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.198 -0.939 . . . . 0.0 109.774 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.38 101.21 5.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.757 . . . . 0.0 110.652 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -91.55 25.31 2.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.565 -0.709 . . . . 0.0 110.389 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.649 HD12 ' CD1' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -134.71 131.91 20.39 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.358 -0.839 . . . . 0.0 110.165 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 51.0 Cg_endo -73.33 117.32 5.04 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.83 1.437 . . . . 0.0 110.768 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.2 m -90.5 141.97 28.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.306 -0.871 . . . . 0.0 109.85 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 0.0 OUTLIER -61.4 -45.44 94.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.385 -0.822 . . . . 0.0 110.345 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.61 -123.56 4.2 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.5 t -137.91 174.78 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.609 -0.936 . . . . 0.0 109.599 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m -87.9 98.96 11.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.7 p -133.54 144.07 49.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.537 -0.727 . . . . 0.0 109.863 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 53.11 40.19 30.81 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.594 -0.691 . . . . 0.0 110.663 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.84 32.52 22.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.089 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 7.0 ptmt -159.25 169.6 23.74 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.173 -0.954 . . . . 0.0 110.603 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 21.4 m -103.86 129.72 51.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.77 . . . . 0.0 110.21 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.687 179.784 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.116 0.484 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.6 p -86.61 161.21 18.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.475 -0.766 . . . . 0.0 110.347 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 16' ' ' ILE . 3.7 mp -87.48 149.44 46.61 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.488 -0.757 . . . . 0.0 110.097 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.27 164.6 35.14 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.986 1.519 . . . . 0.0 110.459 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.4 Cg_endo -71.56 123.79 9.76 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.978 1.515 . . . . 0.0 110.021 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.63 -39.81 1.72 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.7 mmtm -56.34 128.92 74.22 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.682 -0.893 . . . . 0.0 109.909 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.16 127.45 11.31 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.7 1.368 . . . . 0.0 110.626 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 142.66 35.13 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.474 -0.766 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -86.51 77.94 9.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.227 -0.921 . . . . 0.0 110.959 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 51.78 -136.22 33.26 Favored Glycine 0 N--CA 1.498 2.832 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.77 30.04 6.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.462 -1.022 . . . . 0.0 110.602 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.4 m -130.98 88.59 2.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.42 -0.8 . . . . 0.0 109.333 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -139.66 132.88 29.82 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 18.44 6.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.363 -0.836 . . . . 0.0 109.796 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.859 HG13 HD11 ' A' ' 3' ' ' LEU . 8.8 tp -139.97 122.99 10.29 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.668 -0.645 . . . . 0.0 109.851 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.556 ' HD2' HD12 ' A' ' 16' ' ' ILE . 50.7 Cg_endo -76.89 130.37 11.36 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.689 1.363 . . . . 0.0 110.921 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 3' ' ' LEU . 12.6 m -83.1 148.0 27.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.75 . . . . 0.0 109.386 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -46.33 83.06 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.243 -0.911 . . . . 0.0 109.841 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 -130.47 6.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.2 t -132.07 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.397 -1.061 . . . . 0.0 109.57 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 25' ' ' ASN . 43.5 t -91.67 97.7 11.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.418 -0.801 . . . . 0.0 110.296 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 t -98.63 113.84 26.06 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 55.63 46.32 22.98 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.506 -0.746 . . . . 0.0 109.089 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 3.0 t30 63.58 36.63 10.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.809 -0.557 . . . . 0.0 110.595 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 3.1 mmpt? -138.49 114.33 9.95 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 110.465 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 18.5 m -71.21 117.18 12.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 109.701 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.515 -179.894 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.179 0.514 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.8 p -118.09 169.82 9.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.426 -0.797 . . . . 0.0 110.647 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD11 HG13 ' A' ' 16' ' ' ILE . 1.1 mp -90.11 158.0 44.7 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.459 -0.776 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 7' ' ' LYS . 46.8 Cg_endo -72.34 158.69 51.07 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.821 1.432 . . . . 0.0 110.126 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.54 122.11 7.2 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.874 1.46 . . . . 0.0 110.844 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.66 -34.74 3.81 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG3' ' HG2' ' A' ' 4' ' ' PRO . 26.3 mmtm -59.65 148.46 74.84 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.544 -0.974 . . . . 0.0 110.1 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' LYS . 43.1 Cg_endo -70.77 136.27 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.728 1.383 . . . . 0.0 110.799 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -111.24 145.98 37.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.798 -0.564 . . . . 0.0 109.487 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -92.87 71.67 4.78 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.363 -0.836 . . . . 0.0 110.562 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.16 -143.94 33.13 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -116.47 48.48 1.27 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.466 -1.02 . . . . 0.0 109.968 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 13' ' ' THR . 12.1 t -150.27 64.67 0.96 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.277 -0.889 . . . . 0.0 110.242 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -138.89 168.15 20.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.355 -0.841 . . . . 0.0 110.275 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 15.8 5.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.333 -0.854 . . . . 0.0 111.246 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 16' ' ' ILE . 7.4 tp -147.48 101.48 3.76 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 110.082 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.56 138.18 23.84 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.523 1.275 . . . . 0.0 111.389 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 t -63.99 145.74 55.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.759 -0.588 . . . . 0.0 109.763 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.52 -50.32 70.29 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.768 . . . . 0.0 109.353 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.36 -96.7 0.89 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 22' ' ' CYS . 1.9 t -144.84 175.57 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.56 -0.965 . . . . 0.0 109.986 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' H ' HG12 ' A' ' 21' ' ' VAL . 38.3 t -105.89 113.61 27.26 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.512 -0.743 . . . . 0.0 110.031 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 26' ' ' LYS . 4.3 t -100.12 -139.57 0.33 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 0.0 109.594 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -70.22 80.14 0.52 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.446 -0.784 . . . . 0.0 110.25 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.65 49.58 8.15 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.768 -0.582 . . . . 0.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 6.3 ptmt -161.8 161.2 29.0 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.292 -0.88 . . . . 0.0 110.74 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.2 t -107.07 112.37 25.27 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.453 -0.78 . . . . 0.0 110.005 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.173 179.822 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.7 tttp . . . . . 0 N--CA 1.496 1.836 0 CA-C-O 121.025 0.44 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.427 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 24.9 p -143.27 169.11 18.25 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.439 -0.788 . . . . 0.0 110.69 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 16' ' ' ILE . 1.2 mt -86.51 135.08 36.69 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.483 -0.761 . . . . 0.0 110.266 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.4 172.37 10.31 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 O-C-N 123.823 1.433 . . . . 0.0 111.011 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.651 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.42 124.89 11.68 Favored 'Trans proline' 0 N--CA 1.488 1.173 0 O-C-N 123.852 1.448 . . . . 0.0 111.004 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.572 ' HA2' ' HD3' ' A' ' 26' ' ' LYS . . . 107.81 6.03 32.98 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.211 -0.995 . . . . 0.0 110.648 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -88.2 152.84 50.92 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.101 -1.235 . . . . 0.0 109.787 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HE2' ' A' ' 7' ' ' LYS . 45.8 Cg_endo -70.99 135.43 27.5 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.73 1.384 . . . . 0.0 111.032 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.26 147.05 49.26 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.578 -0.701 . . . . 0.0 110.01 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.0 m-30 -102.45 173.61 6.27 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.327 -0.858 . . . . 0.0 110.486 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.74 -99.61 0.05 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -106.6 34.72 3.27 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.431 -1.04 . . . . 0.0 110.721 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.6 m -140.41 79.15 1.69 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.287 -0.883 . . . . 0.0 109.768 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG3' HG22 ' A' ' 16' ' ' ILE . 26.9 tt0 -163.48 117.38 1.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -90.91 21.89 3.93 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.434 -0.791 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' ILE . 3.3 tp -131.65 107.23 14.26 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.333 -0.855 . . . . 0.0 109.512 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.6 143.98 35.01 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.743 1.391 . . . . 0.0 111.336 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' SG ' ' A' ' 22' ' ' CYS . 31.4 m -76.38 158.24 31.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.546 -0.721 . . . . 0.0 109.439 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 89.3 m -57.64 -32.16 66.99 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.155 -0.966 . . . . 0.0 109.79 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -114.9 -93.66 1.94 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 22' ' ' CYS . 2.1 t -143.56 178.94 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.603 -0.94 . . . . 0.0 110.083 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.538 ' H ' HG12 ' A' ' 21' ' ' VAL . 1.1 m -104.21 117.55 34.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.279 -0.888 . . . . 0.0 109.958 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.9 p -134.89 128.62 32.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 110.576 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.96 52.64 14.04 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.717 -0.615 . . . . 0.0 110.415 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.31 39.93 31.4 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.657 -0.652 . . . . 0.0 110.226 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HD3' ' HA2' ' A' ' 6' ' ' GLY . 3.8 ttmt -142.78 161.44 38.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.072 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 13.9 m -107.28 106.97 17.68 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 109.633 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.498 1.942 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 179.838 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.166 0.508 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.519 ' HB2' ' N ' ' A' ' 19' ' ' CYS . 7.5 p -119.26 172.98 7.22 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.474 -0.766 . . . . 0.0 110.523 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 16' ' ' ILE . 1.9 mp -84.08 152.69 62.39 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.574 -0.704 . . . . 0.0 110.535 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.54 171.25 13.39 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.996 1.524 . . . . 0.0 110.925 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 27' ' ' CYS . 43.2 Cg_endo -69.4 123.8 10.59 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.939 1.494 . . . . 0.0 110.782 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.76 -24.28 5.5 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 136.67 96.82 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.128 -1.219 . . . . 0.0 110.099 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.09 134.99 18.33 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.661 1.348 . . . . 0.0 111.204 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 11.6 p -110.2 124.9 52.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.0 109.848 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -82.39 88.33 6.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.445 -0.784 . . . . 0.0 110.38 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.32 -156.68 53.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.91 30.87 6.94 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -1.001 . . . . 0.0 110.359 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 m -143.89 90.17 2.11 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.845 . . . . 0.0 109.858 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.99 168.88 22.58 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.86 23.71 2.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -133.51 107.8 12.07 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 109.753 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.79 129.89 4.16 Favored 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.689 1.363 . . . . 0.0 110.529 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.53 149.38 22.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.313 -0.867 . . . . 0.0 110.05 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.519 ' N ' ' HB2' ' A' ' 2' ' ' CYS . 78.3 m -55.28 -43.99 75.24 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.383 -0.823 . . . . 0.0 109.964 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.44 -121.54 3.47 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 1.4 t -139.31 173.5 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.559 -0.965 . . . . 0.0 110.025 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' LYS . 41.9 t -88.9 114.71 25.81 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 0.0 110.054 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 p -133.64 120.75 21.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.56 -0.713 . . . . 0.0 109.406 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 54.1 45.03 28.34 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.534 -0.728 . . . . 0.0 109.523 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.5 ' C ' ' HG2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER 60.42 34.79 20.54 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.763 -0.585 . . . . 0.0 110.685 -179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HG2' ' C ' ' A' ' 25' ' ' ASN . 0.5 OUTLIER -138.13 164.18 29.79 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.413 -0.805 . . . . 0.0 110.182 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 46.2 m -116.43 112.46 21.48 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.37 -0.831 . . . . 0.0 109.695 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.4 p . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.258 -0.901 . . . . 0.0 110.508 -179.804 . . . . . . . . 0 0 . 1 stop_ save_